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ABSTRACT
This thesis aims to investigate the nature and aetiology of Bell's palsy
by studying its natural history and epidemiology in general practice,
and by means of virological studies.
A new hypothesis is outlined of the aetiology of Bell's palsy which
provides a framework for the investigations:-
"Bell's palsy is due to a reactivation of HSV in the geniculate
ganglion. During this process, neurotransmitters (opioid peptides)
and interferon are produced. These cause local vaso-dilation and damage,
particularly to the suprageniculate part of the facial nerve."
This thesis is concerned principally with testing the first part (sentence)
of this hypothesis.
The virological studies set out to examine a possible role for HSV
in Bell's palsy, which is contingent on the belief that HSV is normally
resident or resident to some degree in the geniculate ganglia of the
general population. The evidence of the DNA/DNA hybridization study
suggests that HSV may be ubiquitously present in human cadaveric geni¬
culate ganglia. From these a substantial proportion might be expected
to reactivate. In contrast the observed incidence of Bell's palsy in
the descriptive study of 16.4 per 100,000 per year suggests that if
HSV is a cause the mere occurrence of reactivation is an inadequate
explanation of the disease mechanism.
The epidemiological studies describe Bell's palsy in British general
practice where cases are less strongly selected than in hospital studies.
By means of a case-control study and match-pair analysis further inves¬
tigations are made as to the effect of different factors including various
types of stress in the aetiology of Bell's palsy. The results of these
studies suggest numerous aetiological agents,of particular relevance
to the hypothesis are genetic factors, states of increased "stress"
and opioid "sensivity", which are discussed.
In conclusion the balance of evidence is compatible with the proposed
hypothesis, which in the author's opinion justifies further research,




1.1 Introduction and Definition
To explore the aetiology of Bell's palsy is to explore a fascinating
labyrinth for Nature's clues.
Bell's palsy is named after Sir Charles Bell who first drew attention
to the distribution and function of the facial nerve in 1821. Clinically
it is an acute lower motor neurone lesion. The lesion may be sited anywhere
peripheral to and including the facial nerve motor nucleus, or by contiguity
affect the nerve along this route. Bell's palsy is an 'exclusion diag¬
nosis' and represents between 28-80% of all causes of facial paralysis
(Alberti 1972, ZUlch 1970).
It is widely accepted that the cause or causes of Bell's palsy, also
known as acute idiopathic facial paralysis are unknown. This remains
so despite considerable research, effort, debate and ingenious speculation
into its cause or causes. One hesitates before adding to such a weight
of literature.
'Nature is conservative', it adheres to its own consistent mechanisms
or active processes. Could Bell's palsy have but one mechanism though
its causes may be diverse? The search for uniformity characterizes the
empirical scientific approach. It is worth pursuing in the aetiological
debate surrounding Bell's palsy; though many probably rightly claim its
causes are 'legion', it does not follow that its mechanism is.
ZUlch states, "an unambiguous explanation may never be forthcoming:
different factors may be capable of triggering the same mechanism". His
comments reflect contemporary understanding. The fact that there is
extensive speculation as to the aetiology of Bell's palsy is indicative
that no theory is sufficiently convincing, or is able to resolve conflicting
interpretations of clinical and experimental work. The aetiology must
be one which can produce a sudden facial paralysis with a high probability
of a full spontaneous recovery. It should also explain why the incidence
of recurrent disease is low - less than 10% (Park 1949, Peiterson 1982,
Yanagihara 1984, Pitts 1988).
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Bell's palsy also attracts wider controversy. Ambiguities of
definition remain. Should Bell's palsy be considered a mono- or poly¬
neuropathy? Is- the lesion sited in the intratemporal portion of the
facial nerve, in the brain-stem or both? Should the presence of diabetes
result in its exclusion from this diagnostic group, or is Bell's palsy
sometimes a diabetic mono-neuropathy?
In 1916 Patrick observed facial diplegia with polyneuritis and
questioned the clinical dividing line with Bell's palsy diplegia
(paralysis ex-frigore). In 1919 Antoni suggested Bell's palsy was a
sub-category of acute infectious polyneuritis and described 5 patients
with Zoster vesicles who had facial paralysis and polyneuritis. This
idea is further supported by Friedman 1970 and McCormick in 1972. Adour
in 1978 in a study of 150 patients with Bell's palsy noted a high incidence
of other cranial nerve involvement. Of 48 consecutive patients in this
series,19% had a trigeminal involvement, 19% had glossopharyngeal
involvement and a further 29% had both nerves involved. The author
states that, "the basic problem is a lack of understanding that acute
facial paralysis is not a localised disease of the 7th cranial nerve
but a variant of acute benign cranial polyneuritis". In this context
it would have been more correct to state,"not confined to the 7th cranial
nerve", rather than 'localised', as evidence exists for an anatomically
discrete lesion of the 7th nerve in Bell's palsy patients. Fisch's
findings of damning of axoplasm with an electroneurographic block
(obtained at operation) at the narrow entrance to the Fallopian canal
incriminates the suprageniculate part of the Facial Nerve in patients
with acute Bell's palsies (Fisch 1982). This has proved a fascinating
but contested observation. However further support has come from O'Donoghue
at Oxford who also noted damming of axoplasm at the entrance to the
Fallopian canal (O'Donoghue 1985). Esslen (1977) postulates that local
anatomical factors provide congruence for palsies of different aetiologies,
and suggests the term acute facial palsies of meato-labyrinthine
localization, as a substitute for the term Bell's palsy.
In an Israeli study Korczyn 1971 found abnormal glucose tolerance
tests or overt diabetes in 66% of 130 Bell's palsy patients. Pecket
in 1982 postulated that Bell's palsy should be considered as a diabetic
mononeuropathy. It could be argued that a facial paralysis associated
with diabetes cannot be idiopathic as it is secondary to diabetes.
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Conversely to exclude the diabetic group is to presume Bell's palsy
cannot occur in diabetics. It is against such a background and uncertain¬
ties that any aetiological theory has to be measured.
1.2 Historical Review of Aetiological Theories
Sir Charles Bell, surgeon to the Middlesex Hospital and principal of
the Great Windmill Street School of Anatomy first drew attention to
the anatomical features and function of the 7th cranial nerve. He
described it as the respiratory nerve in order to emphasize what he thought
was its main function. In a book on the nervous system Bell (1830, revised
1883), later outlined his collected works on the facial and other nerves
(principally the 5th). With time Bell's name became attached to facial
paralysis, and initially described all cases of facial paralysis no
matter what the cause.
In 1836 Berard postulated that a "rheumatic neuritis" in which the
swollen nerve pressed against the walls of the Fallopian canal, was the
cause of Bell's palsy.
In 1909 Ramsay-Hunt described hypoaesthesia of the face in association
with 'refrigatory facial paralysis'. Interestingly the trigeminal (5th
cranial) nerve was not implicated at the time, even though Sir Charles
Bell had by then defined the sensory function of the 5th nerve. It was
believed that denervation of stretch-receptors in facial muscles must
account for this symptom. However since they have only been found
in the extrinsic ocular muscles such a statement would appear to be
stretching credulity! Numbness of the face is however an ambiguous term
for patients and needs careful interpretation.
Some of the earliest aetiological concepts of Bell's palsy centred
around the idea that it was secondary to a sub-clinical infection of
the middle-ear space. This was proposed by Reik in 1904. He recommended
that all patients with the disease be seen by an 'aurist'. These studies
demonstrate the importance of excluding middle ear pathology, and indeed
other pathology along the course of the nerve in Bell's palsy. Bell's
palsy has become redefined with advances in understanding; the diseases
to which facial paralysis is secondary have grown leaving the idiopathic*
group to become smaller.
* Gr. idioiraOeia, Galen 1640 - a disease not preceded or occasioned
by any other, a primary disease.
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1.2.1 The cold hypothesis - a or ex-frigore
This is one of the hypotheses accepted by Sir Charles Bell, namely that
exposure to dralight or chill results in a paralysis. This is still
supported by Zlllch (1970) who believes rapid cooling or chilling may
produce Bell's palsy. Other writers refute these findings. In a review
of this theory by Diamond and Frew (1979) the authors state "The enclosure
of the nerve in the Fallopian canal should be a protective advantage
as far as cold injury is concerned, and the adjacent cranial and cervical
nerves would appear to be immune from this proposed lesion". This line
of thinking presumes that cold injury may only be direct, and ignores
the possible effect of the body's physiological response to cold-stress.
Although it may be argued that few physicians today take this theory
seriously, some respect should be afforded to a traditional explanation
in the author's view.
1.2.2 Genetic factors
Although it has long been known that Bell's palsy tends to run in families
(see p.142) very few control studies have been done. Recent interest
has centred on a possible association of certain HLA types, particularly
BW67 and Bell's palsy (Shibahara 1988).
1.2.3 Vascular theories
In 1936 Audibert proposed that vascular factors e.g. thrombosis or
vasospasm, could be aetiologically linked with Bell's palsy. He was
further supported by Kettel in 1947. Later Hilger in 1949, Sullivan
and Smith in 1950 and'also Blunt 1956, concurred with the belief that
an initial local vasospasm occurred in the region of the external carotid
and its branches to the mastoid segment of the nerve. The result was
primary ischaemia which produced transudation and a rise in intraneural
pressure. This caused a block, or impedance of the arterial blood supply
to a larger segment of the facial nerve, and secondary ischaemia sufficient
to produce the symptom of paralysis.
Motivated by the belief in a primary vascular cause, Cawthorne and
Haynes (1956) advocated surgical decompression of the nerve (mastoid
segment), as treatment in selected cases. Whatever the merits of this
technique there is no doubt that surgical exposure of the nerve throughout
its intratemporal course has yielded much useful, though often conflicting,
information.
5
Early attention centred on decompressing the mastoid segment, and
later the vertical and suprageniculate parts of the facial nerve. The
modern view is .that the disease process occurs most often at the entrance
to the Fallopian canal (Fisch 1982), with the labyrinthine portion of
the facial nerve being supplied by branches from the anterior inferior
cerebellar artery (A.I.C.A.); and branches from the petrosal and geniculate
ganglion arteries.
Cervical sympathectomy enjoyed a short vogue as a surgical treatment
for Bell's palsy. It was introduced by Korkis in 1959. Fearnley in 1964
demonstrated that cervical sympathetic block was of no value - a disappoint¬
ing finding in terms of treatment, and a difficult one to explain if vasospasm
were involved (with the lesion lying in the territory of the external
carotid).
Janetta in 1978 postulated that Bell's palsy is due to the facial
nerve being compressed by a loop of A.I.C.A., suddenly shifting in the
cerebello-pontine angle and stretching the nerve. Such may be the case
in a small percentage of Bell's palsies: but it is surely limited as
an explanation in being perhaps too "accidental", and in the detail which
it fails to embrace.
A vascular aetiology is also supported by such independent authorities
as Bosatra 1956, Fowler 1958, Williams 1959, Kettel 1959, Jongkees 1972,
Miehlke 1973 and Calcaterra 1976.
In support of a vascular aetiology are the sudden onset of the
paralysis, usually in several hours, although acute demyelination of
viral onset may also be rapid; and lack of a marked cellular infiltra¬
tion in most pathological studies. The suprageniculate localization
of the lesion, as estimated by nerve conduction studies, cannot be
explained so easily by a demyelination model. The central/peripheral
myelin junction is near the brain-stem in motor nerves and does not
coincide with the proximal level of nerve block observed by Fisch.
Although animal experiments and clinical studies exist (Calcaterra
1976), which show that ligature or embolization of the arterial supply
to the facial nerve produces a paralysis, to say this is the cause of
Bell's palsy is to confuse what is possible with what is probable.
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Bell's palsy patients do not appear to be suffering from thromboembolic
disease nor if vasospasm is the cause is the frequency of recurrent
attacks as high, as would be predicted for such a mechanism (cf. migraine
and Raynaud's disease).
In conclusion and despite the appeal of some aspects of vascular
theories, it must be stated that firm evidence for a primary vascular
cause of Bell's palsy is lacking.
1.2.4 Immunological theories
Immunological theories concentrate on the mechanism of nerve injury
and not the causes. Some authors believe Bell's palsy to be a forme
fruste of Guillain-Barrd syndrome - although CSF protein levels are
normal in Bell's palsy patients. Charous and Saxe noted in 1962 that
oedema of the 7th nerve and degeneration was present in both conditions.
They further remarked that both have a spontaneous onset and rapid recovery,
often with preceding symptoms of a viral illness. The observation of
multiple cranial nerve involvement in Bell's palsy lends further weight.
The main proponent of the auto-immune theory is McGovern who in
1966 published results of animal experiments. The facial nerves of
dogs sensitized to horse serum showed a more severe facial paralysis
with histological evidence of more severe nerve damage after injection of
saline, horse serum, and epinephrine into the Fallopian canal than in
non-sensitized dog controls. The intensity of oedematous response
appeared to be related to the loss of perivascular mast-cells (McGovern
1977).
In 1975 Abramskey noted the lymphocyte response to neural antigen
PIL was positive in in-vitro studies in Bell's palsy patients and
Guillain-Barrd patients only. 26 control patients with 7th nerve
palsies of different aetiologies were all negative.
In 1982 McGovern put forward the idea that Bell's palsy should
be considered an "immunopathophysiological" reaction. The reaction
is one of immediate-type hypersensitivity in which "the role of the mast
cell and the release of vasoactive amines induced by antigen-lgE
interaction, and other immune-complexes are well understood". He
further cites experimental evidence of the control of neural oedema
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by the use of cromolyn sodium.
1.2.5 Viral theories
The viral hypotheses gain most weight from the fact that some facial
palsies are undoubtedly produced by viruses. Some authors believe
Bell's palsy is a Herpes Zoster (VZV) infection without an auricular
rash, a more cryptic variant of Ramsay-Hunt syndrome (Herpes Zoster
oticus). Aitken and Brain in 1933 demonstrated complement fixing
antibodies to VZV in 4 of 22 cases of Bell's palsy without a rash. Mair
in 1976 found 9 of 133 patients with peripheral facial palsy to have
elevated VZV antibody levels. 7 of these patients were Ramsay-Hunt
syndromes but 2 had neither a rash or auditory symptoms. Djupesland
(1977) found evidence of elevated VZV antibody levels in 9 of 51 patients
and Tomita in 1972 found evidence of rising titres in 18% of 247 patients.
However Berg in 1976 in 44 patients found VZV antigen only in those
patients with Ramsay-Hunt syndrome.
Other viruses incriminated by antibody studies include Influenza
A (Brodie 1979), Influenza B (Djupesland 1977), Mumps (Saunders 1959),
Rubella (Fowler 1963), Adenovirus (Brodie 1979), RSV (Brodie 1979),
Mycoplasma P1 (Brodie 1979), Polio (Menkes 1974), HTLV (Wiselka 1987).
Herpetoviridae include CMV (Mair 1983), E.B.V. (Grose 1973, Mendonca
1973, Weintraub 1976) and HSV which will be discussed later. One patient
in this study developed a Bell's palsy after taking the polio-Sabin
vaccine (see case report p-.124).
Viral theories have found further support from Djupesland (1977),
who performed C.S.F. studies and found a mild lymphocytic pleocytosis
with moderately elevated proteins.
Some antibody studies have shown negative results and these include
Dodge and Pokanzer 1962, McCormick 1972 and Korczyn 1973, Mees 1981,
Traavik 1983. Viral culture and electron microscopy studies of geniculate
ganglion cells in one Bell's palsy patient showed no evidence of growth
or nuclear structures compatible with HSV or CMV viruses (Palva 1978).
Even when results are taken from those studies showing most positive
results, still approximately jrds of cases show no evidence of a recent
viral infection.
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Aviel in 1983 studied 32 patients with Bell's palsy by measuring
serum alpha interferon levels in patients who showed no evidence of acute
intercurrent viral infection. 66% had higher than normal IFN levels
(normal < 16 u/ml) at the first examination. During the first three
days IFN levels were highest (mean 95 u/ml) with a sharp decline on
the 4-6th days, and a return to normal values from the 7th day onwards.
Antibody levels to HSV and VZV did not show any changes at repeated
examinations. Aviel concludes that an unusual virus may be the cause,
or a latent reactivation of HSV should be considered. Jonsson (1989)
found that the content of IFN in the serum of patients with Bell's palsy
was increased in both acute (n = 46 p < 0.5) and convalescent (n = 46
p < 0.05) stages as compared with 17 control subjects. He concludes
that this may indicate a low-grade antiviral response that may reflect
the reactivation of a viral infection.
With respect to a route of entry into the C.N.S., Blatt (1966)
proposed that an ascending viral agent entered through taste receptors
to produce inflammation of the chorda tympani nerve. May (1978) suggested
that a viral agent could lead to the observed retrograde pathology producing
strangulation of the facial nerve in the Fallopian canal. This route
may be particularly important when considering HSV as a cause.
It is worth remembering that other infectious agents than viruses
may produce apparently idiopathic facial paralysis e.g. Lyme disease -
borrelia burgdorferei, which is one of the commoner causes in the New
Forest area.
1.3 Origins of Present Studies
1a3.1 HSV as a cause of Bell's palsy?
Herpes Simplex Virus (type I) was first postulated as a cause of Bell's
palsy by McCormick in 1972. He based his theory largely on the evidence
of experimental animal work which described the behaviour of HSV in
the nervous system. However he believed HSV to "reside" in the axon
of the peripheral nerve where it was unaffected by neutralizing antibody,
and from which it subsequently 'ruptured'. It is the modern view however
to implicate the ganglia rather than the axon as the favoured site of
residency by HSV. Adour in 1975 and 1978, using evidence from antibody
and epidemiological studies further developed the idea of herpes simplex
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reactivation as a cause of Bell's palsy. Adour states "we looked by
computer-assisted statistical methods for a factor that could cause
polyneuritis, and that could be found in all of our patients with Bell's
palsy. The only factor common to all patients tested for its presence
were antibodies to herpes simplex virus". He further notes that a high
but stationary titer to herpes virus is seen in recurrent or reactivated
herpes virus infection. Adour interprets his work as being commensurate
with HSV reactivation occurring in patients with Bell's palsy, and points
to a lack of evidence to support the notion of a primary infection, although
sporadic reports do occur in the literature (Smith 1987, Ghonim 1988).
Vahlne in 1981 using C.F., envelope-antigen radioimmunoassay and capsid-
antigen radioimmunoassay in 142 cases and 53 controls came to similar
conclusions as Adour. IgM levels showed no statistical difference between
the groups.
Adour noted from his epidemiological studies that Bell's palsy like
cold sores (a recrudescence of HSV infection)* was associated with
menstruation, pregnancy, stress and preceding respiratory infection.
Adour (1978) quoting his own work (1975, 1976) states "these studies
indicate rather conclusively that herpes simplex virus is causative
in idiopathic facial paralysis". His findings are of considerable
interest but his assertions lack validity. Firstly he presents no
evidence that the association is a causative one. Secondly on probability
grounds the high prevalence of HSV in the indigenous population, > 90%
by the 4th decade of life (Nahamias 1973), mitigates against a
straightforward argument. Thirdly the epidemiological study was based
on a pre-selected group (insurance based) operating within the terms
of an American open-access type referral system. Fourthly a point of
confusion in Adour's work appears to be that he does not emphasize herpes
labialis as a recrudescence of HSV, a process which must include reac¬
tivation of HSV and other active processes (asymptomatic viral shedding
has a point prevalence of 5% in the general population - reactivations
are relatively common without demonstrable e.g. cold sore lesions).
Adour's analogy between neural reactivation of HSV in Bell's palsy and
cold sore lesions,thus remains arguably inspired guesswork. Nonetheless
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The hypothesis of HSV reactivation is very difficult to either
prove or disprove. Biopsy of the facial nerve in patients suffering
from facial par'alysis is not an ethical approach, although the geniculate
ganglion and chorda tympani nerve have been biopsied. Thus far the
Koch-Henld postulates for an infective cause of Bell's palsy remain
unfulfilled. No infective agent has been constantly associated with
the pathological condition or found "mostly but not inevitably in the
lesions". In Bell's palsy such verification may be limited by having
a number of aetiological agents rather than being a single disease
entity.
Antibody studies often the mainstay in confirming a specific viral
aetiology are problematical when studying a reactivation rather than
primary infection of herpes simplex. This is because:-
a) Most of the population under study are over 30 yrs old with
high C.F. antibody levels to HSV in this group approaching
100%. (Nahamias 1973).
b) A rise in level may indicate infection elsewhere e.g. cold
sores, genital herpes, keratitis etc.
c) It is well established that reactivations of the virus (neural)
may occur without a demonstrable rise in antibody levels which
are often already high (Ross 1975, Corey 1986).
Nonetheless many workers have examined for HSV using serological tests
in Bell's palsy patients. See table (1) opposite.
General support for the HSV reactivation hypothesis is gained
from HSV induced demyelination in animal models; the rabbit-eye 5th
nerve model (Kristensson 1979) ; and the mouse-ear model (Hill 1983).
The lesions produced show broad similarities with those observed in
Bell's palsy. Neither animal is a natural host of herpes simplex, and
such artificiality should be considered in extrapolating to the situation
in human HSV infection. Vahlne in 1985 further discusses HSV induced
demyelination in animals as a model for Bell's palsy and also other
diseases such as multiple sclerosis.
Most recently in 1988 Thomander using a mouse-tongue model success¬
fully isolated HSV from the geniculate ganglion. He writes that 3 days
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after inoculation "50% of the facial nerves, 30% of the trigeminal ganglia
and all brain stems were infected. Because of difficulty with the dis¬
section of the -temporal bones, it is most probable that the geniculate
ganglion was not obtained from all animals".
A possible method to test the hypothesis of HSV reactivation arises
from observations in human post-mortem sensory ganglia. Baringer first
isolated HSV from human trigeminal ganglia by co-cultivation in 1972.
Since then a number of workers have isolated herpes simplex from other
primary afferent sensory ganglia including the vagus, cervical sympathetic,
thoracic, coeliac and sacral ganglia by a variety of techniques.
To date there has been no successful isolation or detection of HSV from
the geniculate ganglion (obtained from temporal bones), or from the facial
nerve in humans. The finding of the virus in the geniculate ganglion
indicating persistence (latency) in the normal population would in the
author's view allow the advancement of HSV reactivation, as a cause of
Bell's palsy as a more substantial hypothesis, since the virus must be
latent in a proportion of the normal population if it is subsequently
to reactivate. If however the virus could not be identified at such
a site using a reliable control method, this would be against such a
hypothesis, to quote Popper's dictum the "hypothesis would be falsified".
(This argument is expanded under aims and objectives, p. 40).
A criticism of the above method might be that although Adour explicitly
states HSV reactivation is the mechanism in Bell's palsy, this notionally
might occur in other afferent sensory ganglia or at other sites in the
C.N.S. Immunological damage at a distance from the culpable ganglion
whilst leaving its immediate environment relatively intact would appear
to be an unnecessary embellishment of such a theory. Especially since
aetiologically Bell's palsy must by definition affect the facial nerve
at least more often than any other cranial nerve. Thus in the author's
opinion possible residency of HSV in the C.N.S. with respect to Adour's
hypothesis and his own, is respectively best, and must be tested at this
site (geniculate ganglia). Since Adour's supporting observations stem
primarily from observations about recrudescence of HSV (cold sores),
then he is in fact using a model of local destruction by HSV virus.
Surely for his analogy to be valid some predominantly local mechanism
of tissue destruction is still required in the C.N.S. This seems to
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the author an inconsistency in Adour's apparent distaste for the evidence
which implicates the facial nerve in the proximity of the geniculate
ganglion in most instances.
The technique to be employed by the author, co-cultivation and
DNA probing are however less sensitive methods than serological tests.
1.3.2 The need for further epidemiological studies
There is a need for Adour's work to be repeated by an epidemiological
study from this country. What information is available about the natural
history of Bell's palsy has come primarily from hospital studies such
as Brodie's (1979), with only sporadic reports coming from general practice
(Grout 1977, Presley 1978). Seymour (quoted by Fish 1977) states:-
"Because of the lack of adequate record keeping for this type of disease
in Australia, I attempted to obtain information regarding treatment
and incidence by sending a questionnaire to 3,000 of our general prac¬
titioners. This has been done because the practitioner treats primarily
Bell's palsy".
As yet no study from this country has looked at the natural history
of Bell's palsy by using a case-finding method involving large numbers of
general practitioners. Combined with a case-control study and match-
pair analysis Adour's findings can be further tested. Such a study
would also have the advantage of describing the natural history in a
different type of population than is usually examined in hospital studies.
1.3.3 The value of a case-control study
1) Where the evidence for a hypothesis is weak there is a need to
have as many sources of information as possible.
2) The study would augment the viral work proposed (temporal bone
studies).
3) By looking for "triggers of reactivation" in cases and controls
give an idea of the probability of the "reactivation hypothesis".
The temporal bone studies in contrast would give an idea of "resi¬
dence" also known as the persistent or latent state.
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4) To look at histories of cold sores between the groups. This is
a development of McCormick's (1972) suggestion that differences
in cold sore history should be observed between Bell's palsy cases
and controls. This examines recrudescence.
5.) The need to assess the value of other aetiological factors (than
linked with the hypothesis).
1.3.4 The value of a descriptive study
1) A community based study would contribute to the understanding of
the natural history of Bell's palsy.
2) Would give a clearer idea of the incidence with implications for
the temporal bone study.
3) Would provide a background against which the hypothesis could be
discussed.
4) Need to repeat Adour's work using a different denominator.
Adour's work also needs to be repeated by an antibody study to see if
high (but stationary) antibody levels to HSV exist in Bell's palsy patients
- a state observed during HSV reactivations.
1.4 Summary
Existing research is inconclusive as to the cause or causes of Bell's
palsy. Whilst appreciating that widely divergent views are held about the
aetiology it is the author's observation that in recent years a
viral cause has been sought by most researchers. May (1987) writes
"accumulating evidence supports a viral inflammatory immune mechanism".
Of viral aetiologies the HSV model proposed by McCormick and developed
by Adour is arguably the most viable (or less arguably - difficult to
disprove). Difficulties in finding methods to confirm or refute this
hypothesis have been discussed. Of these the author faovurs two main
areas of enquiry. Firstly a temporal bone study to determine if HSV
resides in the geniculate ganglion of the normal (deceased) population
(a reasonable assumption of a reactivation hypothesis). Secondly by
supporting this work with epidemiological studies in Bell's palsy cases
and controls which looks for associations with factors which are known
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The author's own hypothesis is an original development of McCormick's
and Adour's ideas, and is used not only in directing the research but
also and primarily as a means of making sense out of existing research
about Bell's palsy.(see chapter 3).




The Nature of Bell's Palsy
2.1 Summary P.eview
The purpose of this chapter is to consider aspects of the clinical and
pathological nature of Bell's palsy. The first part describes the clinical
features of Bell's palsy. The evidence for the site of the lesion is further
discussed first in relation to conduction studies, and secondly in relation¬
ship to clinical assessment of polyneuropathy in Bell's palsy. Prognosis
and outcome complete this section. In the second part the evidence
for the site of the lesion is again examined along with curious features
of the pathology.
To some extent the contents of this chapter must represent an arbi¬
trary selection from a large topic area, representing fact and speculation.
Aspects of the nature of Bell's palsy are covered elsewhere in the thesis
particularly under the background to the epidemiological studies.
2. 2 Clinical Features
2.2.1 Symptoms in Bell's palsy
Apart from facial weakness these include:- auricular pain and tenderness
which may precede the paralysis by several days. The pain may be felt
within the ear or over the mastoid and occiput, and occasionally in the
jaw and neck, and even over the whole side of the face and neck. About
50% of patients with Bell's palsy complain of pain in the ear or headache.
Pain is thought to be of bad prognostic significance by Taverner 1959
and McGovern 1966, but conflicting evidence was found by Park and Watkins
1949 and Jongkees 1973.
Taste to the anterior two-thirds of the tongue is through the chorda
tympani branch of the facial nerve. Lesions of the chorda tympani or
proximal facial nerve often produce very discrete defects of taste sensa¬
tion which the patient can localise accurately. About ird of patients
with Bell's palsy have this symptom. (Byl & Adour 1977).
Taste loss may precede the paralysis by days, as may occipital head¬
ache. Lacrimation may appear to be increased in Bell's palsy but this
is mainly due to mechanical factors. The drooping lower lid impairs
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the drainage of tears through the nasolacrimal ducts. This may be tested
using Schirmer's test. A dry eye may be the result of a lesion proximal
to the greater -superficial petrosal nerve. Crocodile tears and gustatory
sweating occur in less than 10% of patients with Bell's palsy. Vertigo
may be associated with Bell's palsy as studied by Rauchbach (1975). The
patient may complain of rotational vertigo or 'dizziness' and spontaneous
nystagmus may be noted.
2.2.2 Features of L.M.N, lesions of the face
LMN lesions of the facial nerve are distinguished from UMN lesions clini¬
cally by involvement of the frontal belly of occipito frontalis. A
useful classification of UMN lesions is found in Mathews and Miller
(1975). UMN lesions produce a shock period of flaccidity followed by
spasticity of the facial muscles. Loss of the nasolabial fold is often
observed. LMN lesions may produce a paralysis or a stimulation of the
muscles inervated. The paralysis is usually of sudden onset, with the
patient often noticing it on waking. It is often at its worst within
48 hrs and electroneurographic studies show 90-98% degeneration of fibres
reached by the 14th day (Fisch 1983).
The motor paralysis usually affects the whole of one side of the
face and the severity may be graded. (See fig. 10,9). Facial asymmetry
is noted with loss of forehead creases, and the nasolabial fold, and
inability to close the eyelids. The corner of the mouth droops and
this is more noticeable whilst smiling, and is a problem to the patient
whilst eating and drinking.
2.2.3 The somatic sensory function of the facial nerve
This sensory function of the facial nerve is confined to a small area
of skin in the external auditory meatus, and neuralgic pains in the ear
may be relieved by division of the nervus intermedius (of Wrisberg).
This is the region in which Zoster vesicles occur in Ramsay-Hunt syndrome.
2.2.4 Further signs in Bell's palsy
Bell's phenomenon may be observed - named after Sir Charles Bell who
described it in 1829. The patient he described had a traumatic facial
palsy and was unable to close the eye. An upward rotation of the eyeball
was observed; this is in fact a normal movement on closing the eyes.
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In some patients when asked to look up, the eyeball goes up higher than
on the non-paralysed side. This is Negro's sign and is thought to be
an attempt by the ocular and palpebral levators to compensate for the
defective contractility of the occiptofrontalis muscle.
When the orbicularis oculi is involved Dupuy-Dutemps sign may be
observed which is the gradual opening of the eyelid after the patient
has been asked to look downwards and close his/her eyes tightly.
The Bergara-Wartenberg sign or reflex, which is the vibration of
orbicularis oculi in normal people when lightly pressed with a finger,
may be absent as an early sign of involvement of the temporal and upper
zygomatic branches of the facial nerve.
2.2.5 Differential diagnosis
Lower motor neurone paralysis of the face includes a wide differential
diagnosis. It may be a symptom of serious intracranial disease, such
as a tumour in the cerebello-pontine angle, metastatic deposits, multiple
sclerosis or a brainstem infarct. As the facial nerve passes through
the temporal bone it may be damaged by fractures or during surgical
procedures. It may be produced by otitis media, acoustic neurofibroma,
or carcinoma of the middle ear or exhibit the Ramsay Hunt syndrome as
a result of Herpes Zoster (although there is some evidence that this
latter condition is a brain stem syndrome and nothing to do with geni¬
culate herpes). Extracranial causes include tumours of the parotid
gland, trauma or such general conditions as polyneuritis, mononucleosis
and sarcoidosis. Of all causes of facial palsy the commonest are injuries
of the nerve at various levels, otitis media especially associated with
cholestectoma, and the Ramsay Hunt syndrome.
Headache is most frequently found in LMN facial palsies associated
with chronic ear disease and its onset may be of great clinical significance
(indicating involvement of the meninges). Neoplasms of the middle ear
with dural involvement often give rise to temporal headaches. Acoustic
neuromas and posterior fossa tumours produce occipital headaches. Although
acoustic neuromas often cause considerable pressure on the facial nerve
this seldom gives rise to facial weakness (R.T. Ramsden personal communica¬
tion) .
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Viral infections of the CNS may cause a meningo-encephalitis and
prodromal symptoms include general malaise and headache. Migrainous
type headaches may be associated with transient facial palsies often
with paraesthesia of the face (Pearce 1975). Such headaches are usually
extremely severe and associated with nausea and vomiting as well as
other focal neurological deficits.
Apart from serology and conduction studies few investigations are
performed for a straightforward case of Bell's palsy. Time may be used
both in a diagnostic and therapeutic sense providing the clinician is
satisfied that he or she is not missing any potentially serious or correctable
causes.
2.3 Clinical Evidence of Polyneuropathy in Bell's Palsy
Adour (1976) states that other cranial nerves are involved in Bell's
palsy. In 40% of patients he noted a vestibular disturbance (8th nerve),
35% had an abnormal gag reflex (9th nerve) and in 25% facial numbness
was noted (5th nerve).
In 1978 Adour records the incidence of 5th nerve and 9th involvement
in 48 consecutive patients. 19% had 5th nerve only^ 19% 9th nerve only
and 29% had both.
Bell's palsy may not affect exclusively the 7th cranial nerve but
may also be part of a widespread cranial and even peripheral neuropathy
(Adour 1975, Djupesland 1977, Lundgren 1977, Adour 1978, May 1978, Sandstedt
1981, Nieuwmeyer 1982, Odkvist 1982, Abdel-Baki 1988). Adour argues
that hyperacusis is not due to stapedial muscle involvement but is a
feature of recruitment and is due to cochlear or retrocochlear lesions,
which he found in 10% of patients with Bell's palsy (Adour 1978).
Pietersen (1982) has noted phonophobia in 12% of cases. Abnormal ENG's
have also been recorded in Bell's palsy.
In conclusion the evidence that Bell's palsy can sometimes be part
of a polyneuropathy seems without doubt. The strength of the association
is difficult to assess however. Selected patients might be expected
to have an artificially high frequency of polyneuropathy, and this is
discussed further in the results section (p.158).
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2.4 The Evidence of Conduction Studies in Bell's Palsy for the Site
of the Lesion
Broadly speaking these studies are indicative of multifocal and sub¬
clinical disease in Bell's palsy. Adour in 1975 demonstrated in his
patients that 50-75% had pathological nerve conduction on the opposite,
uninvolved side. Although clinical simultaneous bilateral palsies are
very uncommon (about 1% in most series).
2.4.1 Trigeminal evoked potential
Hanner in 1986 showed that 47% of patients with Bell's palsy had an
abnormal response suggesting a lesion somewhere along the trigeminal
nerve and tracts into the sensory cortex.
An abnormal blink reflex (described by Kugelberg 1952, Kimura 1983)
was found in 60% of patients. In 2 patients in Hanner's study a TEP
was pathological but the B.R. was normal suggesting a more central trigeminal
affection and may demonstrate multifocal lesions. Of the 60% with abnormal
blink reflexes 24% had a solitary brain stem lesion (R & R components
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generated in the brain stem) whereas 36% had trigeminal involvement
as part of a cranial polyneuropathy and or with a brain stem lesion.
Vahlne (1985) produced corroborative evidence stating that of 28
patients with Bell's palsy who were extensively neurologically examined
57% showed evidence of brain stem impairment or cranial polyneuropathy.
The most frequent abnormality was an impaired contralateral corneal
reflex.
There is a close anatomical relationship between the facial tract
and the trigeminal nuclei and there may be coordinating functions between
the facial and trigeminal neuronal systems (Hanner 1986). In Hanner's
study 14 out of 17 with a complete palsy had trigeminal dysfunction
but only 6 of 13 with an incomplete palsy had a corresponding trigeminal
dysfunction. Facial pain which is arguably a bad prognostic criterion




Takahashi (1985) discovered preparalytic conditions of the facial nerve
by evoked electromyography. 2 patients with herpes zoster oticus who
had developed vesicles but with no apparent paralysis showed abnormal
EMG responses (low amplitude, short duration). The interesting
conclusions from this study are that sub-clinical or preparalytic
pathology exists with herpes oticus and by inference with other
speculated causes of Bell's palsy e.g. HSV.
2.5 Assessing Prognosis and Outcome
A detailed method has not been used in this study to assess facial nerve
function but rather the paralysis has been graded either complete or
incomplete. Pietersen (1982) showed that of 1,071 patients from
Copenhagen collected over a 15 year period, complete paralysis was
noted in 69% of patients and incomplete in 31% of patients.
The chances of complete remission decreased with each decade with
90% recovering at 0-14 yrs, 85.6% at 15-29, 76% at 30-44, 61% at 45-
59 and 37% over 60 years.
Pietersen used the following detailed grades to assess outcome:-
0 No associated movements.
1 Slight palsy and contracture less than 1mm just visible without
associated movements.
II Moderate palsy with clearly visible contracture and associated
movements.
III Severe palsy with disfiguring palsy and associated movements.
IV Complete atonic facial palsy without contracture and associated
movement (no cases seen).





From Pietersen's study it appears that complete remission occurs
in 30%, at 1 month after the onset of the palsy, is slow from the 3rd
week to the 3rd month and then tails off to 6 months as recovery
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approaches 100%. Most patients with incomplete paresis obtain
remission within 1 month.
Pietersen found that idiopathic and pregnancy groups have the best
prognosis. 75% without sequelae (other groups zoster, diabetes,
polyneuritis and neonates) have sequelae in 75%.
Diabetic patients have been noted to have a more severe nerve
injury and a less favourable outcome. (Adour et al 74 - 2 refs).
Adour calculates the extra risk to be 3X greater of developing
degeneration (diabetic v. nondiabetic). Younger and older diabetics
appeared to be at equal risk.
Pain is a symptom in 62% of patients with Bell's palsy. When the
pain is limited to the occipital (retro-auricular) region it has no
prognostic significance. However when the pain is in the ear canal,
face or neck the patients are at higher risk of denervation. The time
delay in starting therapy in Bell's palsy also significantly alters
the prognosis (Taverner 1971).
2.6 The Pathological Nature of Bell's Palsy
The pathology is reviewed because the findings represent 'hard evidence'
in an area where all aetiological hypotheses should have a sure base.
Furthermore the pathological findings themselves are both central and
difficult to explain in the aetiological controversy around Bell's
palsy.
2.6.1 Surgical appearances of the nerve
The macroscopic appearances of the nerve in Bell's palsy is based
predominantly on the operative findings of surgeons performing decom¬
pression operations. Hilger (1949) states "that the usual finding upon
surgical exposure is oedema of the nerve with the trunk most tightly
constricted by the nerve sheath at its point of issuance from the
stylomastoid foramen". Cawthorne's findings are in agreement, he also
noted swelling of the nerve above the stylomastoid foramen. At the
site of constriction haemorrhagic streaks were noted running
longitudinally.
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Kettel (1947) noted that the nerve in Bell's palsy was swollen
in 28 cases out of 50 operations. At operation (in patients within
2 months of onset of the palsy) "there was always a strong swelling,
mostly with a fierce redness of the nerve sheath". In older cases there
was less congestion and the redness had disappeared. In some long standing
cases marked atrophy of the nerve was described as "looking like a silk
thread".
Macroscopic findings in recent years of swelling of the facial
nerve have focused on the suprageniculate part of the nerve. Fisch (1983)
states that at decompression operations damming of axoplasm can be seen
at the entrance to the fallopian canal where the diameter is narrowest
in 19 out of 20 cases. His findings have aroused considerable interest.
O'Donoghue (1985) also reported a case of Bell's palsy where these same
appearances were noted.
2.6.2 Descriptive pathology in Bell's palsy
Histological examination of the nerve in Bell's palsy has been under¬
taken very few times, since it is a non-fatal condition and biopsy
impairs function.
Minkowski (1891) noted in a 27 year old man who died 8 weeks after
the onset of a facial palsy normal appearances of the facial nerve from
the nucleus to the geniculate ganglion. In the most external part of
the Fallopian canal however there was a very marked degeneration. The
axon cylinders were mostly intact but the medullary sheaths were
greatly swollen. He noted at the point of departure of the chorda
tympani the greatest part of the fibres were degenerated.
Dejerine and Theorai (1897) found changes similar to Minkowski
with no evidence of inflammation.
Alexander (1902) noted round cell perivascular infiltration along
the endoneurium as far proximal as the geniculate ganglion. He states
there was no evidence of inflammation in the perineurium and endosteum.
No mention is made of vessel engorgement.
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Mirallid (1906) observed globules of myelin in various sizes peri¬
pherally with absence of axon cylinders.
Andrd Thomas (1907) found evidence of peripheral Wallerian
degeneration and stated "11 n'existe nulle part de perineurite ni
d'endoneurite". A finding which still holds true today and which
should therefore preclude the use of the term 'neuritis' when applied
to Bell's palsy. Mills (1910) also found no evidence of inflammation
in an 80 year old patient.
In more recent times Fowler (1963) reports the histology of a patient
dying with a palsy of 14 days duration. The sections were performed
serially on the decalcified temporal bone and mounted in collodium.
"The left seventh nerve was most unusual. Its entire course
contained or was surrounded by dilated and engorged veins and
venules. Degeneration of the myelin sheath and axis
cylinders was more or less apparent in the entire intra-
temporal course of the nerve. There were small fresh
intraneural haemorrhages here and there on both sides of
the stylomastoid foramen and all along the fallopian canal.
The arteries and arterioles looked normal ... Most striking
and unexpected were the fresh haemorrhages in and around
the facial nerve in the internal acoustic meatus between the
region of the normal vestibular ganglion (Scarpa's) and the
narrow bony channel of the porus acousticus proximal to the
geniculate ganglion. Here there were several quite large and
separate intraneural haemorrhages as well as general infil¬
tration of the nerve with red blood cells. No evidence of
inflammation of any kind was found".
The author supposes the haemorrhages noted in the suprageniculate part
of the nerve to be due to the widespread vascular disease found in the
patient and not part of the disease process. Since he does not cite
evidence of other endoneural haemorrhages this interpretation remains
hypothetical.
Fowler continues "Some of the ganglion cells of the geniculate
ganglion stained more palely than the normal side and some of them look
pyknotic. If disease was present in the ganglion it was neither impressive
nor conclusive". The stump of the facial nerve as it entered the brain
stem was also examined and found to be normal.
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Jongkees (1972) noted swelling of the facial nerve at the genu
with a swollen chorda tympani nerve. This latter was biopsied. Prof.
Deelman noted "no sign of inflammation can be found anywhere. Nor
is there increase in the number of cells. The nerve fibres are dis¬
tinctly at least locally degenerated". Jongkees concludes from the
macroscopic and microscopic evidence that it is quite acceptable to
make the assumption of an acute vascular disturbance followed by
degeneration.
Proctor, Cargill and Proud (1976) reported on the histology of
a patient dying with Bell's palsy on the 10th day - the patient dying
of a cardiac arrest on the operating table, the surgeons's intention
being to decompress the nerve.
They note phagocytosis of myelin by macrophages, beginning of axonal
swelling, increased cellularity due to lymphocytic infiltration, and
a moderate proliferation of Schwann cells and fibroblasts. These changes
are evident throughout the entire course of the facial nerve from the
internal auditory meatus to the stylomastoid foramen. No information
was obtained from the nerve at brain stem level as only the intratemporal
course of the nerve was examined. Adour (1978) contests Proctor's
findings by stating that Bell's palsy "may represent inflammation and
demyelinization rather than ischemic compression". Proctor notes "acute
inflammatory changes in the nerve trunk with subsequent swelling and
compression of the vascular channels in the fallopian canal". The use
of the word "subsequent" by Proctor appears as an unsupported rationali¬
zation in this context.
Proctor also notes "markedly dilated blood vessels accompanying
the swollen chorda tympani nerve" but there was "absence of evidence
of vascular occlusion".
Fisch (1983) in a study involving 6 biopsies of the greater super¬
ficial petrosal nerve noted lymphocyte infiltration in 3 patients. In
the 3 geniculate ganglia studied the appearance was normal and there
was no evidence of degeneration in the unmyelinated fibres whereas 5
of the 6 biopsies showed moderate to severe degeneration of the myelina¬
ted fibres.
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The most recent post mortem report in the literature is O'Donoghue's
(1985). In contrast to most earlier studies large numbers of lympho¬
cytes were noted infiltrating the geniculate ganglion. Michaels the
pathologist involved writes (1987), that the specimen showed "a geniculate
ganglionitis possibly of viral origin with secondary periostitis of
the adjacent bony canal". The histopathology of Bell's palsy is further
reviewed by Liston (1989).
2.6.3 Discussion
The pathology of Bell's palsy is markedly understudied due to obvious
difficulties in obtaining specimens.
Most studies have failed to show an acute inflammatory response
which is a significant finding in a condition of abrupt onset. Proctor,
O'Donoghue and Mills all noted a small round cell infiltration however.
Vascular dilation particularly of the venules with congestion and
haemorrhage has been more consistently noted.
Is the pathology thus outlined consistent with a viral aetiology?
Unfortunately most virus infections do not produce diagnostic lesions.
They may produce cell necrosis, cell proliferation or no lesion at all
in the case of latency. "Neuronophagia" is seen in polio C.N.S.
infections and phagocytosis of neuronal debris by macrophages is indeed
noted in Bell's palsy. The lack of a heavy small round-cell infiltra¬
tion and meningeal perivascular cuffing is against certain types of viral
infection (e.g. polio). It is interesting that Schwann cell proliferation
has been noted but not so far, gliosis.
Electron microscopic studies of the geniculate ganglion for viral
inclusion particles have been inconclusive (Palva 1978).
The pathology supports a vascular process as part of the disease
mechanism but whether it is primary or secondary is not clear. What
is clear is that there is no evidence of thrombosis or vessel occlusion
in the vasa nervorum. Curiously inflammatory cells and lymphocytes are
not present in most cases.
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The anatomical site of the lesion in Bell's palsy is also a subject of
controversy. The evidence that the brain stem is involved comes princi¬
pally from evoked potential studies. The evidence of other nerve involve¬
ment comes principally from further nerve conduction studies and clinical
examination. In contrast the localised nature of the lesion is emphasized
by operative findings - ^he macroscopic appearance of the nerve". This
is supplemented by Fisch's work (1983) on intraoperative electroneuro-
graphy showing a conduction block near the entrance to the Fallopian
canal. These findings are also supported by the pathological reports
of the infratemporal portion of the facial nerve in Bell's palsy cases.
The evidence appears sufficiently strong to support the idea that
Bell's palsy is a localised disease of the 7th nerve and also
quite often part of a generalized disease process. It is quite possible
to interpret the evidence in conflicting ways. Firstly that it supports
the notion of multiple aetiological agents in Bell's palsy - making
it a type of syndrome. Or alternatively that like atheroma for example,
localised disease may exist as part of a generalized process, in a more
florid form as a result of anatomical, mechanical, and other factors.
The author inclines to the economy of the second view, with the narrow
entrance to the Fallopian canal making "strangulation" and ischaemia




The Aetiology of Bell's Palsy - Hypothetical Considerations
3.1 Introduction
The purpose of this chapter is to discuss an original hypothesis for
a pathomechanism in Bell's palsy. The first hypothesis is a develop¬
ment of the hypothesis proposed by McCormick and Adour that Bell's palsy
is due to reactivation of HSV but at a defined site, in the geniculate
ganglion1; as a result of which further events are proposed to happen2.
This "extension" or wholly new hypothesis is drawn from a wide area
of existing research.
The value of including it within the context of the thesis is primarily
as a means of attempting a fuller or more cogent explanation of the
curious facts of Bell's palsy. That is, it is an attempt to incorporate
a wider body of research into the explanation of observed clinical events.
Events which in the author's opinion are not adequately explained by an
HSV reactivation hypothesis alone.
However because of the dangers inherent in attempting to link hypo¬
theses the author has formulated his own research in the logical order
of testing the first unproven hypothesis first, and the scheme for this
is outlined in the next chapter under aims and objectives. Testing the
second part of the hypothesis requires further research and this is dis¬
cussed in the final chapter. Thus in terms of a research base this chapter
stands alone from the rest of the thesis, but provides it with a wider
framework for interpretation.
A Mechanism in Bells Palsy
Due deference should be given to the difficulty of finding a solution
to the cause or causes of Bell's palsy when considering the enormity of
the historical debate. Although the linked hypotheses here discussed,
present many difficulties they present 'a substrate' from which the
'analytical appetite' may feed with appropriate scepticism. However to
continue with the metaphor, excessive scepticism in the search for meaning
can result in 'anorexia', just as too little may result in 'obesity'. In
the aetiological debate around Bell's palsy rival theorists often hold
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on to a flimsy certainty whilst being dismissive of alternative accounts.
It is hoped that the linked-hypotheses here outlined by maintaining some
of the strength-s of opposing arguments, and by taking cognisance of some
of the 'curiosities' of Bell's palsy achieves a way of reconciling the
evidence, rather than simply being syncretic statements of belief.
3.2 Hypotheses
1) That a viral agent resident in the geniculate ganglion, most probably
H.S.V., undergoes reactivation in response to a biological stimulus -
"stress".
2) This results in a production of interferon and opioid peptides which
have a local vasoactive effect. This effect is most marked where the
nerve is bathed in CSF (also where these peptides have a longer half-
life). The concentration of peptides is biologically variable. In those
individuals particularly sensitive to opioid peptides this may lead to
loss of local autoregulation, and where anatomical factors impede venous
return in the swollen nerve - such as at the narrow entrance to the
Fallopian canal more severe damage to the nerve (rather than dysfunction)
may be expected. The damage to the nerve will be variable depending on
the degree of vasodilation produced and its duration. This mechanism
would be compatible with a conduction block in most instances with
degeneration only occurring when the nerve is "strangulated" - using the
hernia analogy by the narrow entrance of the Fallopian canal (see Figs.3,1,
3,2). It has been shown in cats that increasing the pressure inside the
nerve is detrimental to the function of the nerve (Devreise 1972)
The linked-hypotheses are multifactorial incorporating viral, vascular
and constitutional elements. It is in essence an abnormal local
"physiological " response induced by a virus i.e. an exaggeration of the
"stress" response. Since this virus-induced disorder of physiology is
the basic "event" of the mechanism, antibody responses to the virus may
not be significant as observed with HSV neural reactivations.
Interferon and opioid peptides may be produced by physiological as
well as diverse stimuli (Bocci 1985). These stimuli include other infec¬
tious agents than HSV. Also glucocorticosteroids inhibit the production
of interferon and its actions, pyrexia stimulates it (Isaacs 1962).
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Figure 3.2: Hypothesis in algorithmic form
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Thus the second part of the hypothesis could be "triggered" separately
and be considered independent of the suggested first mechanism. The
main direction of research has followed amassing more evidence for the
HSV reactivation hypothesis on the grounds that some definite mechanism
for inducing the interferon/opioid system is needed for the second
part to be a viable proposition and that on the basis of research already
discussed in relation to the aetiology of Bell's palsy the HSV reactivation
hypothesis seems most worthy of further scientific enquiry; and preceding
pyrexia is also of some interest.
3.3 Viral Factors in Bell's Palsy
It is known that at least in some instances Bell's palsy may be associated
with a viral infection. Furthermore Fisch has made the interesting
observation that the level of facial nerve injury is suprageniculate
in over 90% of cases. This also corresponds with the part of the nerve
that is bathed in CSF (see fig. 3.1) and does not correspond with the
central/peripheral myelin junction. Fisch theorizes (1979) that this
may be due to the actions of concentrated viral "toxins" on the nerve
root. The idea seems an attractive one apart from two faults. Firstly
there is no evidence that CSF is concentrated around nerve roots, and
secondly and more significantly viruses do not produce "toxins" as such
(typically this is a property of bacteria). Fisch thus gives important
information about the site, and his ideas about a local "toxin" deserve
development where this is possible.
A virus in a geniculate ganglion neurone might be expected to act
by increasing cell production of viral protein and/or host cell
proteins, including interferon. It is not unreasonable to suppose that
an infected ganglion cell might produce excessive quantities of
neurotransmitter. Although little is known of the neurotransmitters
of primary afferent neurones, substance P, dynorphin, and opioid-like
immunoreactivity have all been found. (North & Egan 1983, Sweetnam
et al. 1982, Boticelli 1981, Jessell 1979). It is also known that the
tractus solitarius (fig. 3,2) is an autoradiographic 'hot spot' for
the enkephalins (Kuhar & Uhl 1979, Miller & Cuatrecasas 1979).
As a working assumption it will be supposed that a percentage of the
geniculate ganglion neurones normally produce opioid peptides. The
fact that this group of transmitters requires mRNA for synthesis unlike
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most other types of neurotransmitter renders it particularly compatible
with a viral mechanism.
There is no doubt that interferon is produced by cells infected
with numerous viral agents including H.S.V. Elevated levels of y
and a interferon have been observed in the CSF as an early response
in HSV encephalitis (Meyer 1986, Frei 1988, Lebon 1988). It has also
been observed that serum interferon levels are raised in Bell's palsy
patients. There are no studies to date of CSF interferon levels in
Bell's palsy.
Further interesting work comes from Blalock (1984) who noted that
when lymphocytes were stimulated with mitogen both interferon and opioid
peptides were produced simultaneously. He concluded that there is
considerable interrelatedness between the immune and neuroendocrine
systems, and this is supported by earlier work (Blalock 1980, 1981).
Furthermore he also noted antigenic and structural relatedness between
y endorphin and human leukocyte interferon. This intriguing relationship
between interferon and opioid peptides is worthy of careful consideration
when extrapolating to the ganglionic "reactivation" scenario.
It is speculated that either geniculate ganglion cells or in some
cases lymphocytes are the source of interferon and opioid peptides in
the pathogenesis of Bell's palsy. Lymphocytes have been shown to be
ubiquitously present in trigeminal ganglia (Ball 1982). According to
Hill (1983) "whether such immune cells are present as a response to
reactivation of latency, or whether they are concerned with maintenance
of latency, remains to be established",
3.4 Interferon as a "Neurotoxin"
It is known that neuropathies occur in patients taking high dose inter¬
feron therapy, even when using highly purified forms (Nethersell et al.
1984). The authors of this paper also noted that 3 patients with painful
bone metastases required less analgesia on interferon therapy. This
observation seems to be in keeping with the mechanism of interferon
induced CNS toxicity as discussed by Bottomley (1985). She argues that
the work of Blalock (1980, 1981) suggests that "potent endorphin like
opiate activity of a-interferon may be related to CNS toxicities experienced
during therapy in humans".
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Disorders of taste and smell have also occurred in patients taking
purified interferons (Inigmarsson 1979, Mattson 1983, Gutterman 1982,
Laszlo 1983, Sarna 1983). That interferon has been shown to produce a
neurotoxicity affecting the taste pathways is of considerable relevance
when interpreting the clinical picture of Bell's palsy. Firstly because
a viral mechanism is considered a strong possibility; secondly because
elevated interferon levels have been observed, and thirdly because a high
proportion of Bell's palsies have an associated taste disturbance.
Numbness and tingling as part of a peripheral neuropathy are noted
both in Bell's palsy patients and in those on high dose interferon therapy.
Mattson (1983) noted slowing of motor and sensory conduction velocities
recorded by electromyography in patients receiving intravenous interferon.
Fever and fatigue noted in patients on interferon are also observed in
some patients prior to developing a Bell's palsy
All this raises the intriguing possibility that the clinical picture
of Bell's palsy may be due in part to a neurotoxic effect of interferon
or a related mediator (opioid peptide). There is broad support for this
idea from Mattson's work; she states that there is the "possibility that
endogenous IFN plays a role in the pathogenesis of virus-induced encephalo¬
pathy and neuropathy". Since intravenously administered interferon does
not cross the blood-brain barrier its effects could well be mediated by
endorphins. However if the geniculate ganglion were the site of "infection"
in Bell's palsy - then this should be considered part of the peripheral
nervous system. The argument would then be that both interferon and endor¬
phins could be released into the C.S.F. or have neurological effects on
local vasculature.
A high local concentration of interferon and opioid peptides might
thus be found in the ganglion cells and the C.S.F. bathing the supra-
geniculate part of the facial nerve as a consequence of HSV reactivation.
This could produce a neurotoxicity of the chorda tympani nerve and a dis¬
order of taste sensation. Where intravenous interferon is given however
neglible concentrations of interferon in the CSF might be expected and
a lower incidence of neurotoxicity.
How interferon produces a neurotoxicity may be further considered.
Most of the neuropathies observed have been reversible when the dose was
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decreased or stopped. This squares with a vascular mechanism of nerve
"damage" (amongst other possibilities). Nothing is known of the effect
of interferon on the cerebral circulation although a interferon produces
a marked flare response when injected intradermally. This was observed
in 5 patients by the author whom he skin-tested prior to their being
treated for laryngeal papilloma (see appendix 4c). If it could be demon¬
strated that this effect were mediated by a cell of neuroectodermal origin
this would greatly increase the salience of these observations in support
of the hypothesis. (The merkel cell may be a mediator of opioid induced
skin flushing. Do similar cells exist in ganglia and/or the CNS and behave
in broadly similar ways?).
A further interesting study showed paradoxical effects of interferon
on reactivation of oral infection with herpes simplex virus after micro¬
vascular decompression for trigeminal neuralgia (Ho et al. 1984). This
study suggests interferon may actually precipitate or accentuate herpes
reactivation. If this is the case then this would result in a rewording
of the hypothesis such that interferon and opioid peptides would be
produced by some process prior to reactivation which when this occurs
further amplifies this process.
3. 5 Opioid Peptides and Vascular Responsiveness
The physiology of opioid peptides is extremely complex with ever
increasing amounts known since their discovery in 1975 (Kosterlitz 1975,
Hughes 1975, 1977, Goldstein 1976) and their physiology and pharmacology
are reviewed by Lord 1977, Guillemin 1978, Spence 1984, Thompson 1984
and Miller 1979. They are characterised by a short half life in plasma,
usually less than a minute, but this is prolonged significantly in C.S.F.
(by a factor of 3 or 4 for the enkephalins). Because of this short
half-life they are thought to act as local messengers or cybernins,
and their complex pharmacokinetics makes it difficult to assess local
activity e.g. in the C.S.F. around the facial nerve from blood tests.
The term opioid peptide is used generically throughout the thesis and
it is accepted that this is an imprecise way of relating information.
It is serendipitous for the hypothesis therefore that from the little
that is known about the effects of these peptides on the cerebral
circulation most of the evidence is consistent in indicating loss of
vessel wall tone, irrespective of the opioid peptide studied.
(Hanko 1978, Partridge 1981, Baskin 1981, Dashwood 1978, Koskinen 1983,
Moore 1979).
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In Hanko's study on cat pial artery blood vessels, dilation was
produced in a dose dependant manner by enkephalins and morphine in vitro.
This vasodilation was blocked by naloxone suggesting the presence of
opiate receptors on the vessel walls. Increasing the dose of leuenkephalin
from 2 pmol/ml to 11 pmol/ml was sufficient to cause 50% dilation of the
vessel wall. These concentrations indicate high activity at very low
concentrations (similar to the vascular action of interferon). This paper
is limited in being an in~vitro study, which alters the compliance of
the vessel wall (this usually decreases) compared to in-vivo studies.
Knoll in 1976 showed an effect of enkephalins on the ear artery of
the rabbit by acting on a specific presynaptic neuronal receptor. The
receptors involved in such studies if specific would be jj receptors
for morphine or 6 for leuenkephalin. However dynorphin 'the most likely
opioid peptide' to be found in afferent ganglia would act on K receptors.
Further experimental work by Koskinen and Bill 1983 has shown that
morphine can increase cerebral blood flow in some parts of the rabbit
brain, (e.g. by up to 30% - the hippocampus). Interestingly this is also a site
of predilection of HSV within the CNS (Esiri 1982) and the taste and smell
pathways are typically involved in interferon neurotoxicity (Mattson 1983).
Are these merely coincidental observations or is there a viral-cellular
connection?
Facial flushing induced by chlorpropamide and alcohol can be blocked
by naloxone suggesting a role for enkephalins in arterial dilation in
humans (Leslie 1978, 1979, Barnett 1980, Johnston 1984) but contested
by Kobberling 1980. Although the plasma I.R. enkephalin level rises this
is not thought to be the mechanism,but rather by an action of chlorpropamide
and alcohol on autonomic ganglia. Could 'intracranial flushing' also
be occurring? Facial flushing is known to occur in the distribution of
branches of the external carotid (Leslie and Pyke 1978). The external
carotid artery does supply some intracranial areas including areas supplied
by the stylomastoid artery, (a branch of the posterior auricular artery)
and the petrosal artery and artery to the geniculate ganglion - (the
latter being branches of the middle meningeal artery). The artery to
the geniculate ganglion divides and one branch runs proximally along
the facial nerve to the porus acousticus supplying the labyrinthine
section as do branches from the anterior inferior cerebellar artery,
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a branch of the internal carotid (Nager 1953, Ogawa 1982, Proctor 1982)
Thus it is quite conceivable from the anatomy that flushing around the supra-
geniculate part of the facial nerve occurs during this process (C.P.A.F) and that
like facial flushing some individuals are more sensitive to this process.
The conclusion would be that this group are "constitutionally sensitive"
for the development of a Bell's palsy. This sensitivity is also much
commoner in non~insulin dependent diabetics.
As a development of the C.P.A.F observations as a model for Bell's
palsy, further comments can be made with respect to the hypothesis. Namely
that to be a valid mechanism in Bell's palsy the vasodilation in Bell's
palsy would have to be related to "centrally controlled pathways involving
autonomic ganglia" - such as the cranial parasympathetic outflow and ganglia.
In this respect neurones in the geniculate ganglion directly innervating
the local cerebral circulation might provide the link whereby such
vasodilation might be produced. It is known that the parasympathetic
outflow of the 7th nerve passing through the geniculate ganglion is
the main parasympathetic innervation of the cerebral blood vessels.
A viral reactivation in cells of this pathway might result in excess
production of neurotransmitters (opioid peptides) which would be
inhibitory to fibres maintaining the tone of the vessel wall - usually
noradrenergic fibres (sympathetic). A sustained vasodilation might
well be produced for longer than an effect where neurotransmitters were
acting directly on the vessel wall. With such a mechanism sympathectomy
would be ill-advised.
Many other substances normally produced by cells are capable
of vasodilation. Prostaglandins might be locally increased by an action
of interferon. Mora (1984) showed that indomethacin reduced the side
effects of intrathecal interferon and concluded that interferon induced
prostaglandin formation (other than E2) in brain tissue. Some prosta¬
glandins vasodilate and others vasoconstrict. Although the role of
Prostaglandin E2 in recrudescent HSV (cold sores) seems now established,
the possible role of these arachidonic acid derivatives in Bell's palsy
aetiology remains unknown. Substance P might vasodilate or constrict,
depending on the circumstances. Tullo in 1983 using experimental herpes
simplex keratitis in mice noted that levels of substance P dropped quicker
and for a longer period in inoculated mice than mice controls (which
only had scarification of the cornea). Tullo suggests this may be due
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to destruction of nerve endings by virus or by some inflammatory mediator.
Considering HSV is rapidly transported to the trigeminal ganglion, Tullo
speculated that- damage to the nerve cell body may also have occurred.
It is thus unlikely that substance P is a significant mediator of a
vascular response in HSV infections. However opioid peptides if increased
locally (ganglion or cornea) would inhibit substance P release, thus
providing a fourth possible explanation of Tullo's findings. Given
the complexity of cellular pathways it is impossible to exclude effects
produced by these and other substances. It is the author's opinion
that a stronger case can however be made for interferon and opioid
peptides as 'primary mediators'. Other reasons for considering opioid
peptides particularly salient are that there is a peculiar anatomical
relationship of the nerve swelling to the geniculate ganglion suggesting
a "toxin" which is more active or prolonged on blood vessels bathed
in CSF than those which are not. Furthermore ACTH in high doses is
a worse treatment than prednisolone in comparably high doses for Bell's
palsy (Taverner 1971). "The evidence for this is statistically
unassailable" according to Groves (1979). On careful consideration
of why this should be apart from slight differences Na+ concentration
may make to receptor binding, is the reasonable conclusion that ACTH
which has opioid activity, is in some way involved in the disease
process.
Further arguments come from epidemiological considerations of
different types of stress in the aetiology of Bell's palsy. These
arguments are discussed in more detail in chapter 11. Can stress be
considered to be acting in so simple a way as producing a reactivation
of HSV,or are the possible effects of stress more complex as the outlined
hypothesis might suggest?
3.6 Difficulties with the Overall Hypothesis
The main argument against the hypothesis is that it is 'too general',
and therefore unlikely to be the cause of a relatively rare condition.
It is too general on account of HSV being ubiquitous affecting
almost 100% of the population. Primary infection with the virus occurs
principally in 0-5yr olds and 15-20yr olds whereas Bell's palsy is
commoner in 6-12yr olds and 20-35yr olds (Fisch 1979). Furthermore
"stress" which is difficult to quantify, is also commonplace in society
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and its effects are diverse on cellular pathways. All cells are capable
of just about any response. The key question is, are the responses
likely to be significant in a pathophysiological sense?
Further difficulties with the present hypothesis are that it is
difficult to either prove or disprove. Little is known of the neuro¬
transmitters present in the geniculate ganglion and whether they are
as vasoactive in humans as they appear to be in animals. Systemic
levels of opioids are by no means indicative of what might be happening
locally to the facial nerve.
A further problem with the HSV reactivation model acting by trig¬
gering a vascular response is the fact that HSV produces demyelination
at several sites in the C.N.S. where the 'strangulation model' can less
readily be evoked. So general factors would be needed for the vascular
mechanism proposed to produce nerve damage elsewhere. These would have
to include:-
1) good blood supply to nerve of "sensitive" vessels
2) thin walled veins such as the cerebral veins prone to collapse
(leGros Clark W.E. 1965)
3) no lymphatic drainage (no lymphatics in the skull or vertebral
canals)
4) high Basal Metabolic Rate
5) proximity to cells which can produce interferon and opioid peptide
(vasodilators) and their release from those cells by a virus
"infection" or other trigger
6) anatomical factors likely to cause compression e.g. a narrow
entrance to the Fallopian canal.
In summary it would appear that the hypothesis is almost too general
to entertain seriously. However there are forceful features and curiosities
of the clinical condition which defy explanation except by such a hypothesis
and furthermore it is consistent with the way viruses and in particular
HSV are likely to act.
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3.7 Summary of Supporting Features of Hypotheses Parts (1) and (2)
3.7.1. Primarily supporting part (1)
1) Animal models e.g. mouse ear, tongue, rabbit-eye of HSV induced
demyelination in C.N.S.
2) Finding of HSV in afferent (autonomic) ganglia in animals and man
e.g. geniculate in animals but geniculate in man?
3) Antibody studies incriminating HSV in Bell's palsy.
4) Epidemiological studies of factors common to Bell's palsy and cold
sores e.g. upper respiratory infection, stress and menstruation.
3.7.2 Support for linking hypotheses parts (1) and (2)
1) If a viral agent is involved in the aetiology of Bell's palsy
particularly HSV then activation of the interferon/opioid system
does not involve a quantum leap of credibility.
3.7.3 Primarily supporting part (2)
1) Elevated interferon levels have been observed in Bell's palsy
patients. High interferon levels have been observed to produce
neuropathies.
2) The site of the lesion as observed by Fisch is difficult to account
for by traditional explanations and is indeed a sticking-point for
most theories. However opioid peptides would be expected to act
more forcefully on the CNS side of the ganglion than the infra-
geniculate part, and perhaps explain why Fisch has found a ratio
of nerve damage of 19:1, suprageniculate:infrageniculate.
3) Association of Bell's palsy with N.I.D.D. Some studies show a strong
association between Bell's palsy and diabetes. It has been proposed
that N.I.D.D. may be due to a genetically determined state of increased
opioid sensitivity (about ird of N.I.D.D.'s are opioid sensitive
compared to VlOth of the general population). The chlorpropamide-
alcohol flushing model is a particularly interesting one in relation
to the aetiology of Bell's palsy and of considerable relevance
to the hypothesis. In effect the mechanism could explain the
association of the two conditions.
4) The polyneuropathy observed in Bell's palsy patients and abnormal
electroneurological tests could be explained partly by increased
endogenous interferon production.
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5) The treatment of Bell's palsy has brought to light a curious finding.
Taverner's 1971 study showed that ACTH was worse treatment than a
comparable dose of prednisolone. This perhaps suggests that ACTH
or opioid receptors are sometimes involved in the disease process.
6) Sudden onset; and also a general lack of inflammatory cells in
pathology studies suggest a vascular event as the main part of
the mechanism. Both interferon and opioid peptides can produce
a marked vasodilation in low doses.
3.8 Summary Statement
This multifactorial linked-hypothesis resolves some of the viral/vascular
traditional hypothesis conflicts in as much as it is predominantly a vascu¬
lar response, and not an "acute inflammation", occurring in response
to a viral initiated event, which in sensitive individuals produces
sufficient nerve dysfunction or damage to be noticeable to them.
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CHAPTER 4
Proposed Research: Aims and Objectives
4. 1 Abstract of Hypothesis
The hypothesis of how facial nerve injury might come about in Bell's
palsy can be divided into two parts:-
a) Bell's palsy is due to a reactivation of HSV in the geniculate gang¬
lion .
b) During this process, neurotransmitters (opioid peptides) and inter¬
feron are produced. These cause local vasodilation and damage to
the suprageniculate part of the facial nerve.
The research proposed is directed towards testing the first part (a) of
the hypothesis. Part (b) of the hypothesis provides a further possible
explanation of how Bell's palsy might come about when considering
diverse sources of information from different research disciplines.
The testing of this part of the hypothesis is beyond the scope of this
thesis. It is however relevant to the work of the thesis when trying
to understand if factors supposedly acting by triggering "reactivation"
e.g. menstruation and "stress" actually do act in this way. The second
part is an original mechanism suggested by the author, but drawn from
the research work of others, which it is hoped adds interest to the
discussion, and against which results may be interpreted. In keeping
with the general principle known as Occam's Razor* the thesis will aim
to test the first part of the hypothesis only.
4.2 The Aims of the Research
1) To examine for the presence of HSV in the geniculate ganglia of a
proportion of the general population.
2) To test, by clinical method, evidence which appears to link HSV
infection, particularly recrudescence and reactivation, with Bell's
palsy; and also examine for associations, other factors of suggested
aetiological relevance.
* Entia non sunt multiplicanda praeter necessitatem (entities ought
not to be multiplied except from necessity).
William of Ockham (d.1349)
44
3) To contribute to knowledge about the incidence and nature of Bell's
palsy. As seen in less strongly selected, more community based
patients than hospital studies.
4.3 The Objectives of the Research
Objectives concerned with achieving the first aim
1) To remove the temporal bones of patients dying of natural causes.
To examine the geniculate ganglia for the presence of HSV:-
a) by isolation of HSV - a cocultivation study
b) by examining for the presence of HSV genome - a DNA/DNA
hybridization study.
2) To examine the trigeminal ganglia removed from the same cadavers
as a means of assessing the methods outlined above. Only one attempt
has been recorded in the literature using cocultivation on geniculate
ganglia and none for DNA/DNA hybridization, whereas the literature
using trigeminal material is more extensive.
Objectives concerned with the second aim
3) To use a case-control study to examine for differences between
cases and controls by means of match-pair analysis. The exposure
to factors studied would be:-
a) history of cold sores (recrudescence)
b) history of HSV exposure (primary infection and other recrudes-
cent lesions)
c) factors known to be associated with reactivation/recrudescence
including humoral factors
d) other aetiological factors.
4) To do an antibody study to assess if "high antibody levels to HSV"
are found in Bell's palsy cases. Where possible to use paired
antisera to see if these levels are stationary.
Objective concerned with the third aim
5) To describe the clinical features of Bell's palsy by means of history
and examination in a case finding study based in general practice
over a 1-year period. To make inferences about the incidence and
clinical nature of Bell's palsy.
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4.4 Discussion of the Aims and Objectives
Aims 1 and 2 are hypothesis testing (see chapter 3 for further details
of hypothesis)." The third aim is an expansion or development of the
second aim beyond hypothesis testing and standing in its own right.
The first aim sets out to test the belief -
"That HSV resident (persistent or latent) in the geniculate ganglion,
reactivates to produce a Bell's palsy".
Implicit in the first part of this statement is the assumption that
HSV resides in the geniculate ganglia of a proportion of the general
population. From which a proportion could reactivate and from these
a proportion could develop a Bell's palsy.
To be a valid hypothesis HSV must be found to be actually present
in a proportion of cadaveric geniculate ganglia removed from people
dying of natural causes. Given that a reliable and sensitive method
of identification is being used, and that an adequate sized sample is
taken.
Because it was predicted that the first aim would provide only
limited evidence for the hypothesis, the second aim was developed.
"To use clinical method to explore the HSV reactivation hypothesis".
The first aim being limited in being "detection" rather than recrudes¬
cence or reactivation orientated. The limitations of the first aim
in hypothesis testing and the need for clinical supplementation are
best understood when considering possible outcomes in terms of imagining
frequencies of detection in the ganglia for the general population.
1) Higher identification rate in ganglia of the general population
than predicted from epidemiological, clinical and virological studies.
This would imply that the hypothesis is either not valid or that
factors not considered in part (1) of the hypothesis are important.
2) Identification rate in ganglia of the general population commen¬
surate with epidemiological, clinical and virological predictions.
This would be compatible with a valid hypothesis but not constitute
proof of a causal relationship.
3) Failure to isolate HSV from the ganglia of the general population.
This would falsify the hypothesis.
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These conclusions particularly in 1 and 2 are difficult to maintain
because at best the "carriage rate in the general population" can only
be very crudely- estimated or intelligently guessed. Based on the hypo¬
thesis (part I) and an incidence of Bell's palsy of 20 per 100,000 per
year and taking a cumulative incidence over 70 years. A correction
for under reporting of 2 and a correction for subclinical disease of
2 and a correction for being present and reactivating of 0.5 to 1 would
give a predicted "carriage rate" of 5 to 10 per 100 ganglia studied.
A further serious problem with such "predictions" is the debate about
the frequency of reactivation and the validity of the analogous model
to Bell's palsy - the cold sore lesion. The latter involves the 5th
rather than 7th nerve and the skin rather than the ganglion.
The second aim is a further indirect method of examining the hypo¬
thesis but by clinical method rather than a laboratory approach; and
examining recrudescence and reactivation rather than persistence of
HSV. The information yielded should thus be complementary. A limitation
of the second aim is that it cannot provide causal evidence, but rather
it is the strength of the associations e.g. factors assocated with recrud¬
escence of HSV in Bell's palsy and controls which will be mainly examined.
A clinical approach alone is likely also only to present weak evidence
with which to assess the hypothesis. The problems with the more tradi¬
tional clinical "proofs" e.g. biopsy and antibody studies have already
been discussed in the introductory chapter.
The second and third aims are also linked in relation to hypothesis
testing and the third aim should yield community study incidence information
central to a proper evaluation of the hypothesis.
In summary the first and second aims are primarily hypothesis testing
using different methods of scientific enquiry which are feasible and
valid, to a problem which is complex and difficult. The third aim whilst
also of relevance to the hypothesis is mainly directed to clinical des¬
cription of a condition in an area largely uncharted by studies from
this country.
The stated aims are sequenced from the more specific to the more
general third aim in the historical order in which they were formulated.
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The title of the thesis emphasizes the general nature of the condition
under study and the importance the author attaches to an overview of
his own work, and that of other researchers. It is quite possible that
the problem of how Bell's palsies come about remains so simply because
the boundary of the problem does not coincide with the boundaries of
individual disciplines necessary for understanding.
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PART I OF RESEARCH
The Temporal Bone Studies
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CHAPTER 5
2 studies which attempt to isolate or identify HSV from cadaveric
(human) geniculate ganglia using trigeminal ganglia as controls -
Materials and Methods
STUDY 1 - Cocultivation study
5.1 Materials Used (1)
5.1.1 Study population
Patients who died of natural causes between Feb. 1985 and June 1985 at
Manchester Royal Infirmary. 42 temporal bones were removed yielding 42
geniculate ganglia and 42 trigeminal ganglia from the same cadavers were
used as controls).
5.1.2 Materials used for obtaining ganglia (see materials DNA hybridization
study). The ganglia were collected in:-











Calibrated Gilson micropipettes (France)
Sterile petridishes (Sterilin Ltd. London)
Swann Morton scalpel size 10 blades
Glass-slides
70% alcohol
25 ml plastic cell culture flasks (Falcon U.K. Ltd.)
Eagles Minimal Essential Medium (Flow Lab. Irving Scotland)
20% foetal calf serum (Flowlab. Irving Scotland)
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2 mmol glutamine (Sigma Chemicals U.K. Ltd.)
100 p/ml phosphate buffer (B.D.H., U.K.)
100 jjml streptomycin 100 u/ml penicillin (Flowlab. Irving Scotland)
Incubator at 37°C and 5% C02 (Flowlab. Irving Scotland)
Source of Vero cells (Flowlab. Irving Scotland)
Cell counter/haemocytometer (B.T. Ltd. U.K.)
Binocular microscope x 10 x 20 power (Olympus U.K. Ltd.)
Co-cultivation study
5.2 Methods (1)
The method used for removal of ganglia was similar to that used in the
DNA/DNA hybridization study. Except that all ganglia once extracted
were placed in viral transport medium containing fungizone.
The specimens were taken to the viral laboratory where they were
finely minced by use of a sterile scalpel blade and cleaned forceps
into approximately 1mm3 fragments. The tissue from each ganglion was
divided in half and placed in 25ml flasks. Each flask was then overlayed
with cell growth medium. This contained 100ml of Eagles Minimal Essential
medium with 4ml (4.4%) sodium bicarbonate with pink indicator, 1%
crystamycin (100 u/ml penicillin and 1OOpml streptomycin) and 10ml
(10%) foetal calf serum. 25ml flasks (appropriate labelled) were then
incubated at 37°C in a 5% C02 atmosphere. The growth medium was removed
every seven days by pipette and carefully replaced. The cultures were
monitored three times a week for cytopathic effect. Passage of the
supernatant to vero cells was performed weekly or more frequently for
observation of cytopathic effect.
The above methods were taken from Barringer 1973 and Warren 1977
who obtained isolation rates of HSV of 85% and 60% respectively for
trigeminal ganglia. For a review of the literature see p. 72. Because
of problems with the methodology satisfactory results were not obtained.
This is further discussed in Chapter 7.
Table2;
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STUDY 2




The temporal bones (paired) and trigeminal ganglia (paired) were removed
from 20 patients who died in Manchester Royal Infirmary between December
1985 and January 1986 and in July and August of 1986.
The patients died of natural causes and no coroners deaths were
included. A history of Bell's palsy was not recorded in any of the
patients' hospital records. One patient was noted to have non-insulin
dependent diabetes, and the same patient was also noted to have congenital
syphilis.
The group thus represents a selection of hospital deaths and is
not necessarily representative of deaths in the general population (see
table opposite).
Temporal bones were removed when the following criteria were
fulfilled.
1) Permission from relatives had been obtained.
2) The mortuary staff had available time.
3) The death was not a coroners death.
4) There was no evidence of meningitis.
5) The death had occurred recently (limit of 72 hours).
From these specimens, 40 geniculate ganglia were obtained and 40
trigeminal ganglia were removed from the same patients to serve as
controls.
5.3.2 Materials used for obtaining ganglia
Labelled pathology specimen containers for transport to dissecting room.
(- for temporal bones)
Cotton wool pledgets
70% alcohol
Toothed dissecting forceps - short
Swann-Morton scalpel and blades sizes 10, 12
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Labelled 2ml plastic sterile containers (for trigeminal ganglia)
Circular bone-saw




Selection of drill heads - different burr sizes including diamond burrs
Drill cleaning equipment (antiseptic and brush)
Down's instrument cleaning trough
Swann Morton scalpel and blades sizes 10, 15
Fine toothed forceps
Down's periosteal elevators (selection)
Beale's elevator (Down's)
Weiss microscissors




Liquid nitrogen storage container at -20°C (Union Carbide U.K.)
Extraction of DNA from ganglia
Calibrated pipettes
Eppendorf tubes Sarstedt U.K. Ltd.
1mm ethylene diamine tetraacetic acid E.D.T.A. B.D.H.
0.15m sodium chloride "
Acid washed sand "
P.E. buffer - (10mMTris, 1mM EDTA Ph 7.9) "
Slim glass rods
20ql 10% sodium dodecylsulphate "
Proteinase K stock solution Sigma
Incubator 55°C L.T.E. Ltd. U.K.
400ql phenol/chloroform B.D.H.
Centrifuge M.S.E. U.K.
Chloroform/isoamyl alcohol (24:1) B.D.H.
40jj1 of 3M sodium acetate B.D.H.




U.V. Spectrophotometer Pye Unicam Ltd.
Silicon curettes Pye Unicam U.K.
DNA probes
Plasmid containing Tk probe for HSV, supplied Dr. E. Littler,
Christie Hospital, Manchester, designated - PE Tk^.
Whole plasmid M.W. 9.57 kbp.
Tk gene was contained in a 3.6 kbp fragment of HSV genome - Bam HIQ















BRL Ltd. Paisley Scotland
Scleicher & Schull Andersson








Kodak X-omat S film
Kodak X-omatic S intensifying screens
Bam HI DNA restriction enzyme Amersham U.K.
Gel electrophoresis apparatus Pharmacia
Controls
Positive - DNA extracts from Vero cells
infected HSV-1 strain SC-16
Negative - DNA extracts from inoculated Vero cells
from 3T3 cells known to be TK deficient





5.4.1 Removal of ganglia
The study had been given approval by the Regional Ethical Committee.
Permission for post mortem was obtained by the doctor responsible for
the care of the deceased patient. A standard form in use at Manchester
Royal Infirmary was signed by the next of kin. This gives permission
for tissue to be removed for research purposes (see appendix 4b).
Enquiries were made on a daily basis about arrangements for post
mortems. The author attended the post mortem where appropriate cases
had been found and permission obtained. The calvarium and brain were
removed by the mortuary technician.
The trigeminal ganglia were dissected out from each side before
the temporal bones were removed; thus preventing possible damage to
these ganglia by the bone-saw. Wearing gown, apron, surgeons cap, mask
and gloves the author first cleaned the area at the apex of the temporal
bone and the dura covering the cavernous sinus, and also the area around
the entrance to the cavum trigeminale using cotton wool soaked in 70%
alcohol. Using cleaned toothed dissecting forceps and scalpel with
a sterile size 10 blade the semilunar ganglion was removed from the
cavum trigeminale to incorporate several millimetres of the three main
branches of the nerve, and also a corresponding rim of tissue proximal
to the ganglion. The ganglia were placed directly into labelled plastic
2ml sterile containers (recording name of patient, age, and side).
The temporal bone specimens were removed in pairs by the mortuary
technician, using a bone-saw, under the author's directions. A quadri¬
lateral block of temporal bone was removed of approximate dimensions 4cm
long, 2cm high and of width 2cm anteriorly and 3cm posteriorly (figs 5,1-3).
Laterally the section approximated the middle ear cleft. The anterior
edge lay just posterior to the cavum trigeminale and 2cm in front of
the internal acoustic meatus. The posterior edge lay 2cm posterior
to the internal acoustic meatus. Inferiorly the section was approximately
|cm below the internal acoustic meatus. During removal the landmark
of the superior arcuate eminence was carefully noted and preserved;
(the geniculate ganglion lying close antero-inferiorly). This method of
removal, rather than removal of the whole temporal bone preserved the
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Fig- 5,1 Petrous Temporal Bone Specimen
Quadrilateral Block — Showing Porus Acousticus
Fig. 5,2 Superior Aspect with drilling commenced in
region of geniculate fossa
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Fig. 5,3 Elevator in contact with geniculate ganglion
in its fossa
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outer appearance of the auricular region, and especially since bilaterial
specimens were obtained was in consideration of the relatives supposed wishes.
The specimens were placed in labelled pathology containers and
taken to the temporal-bone room for further dissection. The instruments
used had been cleaned using a brush, and soaked in chlorhexidine in spirit
for 24 hrs. Sterile scalpel blades were used, and the instruments for
right and left sides kept separate to avoid any tissue transfer to the
opposite side container.
Gowned as previously described the author first orientated the
temporal bone. An incision with a scalpel was made 2cm anteriorly to
the superior arcuate eminence, and using a periosteal elevator the
periosteum was removed carefully to demonstrate the greater superficial
petrosal nerve disappearing into its foramen. Having cleared the bone
of periosteum recourse was made to the landmarks of the superior arcuate
eminence, the greater superficial petrosal nerve and the internal acoustic
meatus before drilling. The geniculate ganglion was usually to be found
a few millimetres anterolateral to the arcuate eminence and drilling
was commenced in this area. The facial nerve was exposed in the
horizontal portion as it ran along the fallopian canal to the geniculate
ganglion. This 3-5mm length of nerve appeared curvilinear and ended
in the geniculate fossa. (As the nerve approaches the fossa it rests
on the intervestibulocochlear groove and the cupula). Drilling
superior to the ganglion was through petrosal cortex (which stretches
from the arch of the superior semicircular canal towards the cupula of
the cochlea). This area was variably pneumatized (by cells of the superior
pre-labyrinthine tract). The geniculate ganglion was identified in its
quadrilateral fossa of approximate dimensions 2x2x3 mm. The descending
horizontal portion of the facial nerve was identified anterosuperiorly
to the tympanum, in front of the cochleriform process. (Posteriorly the
geniculate ganglion is related to the anterior wall of the vestibule from
which it is separated by 2-3mm of compact bone).
The ganglion could be gently teased out of its fossa using fine
toothed forceps allowing the intermediate nerve of Wrisberg to be more
readily identified - running in the facial canal. Bone curettes were
used near the ganglion to reduce tissue damage from drilling. The
facial nerve was elevated by gentle traction and divided several
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millimetres proximal to the ganglion with microscissors. It is known
that ganglionic cells may extend proximally up the nerve for several
millimetres beyond the ganglionic 'swelling'. The greater superficial
petrosal nerve was divided close to the ganglion as was the descending
portion of the facial nerve.
A Zeiss operating microscope x6 magnification was used to facilitate
the drilling and the dissection of the geniculate ganglion, but
it was not necessary in all the dissections.
The dimensions of the trigeminal ganglion removed were 2 x 4 x 8mm
and the geniculate ganglion 2x2x3 mm. The trigeminal ganglion
yielding considerably more D.N.A.
The dissection of the geniculate ganglion was done consecutive
to removal of the trigeminal ganglion. The number of hours after death
the post-mortem was performed is included in table 2. The average
time spent removing geniculate ganglia was approximately 15 minutes
per side. All specimens were labelled and stored after dissection in
liquid nitrogen.
5.4.2 Extraction of DNA from ganglia
Tissue samples were removed from liquid nitrogen and placed in a 1-5ml
Eppendorf tube. 400ql of 10mM Tris pH 8.0 and 1mM ethylene diamine
tetraacetic acid (EDTA), 0.15M sodium chloride were added to the tube
together with a small amount of acid washed sand. The tissue was ground
using a slim grassrod. 20jj1 of 10% sodium dodecyl sulphate was added
to give a final concentration of 0.5%. 5pl of 20mg/ml proteinase to
stock solution was added to give a final concentration of 250qg/ml.
The Eppendorf tube was sealed and incubated at 55°C for 3 hrs.
The contents were then treated by addition of 400ql phenol/chloroform
mixture which was thoroughly mixed and then spun for 1 minute at 15,000
r.p.m. to separate the aqueous and organic phases. The supernatant
was retained and extracted with chloroform/isoamyl alcohol, in a ratio
of 24:1, to remove any traces of phenol residue. After further spinning
the supernatant was transferred to a clean Eppendorf tube. To this
were added 40pl of 3M sodium acetate with thorough mixing and 800ql
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of absolute ethanol. The samples were then left at room temperature
for 10 minutes for DNA precipitation to occur.
The tubes were subsequently spun at 15,000 r.p.m. for 20 minutes
and the supernatant carefully removed and discarded. The pellet was
washed with cold 70% ethanol to remove salts, and then dried under
vacuum for 5-10 minutes. The pellet of nucleic acid was dissolved in
50pl of 10mM Tris/1mM EDTA at pH 7.5. Nucleic acid extracts were stored
at -20°C until required.
Assays of the DNA concentrations were performed on each sample
by standard spectrophotometric methods i.e. by reading the optical
density at 260nm and 280nm against a control blank silicon curette.
The ratio of O.D :0.D should be 1.8:1. The concentration of DNA
260 280
was calculated on the basis of a DNA solution containing 50jjg/ml DNA
giving an O.D equal to 1.
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5.4.3 DNA probes
The plasmid carrying the thymidine kinase (T.K.) probe for HSV, was
supplied by Dr. E. Littler of the Holt Radium Institute, Manchester
(Christie's Hospital), and was designated pETK1. The whole plasmid
molecular weight was 9.57 kbp and the TK gene was contained in a 3.6kbp
fragment of the HSV genome (Bam H1Q fragment) inserted at the Bam H1
site within the plasmid.
Plasmids were transfected into E. coli HB 101, amplified, purified
and the HSV insert recovered using standard procedures (Maniatis T.,
1982). All cloned DNA probes were stored in TE buffer (10mM Tris, 1mM
EDTA, pH 7.9) at -20°C.
5.4.4 Hybridization assays
All tissue samples were initially examined by dot-blot hybridization
(Hayes P.C. 1989) using a B.R.L. Hybridot apparatus. 0.45jj nitrocellulose
membranes were pre-soaked in distilled water and equilibrated in 20
x 5.5C (3M sodium chloride, 0.3M sodium citrate).
Patient DNA (2-5qg) was rendered single-stranded by denaturing
for 10 minutes with 0.3N sodium hydroxide at room temperature and samples
were then chilled and diluted with an equal volume of cold 2M ammonium
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acetate and applied to walls of the Hybridot apparatus. After binding
all walls were washed with 100jj1 of 20 x SSC and the filters were air-
dried, and baked at 80°C for 2hrs. Filters were prehybridized using
a non-fat dry milk (Blotto) technique (Johnson D.A. 1984) for 24 hrs
at 65°C. Following this filters were tagged with radio-active probe
(vide infra) which had been rendered single-stranded by boiling. DNA/DNA
hybridization was performed at 65°C overnight in the same Blotto solution.
Filters were washed for two half hour periods in 0.25% Blotto,
2 x 55C and 0.1% SDS at room temperature followed by two thirty-minute
high stringency washes in 0.1 x 55C and 0.1% SDS at 65°C (Tm-17°C).
After drying the filters were put to film and autoradiography carried
out at -70°C. Using Kodak X-omat S film and Kodak X-omatic S intensifying
screens results were obtained in 16-24 hrs.
Further investigations of the ganglion extracts were performed
using Southern transfer analysis (Southern E.M. 1975) following
digestion of the cellular DNA with the restriction enzyme Bam H1.
Positive control included in all the above comprised DNA extracts
from Vero cells infected with HSV1 (Strain SC-16). Negative control
material comprised DNA extracted from uninoculated Vero cells and from
3T3 cells which were known to be TK deficient.
5.4.5 Radio-labelling of probe DNA
Cloned excised 3.6 bhp insert DNA was rendered single stranded by boiling
and labelled with 32p-dCTP in-vitro using random oligo-nucleotide primers
(Feinberg 1983). 50ng of DNA was incubated with 30qCi of labelled
nucleotide yielding probe DNA with specific activities of 2-5 x 109
c.p.m/jjg DNA.
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CHAPTER 6 - RESULTS
-6.1 Cocultivation Study (1)
The results were invalidated because of problems with the
methodology. See p. 75.
6.2 DNA/DNA Hybridization Study (II)
Initial investigations were all performed on 5th nerve DNA extracts
which had been undertaken by Dr E. Littler at the Molecular Biology
Laboratories, Christie Hospital.
The initial probe used (for autoradiographs 6,1 to 6,5 and fig. 6,9)
was a 3.6 kbp segment of the HSV genome, the Bam H1 (Q fragment) which
contains the sequence of the thymidine kinase gene (T.K.) together with
flanking sequences. The probe had been oligonucleotide labelled to
a high specific activity with 32p - approximately 2-5 x 109 c/p.m./ gm
DNA.
The amount of DNA obtained after extraction of the 5th nerve gang¬
lionic tissue varied from 20 gm - 290 gm in total. Initial investigations
were undertaken by dot-blot assays. Each sample was loaded at between
2 and 7.5 gm of DNA total.
The results are shown in Table 3 and Autoradiograph 1 (fig. 6,1).
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6R, 8R,10R,11R
12R,15R,18L,20L
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These specimens were extracted by Dr. E. Littler, Paterson Laboratories,
and losses were due to technical difficulties (breakage in the centrifuge).
The amounts of DNA obtained after extraction of 7th nerve geniculate
ganglion tissue varied between 6 gm and 58 gm total. Initial dot-
blot assays used a total between 1.5 and 4.4 gm of DNA.
In both series of dot-blots controls were included as follows:
a DNA extract from Vero cells which had been productively infected with
herpes simplex virus strain SC16 (a type I). Two separate DNA extracts
from tissue culture cells which were thymidine kinase deficient (TK)
lines, designated 3T3 TK and LM TK.
All the geniculate ganglia tested by dot-blot were positive after
24 hrs for both Left and Right sides. See Autoradiograph 2.
It was decided to investigate patients 3-5 both R and L 7th nerve
extracts by Southern analysis. The amounts of DNA used were limited
to between 0.9 and 4.2 gm total. These extracts were digested with
Bam H1 (Northumbria Biologicals Ltd) for 3 hrs prior to running overnight
on a 0.8% agarose gel.
The controls included a DNA extract from Vero cells which had been
infected with SC16 (HSVi) and two negative controls 3T3 TK and LM TK
as previously described. See Autoradiograph 3.
All clinical samples were positive after exposure for just 2\ hours.
Two lines were produced in each lane, a stronger line approximating
the Vero positive control and a weaker line of lower molecular wt. The
single line produced on the Vero extract was lower than lines on the
clinical specimens by some 3mm.
Autoradiograph 4 shows Southern analysis of trigeminal ganglionic
extracts using the NBL enzyme Bam H1. Autoradiograph 5 shows Southern
analysis of trigeminal ganglionic extracts using the Amersham Inter¬
national enzyme Bam H1. Fig. 6.5 (b) shows the corresponding DNA
loading.
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In order to check the NBL Bam H1 enzyme 5th nerve material was
used for Southern analysis. Furthermore the TK probe was checked by
electrophoresis, and found to be the right order of size i.e. 3.6 kbp.
See fig. 6.9.
HSV isolates from 4 clinical specimens were grown and total cell
DNA extracted:
1) Vulval swab 87/2840 M.R.I, dept. G.U. Medicine
2) Penile swab 87/2842 M.R.I, dept. G.U. Medicine
3) Throat swab 87/2843 Patient with acute myeloid leukaemia
4) Penile swab 87/2953 M.R.I, dept. G.U. Medicine.
These were digested with NBL Bam H1 together with a standard HSV-,^
(Syn17+) and TK controls. The samples were Southern blotted and probed
with PA 29 and also PSG 22 and PSG 124. See Autoradiograph 6.
Results show that different biological strains of HSV migrate
differently with HSV2 strains migrating a little further than HSVj^.
Autoradiographs 7 and 8 show multiple lines with probes PSG 22
(13,000 kbp) and PSG 124 indicating their limited usefulness for the
study - due to non-specific binding.
Subsequently success was obtained using the PA 29 probe with 5th
nerve ganglion extracts from patients 1 and 2 using Southern analysis.
Perfect alignment was shown in the radiograph (not included).








FIG. 6,1: AUTORADIOGRAPH 1
AUTORADIOGRAPH OF TRIGEMINAL GANGLIONIC EXTRACTS (CONTROLS) USING
DOT-BLOT PROCEDURE.
24hr exposure, probe 3.6kbp., Patients 3-20
Key: -
B 1-12: 3R, 3L, 4R, 4L, 5R, 5L, 6R, 6L, 7R, 7L, 8R, 8L
D 1-12: 9L, 10R, 10L, 11R, 11L, 12R, 12L, 13R, 13L, 14R, 14L, 15R
F 1-12: 15L, 16L, 17R, 17L, 18R, 18L, 19R, 20R, 20L, Vero
F10 Vero Positive Control
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FIG. 6,2: AUTORADIOGRAPH 2
AUTORADIOGRAPH OF GENICULATE GANGLIONIC EXTRACTS USING DOT-BLOT
PROCEDURE
24 hr exposure, probe 3.6kbp, patients 3-12
1 2 3 4 5 6 7 8 9 10 11
B— # # • • •
D— # « • m m •
F— # # # • • •
H— • • •
Key: -
B 1-1 1 : (ODD NUMBER COLUMNS): 3L, 3R, 4L, 4R, 5L, 5R
D 1-1 1 : (ODD NUMBER COLUMNS): 6L, 6R, 7L, 7R, 8L, 8R
F 1-11 : (ODD NUMBER COLUMNS): 9L, 9R, 10L, 10R, 11L, 11R
H2 - 12L, H4 - 12R, H6 Vero
H6 Vero Positive Control
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FIG. 6,3(a): AUTORADIOGRAPH 3
SOUTHERN ANALYSIS OF 6 GENICULATE GANGLIONIC EXTRACTS




PHOTOGRAPH OF AGAROSE GEL SOAK, OF SAMPLES 1-9 (AS ABOVE)
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FIG. 6,4: AUTORADIOGRAPH 4
SOUTHERN ANALYSIS OF TRIGEMINAL GANGLIONIC EXTRACTS DIGESTED BY
N.B.L. Bam H1
2\ hr exposure, patients 3-20





















FIG. 6,5(a): AUTORADIOGRAPH 5
SOUTHERN ANALYSIS OF TRIGEMINAL GANGLIONIC EXTRACTS USING AMERSHAM
INTERNATIONAL Bam HI Enzyme
66 hr exposure, patients 3-20
] ? 3 4 5 6 7 s 9 10 1,4 1,5 Iff 1,7 Ifi 2.0 2J
Key: -
1 2 3 4 5 6 7 8 9 10
3L 3R 4L 4R 5L 5R 6R 7L 7R 8L
11 12 13 14 15 16 17
8R 9L 10R 10L 11L 11R Vero
18-TK" and probe DNA gB , 19--3T3 TK and TK, 20 3T3 TK~,
21 Ladder
FIG. 6,5(b): PHOTOGRAPH OF GEL
1 1 3 4- S 6 19 9 iO it <2 <3 it 17 i) is ao
« ♦ » < « ♦ ♦ t » « »* ♦ «»» »■«> ♦
Key: as above
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FIG. 6,6: AUTORADIOGRAPH 6




Key:- 1 - HSV/Vero; 2 patient number 2840; 3 patient number 2842;
4 patient number 2843; 6 patient number 2953
FIG. 6,7: AUTORADIOGRAPH 7
SOUTHERN ANALYSIS USING PROBE pSG 22
4 day exposure




FIG. 6,8: AUTORADIOGRAPH 8
SOUTHERN ANALYSIS USING PROBE pSG 124
72 hr exposure
1 2 3 4 5 6 ,7
4 • I » • • I
Key:- 1 - HSV/Vero; 2 patient number 2840; 3 patient number 2842;
4 patient number 2843; 5 patient number 2953; 7,1kb ladder
FIG. 6,9:
PHOTOGRAPH OF GEL ANALYSIS FOR 3.6kbp PROBE FROM BETHESDA RESEARCH
LABORATORIES
Key: - 1 - kb ladder, 2 - probe between 4.072 and 3.054 kbp
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CHAPTER 7
Discussion of studies attempting to isolate or detect HSV
from human post mortem geniculate and trigeminal ganglia
7.1 Literature Review of Isolation of HSV from 1° Afferent Ganglia
That HSV resides in latent form in sensory ganglia was suggested by
Carton in 1952 who noted the appearance of HSV lesions around the mouth
immediately post-operatively following root section for trigeminal
neuralgia.
Further rationale for studying the trigeminal ganglia is the fact
that recurrent HSV lesions affect predominantly the oral and genital
mucosae and hence the trigeminal and sacral ganglia are the most likely
sites for viral persistence (or latency).
The first successful isolation of HSV from human trigeminal ganglia was
made by Bastion, Rabson, Yee and Tralka in 1972 using an explant technique,
with 2 out of 23 cadavers yielding reactivated virus from ganglion neurones.
Baringer and Swoveland in 1973 using a similar methodology isolated
HSV in 6 out of 7 cadavers, 8 out of 13 ganglia. The ganglia were obtained
at post-mortem less than 12 hours after death and maintained in culture
for 10-45 days. The ganglia were removed in sterile fashion as soon after
death as possible to ensure increased viability of ganglion cells. The
ganglia were minced finely,and washed twice in Hank's balanced salt solution.
The specimens were then centrifuged and resuspended in Leibowitz medium
L-15 with 20% foetal calf serum added. The suspensions were inoculated
into 25ml plastic Falcon flasks, and maintained at 36.5®C with medium changes
twice weekly and observed for cytopathic effect; cytopathic effect being
a specific response of cells to HSV.
The supernatant was frozen at -70°C or direct assay was made for virus
by adding 1ml of ganglia medium onto monolayer cultures of primary rabbit
kidney. Immunofluorescent and neutralizing antibodies (anti HSV hamster
1gG) were used to type the virus. The presence of virus was also confirmed
by electron microscopy studies. Positive results were obtained 10 to 45
days after explanting in 8 out of 13 ganglia studied.
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Rodda in 1973 isolated HSV from the trigeminal ganglion of 1 adult
cadaver but not in 5 children. The ganglion yielding the positive
culture was removed at 9 hours after death. With the appearance of
cytopathic effect passage was made to Green Monkey kidney cells (Vero
line), or human embryonic fibroblasts. The author stressed the importance
of maintaining cultures for 3 months with cytopathic effect usually
occurring at around 1 month.
Plummer (1973) was also able to isolate HSV from trigeminal ganglia
of man, monkeys and cats by co-cultivation, with primary rabbit kidney;
with isolates occurring between days 8-43 (4 out of 10 human ganglia
yielded HSV).
Baringer (1974) isolated HSV from 4 out of 26 cadavers, identifying
HSV type II from the third and fourth sacral ganglia. There were no
successful isolates from 21 thoracic ganglia. In this study trypsinised
human embryonic lung cells (flow 2000), L15 medium, and 10% foetal calf
serum were added to minced ganglion extracts.
Warren in 1977 isolated HSV from 18 out of 39 trigeminal ganglia
obtained within 12 hours of death, including a patient who had died
with multiple sclerosis. The following year Warren made a successful
isolation of HSV from the superior cervical ganglia and the jugular
portion of the vagus ganglion from one cadaver.
Only one study so far has looked at isolation from the geniculate
ganglion of humans. Degrd in 1978 isolated HSV in only 3 of 20 trigeminal
ganglia and in none of the 20 geniculate ganglia studied. The method
used was that of Baringer, 1974.
HSV was isolated from human trigeminal nerve roots by Warren in 1982
(6 positive isolates from 18 patients) suggesting that latent HSV is
not just confined to autonomic and sensory ganglia of humans. The
coeliac ganglion was also noted as a site by Rand (1984) who successfully
isolated HSV in a patient dying after renal transplantation.
Overall the isolation rate for HSV varies between 40-80% of the
trigeminal ganglia studied (Baringer 75, Warren 77, Brown cited by Degrd
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78, Lewis 82). The highest frequency of isolates were found in the
'freshest' specimens with the worst rate 15% quoted by Degrd, in specimens
more than half of which were obtained over 24 hours from the time of
death. Necrolysis it would thus appear adversely affects the isolation
rate.
On reviewing the literature for human cadaver material, HSV has
been successfully isolated using explant and co-cultivation techniques
from trigeminal ganglia, but not from the geniculate ganglia - although
only one study attempted to do so. The paucity of information about
geniculate ganglia almost certainly relates to the considerable difficul¬
ties in obtaining specimens. This lack of information can be supplemented
by considering animal studies. The work of Thomander 1988 has already
been mentiond, and of further interest is the work of Hill and Blythe
1981 who failed to isolate HSV from facial ganglia in outbred mice using
co-cultivation techniques. They obtained positive cultures in the 31
mice examined in 8 trigeminal, 8 vagal and 20 pooled cervical ganglia.
7.2 Background to the Hybridization Study
The two main methods used in this study, cocultivation and blot hybridi¬
zation, are comparatively assessed by Gordon 1984. There have been
no attempts to identify HSV genome by DNA/DNA hybridization techniques
from the geniculate ganglia of human cadavers and only one study to
date, that of Efsthethiou S. et al (1986), has used this technique for
examining the sequences of trigeminal ganglia DNA extracts obtained
at post mortem.
Fraser et al (1981) and Saldanha (1986) have detected HSV virus DNA
in human brain extracts but most of the experimental evidence for this
technique still comes from animal work. Wigdahl (1984) detected linear HSV
DNA in in-vitro mice with established latent infection, inoculated by
the corneal route, finding sequences in trigeminal ganglia and brainstems.
Puga (1984) used a similar model and detected fragments of 'uncharacteristic'
size, suggesting that rearrangement of viral sequences had occurred
within the host cell, or that integration with cellular DNA had been
at more than one, but nonetheless at a restricted number of sites.
More recently attention has focused on detection and mapping of
HSV RNA's in animal models (Rock 1987, Rosen-Wolff 1989).
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In summary the literature on DNA/DNA hybridization techniques
for HSV genome in human neural tissue is sparse, although recombination
DNA technology has been considerably developed over the past 10-15 years
(Glover, D. 1984). It remains, however, a costly technique and specialised
knowledge of both virologist and clinician are needed in obtaining and
processing human specimens in a satisfactory manner. Efsthathiou's work
has shown that HSV genome can be reliably demonstrated in cadaveric tri¬
geminal ganglia - in 11 out of 20 specimens or 55% - which can be used
as a 'standard' by which the control result from this study can be assessed.
7.3 Cocultivation Study - Discussion and Summary of Findings
To isolate HSV from the geniculate ganglia obtained at post mortem several
techniques may be used. Historically co-cultivation was the first success¬
ful method for isolating HSV from primary afferent sensory ganglia. The
study here outlined was conducted by the author as an initial attempt to
isolate the virus.
The techniques used became problematical with microbial overgrowth
in specimens occurring regularly precluding reliable observation for
cytopathic effect, and preventing any meaningful conclusions being drawn
from the study. Co-cultivation was also performed by an experienced
technician who ran into similar problems as the author with evidence
of microbial contamination affecting most specimens after several days.
A considerable number of specimens were processed in this way - 72
in all, 36 trigeminal and 36 geniculate ganglia. Recordings were made
on a cocultivation study data sheet (Appendix 4d).
In an attempt to overcome the problem the following steps were taken:
1) Specimens taken at post-mortems performed shortly after death
wherever possible;
2) Aseptic techniques used despite their limitations in
the post-mortem room; fastidious cleaning of instruments and
work surfaces in temporal bone room, and use of non-touch
techniques; fastidious cleaning of surfaces in virology laboratory
side-room with closure of air-vent, and use of non-touch techniques.
Despite these steps contamination continued to occur. It was felt there
were two main reasons for this.
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Firstly the condition of the specimens was not generally speaking
good and initially in the study, many older i.e. over 36 hrs. after
death, specimens were used. On removal many specimens showed macroscopic
evidence of necrolysis.
There was good rapport with the pathologists at M.R.I, but despite
considerable efforts no specimens could be obtained at 12 hrs or less
after death. This was later achieved during the DNA hybridization
study.because of a serendipitous move towards earlier post-mortems at
the time that the second study was being carried out.
Secondly, in discussion with Prof. Longson it was acknowledged that
the University building air ventilation system had also caused problems for
other research projects with a high level of airborne fungal contamination
occurring.
The contamination continued to occur despite switching specimens to
the regional virus laboratory and so it was surmised that the main reason
for failure was the poor condition of the specimens obtained, and the fact
that it proved impossible to prevent early microbial contamination in the
post-mortem room and temporal bone room. The medium 'fungizone' was
used for transport throughout at a concentration of 5 gm/ml. Higher
concentrations could not be used as they would affect the cell growth
of the culture.
Had the alternative of DNA probing not become available to the author
during the study period he would have attempted to identify the source
of microbial contamination more precisely. If necessary and by further
negotiations, a switch to a different hospital conducting earlier post
mortems might have been relevant.
However during the study period Dr. G. Corbett was able to provide
the facility of processing the specimens by the method of DNA/DNA
hybridization for HSV genome. Subsequently 80 specimens were provided
for investigation by this method, thereby diminishing the magnitude and
the type of problem from microbial contamination.
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7.4 Discussion of Results of DNA/DNA Hybridization Study with Critique
of Methodology
In view of the widely accepted idea that the dorsal ganglion of the 5th
nerve harbours HSV it was reasoned that prior to probing 7th nerve samples
we should show our ability to detect HSV sequence in 5th nerve ganglia.
The reason for employing dot-blot analysis before Southern analysis
was because to detect single copy genes by the latter technique DNA has
to spread down agarose gel, and 10pgm of DNA is needed as a minimum whereas
for a single spot of DNA concentrate, less is required.
Autoradiograph 1 shows that the control material (trigeminal ganglionic
extracts) were strongly positive in 12 out of 36 ganglia (33%); 4 out
of 36 (11.1%) were negative; the remaining 20 (56%) ganglia were weakly
positive. The Vero positive control containing HSV DNA in a total cell
DNA extract appeared of similar density to the weak positive results. Thus
32 of 36 ganglia or 89% of trigeminal ganglia were positive.
A possible reason for the increased density dot-blots or strong
positives might be that HSV reactivation occurs around the time of death
as part of the terminal illness,or alternatively it might be argued that
the strong positives are true positives and that the weak positives are
difficult to interpret because of non-specific probe binding to cellular
DNA. Dr. Littler who provided the probe had no evidence that the probe
was likely to bind to cellular DNA. Furthermore the TK-control showed
no evidence of binding at any stage suggesting there was no non-specific
uptake. Efsthathiou's finding of 11 out of 20 positives (55%) is a broadly
comparable finding given the small numbers involved in both studies and
using "predictions" from co-cultivation studies. It was felt however
that on balance there was probably a 'faint background' representing non¬
specific binding.
Autoradiograph 2 shows that all the geniculate ganglia were positive
on dot-blot analysis and of varying autoradiographic densities. 19 out
of 20 were strongly positive and one was more weakly positive. The finding
that all geniculate ganglia were positive was difficult to accept as
'specific', therefore the membrane was rewashed at very high stringency
0.1 x 5.5c, 68°C for 1 hour, and using two separate washes. After placing
to film after only 3 hours exposure it was shown that all dot-blots were
still giving a positive signal.
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It is argued that the stringency of the methods employed tends to
confirm the specificity of the technique, and that binding of the probe to
the extracted DNA was very strong indeed. These results suggest that HSV
genome resides in geniculate ganglia of the 'general' population and that
it does so at a higher frequency than in trigeminal ganglia.
To further support the findings of the dot-blot method geniculate
ganglionic extracts were examined by Southern analysis as were controls
(trigeminal extracts).
Autoradiograph 3 shows a strong positive response of the geniculate
ganglia compared to the Vero positive control and with appropriate negative
results from the 2 controls 3T3TK and LMTK. The increased electrophoretic
mobility of the Vero positive control by some 3mm is problematical to the
study and difficult to interpret, suggesting a lighter combined M.W. for
the control. One possible explanation for this could be the much heavier
DNA loading of the Vero extract exerting a "pushing" effect during electro¬
phoresis and therefore moving the TK line further with respect to the
clinical samples. See figure 6, 3(b).
A further consideration is that the specificity of the probe is all
important. If it is not 100% specific it can lead to 'odd results', if
plasmid remains bound to it.
The possibilities that different strains of HSV migrate at different
rates is a further explanation, and this is discussed later (vide intra).
A fourth possible explanation is that like the measles virus HSV can become
altered with time in its state of persistence in neurones, thereby exhibi¬
ting different characteristics when analysed by hybridization, and this
is discussed in Efsthathiou's paper (1986). Puga (1984) noted variation
in size of the terminal fragment (Eco R^) but not the Bam Hx fragments.
A second faint line was present in all the clinical samples. The
reasons for this are not clear. However Efsthathiou, obtaining a similar
'double line', suggested homologous sequences in the cellular material
and obtained similar results with hepatic as well as neural tissue.
This protein is absent in the Vero cell controls. If the cadaver
material was contaminated by bacterial growth a further explanation
may be given. That is, the DNA extracted would be a mixture of HSV
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DNA, cellular DNA, and bacterial DNA. As the probe used is amplified
in E. coli plasmids it is possible that sequences of probe DNA have
E. coli DNA contamination, and this is homologous to the sequences in
the contaminated extracted DNA. Therefore the second faint line may
be due to contaminating bacteria and not HSV. Although this is a
possible explanation, on balance it is felt to be very unlikely because
the same contaminant would be consistently required in every specimen,
taken over a period of several months.
Autoradiograph 4 shows unusual results and it was concluded that NBL
Bam HI was not a very good enzyme preparation, and was cutting DNA badly.
None of the positively labelled DNA lines match up to the control.
Autoradiograph 5 shows Southern analysis of 5th nerve material using
the Amersham International Bam HI enzyme, using tissue samples 7 to 11,
left and right specimens. Again, several lines were produced in the radio¬
graphs. It was decided therefore to use a different probe DNA.
A new clone (bacterial and probe DNA within plasmid) designated PA29
was obtained as a kind gift from Dr. S. Efsthathiou of Cambridge. This
carries a small 800bp fragment of the Bam HIQ fragment of HSV DNA, and
contains sequences specific to part of the TK gene of HSV, and amplified
and purified for use.
In an attempt to determine possible variability between strains, four
laboratory HSV isolates were grown up and the total cell DNA extracted.
Autoradiograph 6 shows that different strains of HSV migrate differently
with HSV2 strains migrating a little further than HSVX. However, the
standard HSVx had previously migrated ahead of the ganglionic extract.
Such differences in electrophoretic mobility between strains would there¬
fore be a possible but unlikely explanation for the 3mm misalignment
reported earlier. - considering the general rule that HSVX has a proclivity
above the umbilicus and HSV2 below it!
Two further probes PSG22 and PSG124 were tested but provided limited
usefulness to the study because of non-specific binding.
The PA29 probe proved to be the most promising with respect to good
alignment on Southern analysis of the 5th nerve ganglionic extracts.
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Unfortunately due to funding problems further clarification of the
Southern analysis results will depend on these becoming available.
The next rational step would be to further process the available
specimens of geniculate and trigeminal ganglia using the more highly
specific PA29 probe to determine the repeatability of the findings.
The results of the dot-blot tests and the finding that the positive
control rate was 32 out of 36 for this study and 11 out of 20 for
Efsthathiou's study is broadly comparable, and furthermore close to that
predicted by co-cultivation studies - 60%, - and seroconversion studies
suggesting at least 90%.
The surprising finding that all the geniculate ganglia tested out
of a sample of 20 on dot-blot analysis were positive, can from the limited
evidence here presented be most logically explained by the fact that,
in this particular small sample of the population, all the patients were
harbouring HSV DNA in their geniculate ganglia. If non-specific binding
to neural tissue were always occurring then all the control material
should also have been positive.
Serology would have been a useful adjunct in demonstrating false
positives obtained by the hybridization study even though 90% of the
population over 30 years of age are likely to have demonstrable antibodies
to HSV. In Efsthathiou's paper 4 out of 20 had <1/10 titre to HSV (by
reverse passive haemagglutination). A possible explanation may be that
HSV may gain entry to the nervous system more readily and with little
if anyi immune response, through a mucosal surface as opposed to a
keratinized surface. It is also argued that uptake by taste-bud neurones
in the anterior | of the tongue may occur, allowing invasion of the CNS
via the chorda tympani, geniculate ganglion route. Thus the virus may
creep 'silently' to residence within the geniculate ganglia without much
or indeed any inflammatory reaction occurring. This would either require
that HSV has a predilection for the geniculate ganglion neurones to
the extent of perhaps limiting its spread within the CNS. Or alternatively
immune factors may become important in curtailing spread within the
CNS. Clarification of the surprising findings of this study and their
implications must rest with further hybridization studies, using
reliable specific probes on ganglionic material.
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Epidemiological Studies of Bell's
in British General Practice
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CHAPTER 8
Epidemiological Studies of Bell's Palsy - Materials and Methods
8.1 Introduction
The studies comprise a descriptive and a case-control study. Bell's
palsy cases were selected by means of a prospective case-finding method
with new cases notified over a one year study period.
For the purposes of the studies a case of Bell's palsy might be
defined as:-
"a motor weakness to the face perceived or brought to the attention
of the patient, which resulted in a consultation with a participating
GP who had to "diagnose" or more correctly recognise the condition
and notify the department. These cases were then checked by the
author using stringent clinical criteria, and also information
from 6 month follow-up to exclude latent specific pathology; as
a means of ensuring that the sample of cases was acceptably specific".
Ethical approval
Ethical approval for this study was sought and obtained from the Manchester
Royal Infirmary, Regional Ethical Committee, for which details of the
study were outlined and the questionnaires used submitted. Permission
was requested to study the general practitioners' patients and take blood
samples. Steps were taken to assure all patients and controls of full
confidentiality.
8.2 The Descriptive Study
8.2.1 Materials used;
Letters in the study
1) Letters to individual FPC's
2) 1st letter to GP's (requesting compliance) background to study
(Appendix 2a), completion sheets (Appendix 2b).
3) 2nd letter to GP's (reminder) (Appendix 2c), completion sheets
(Appendix 2d)
4) Follow up letter to patients (at 6 months) (Appendix 2e)
Pre-paid reply envelopes for all of the above.
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Letters to individual patients - arrangements for visiting.
Transport (car) and A-Z of Greater Manchester area.
Bell's palsy case questionnaire (Appendix 1a)
Self administered - Schedule Recent Event, checklist (Appendix 1c)




2) Keeler auroscope/light source





8) 10ml serum bottles
9) Virology cards
10) Labstix
11) Prepaid parcels containing 10ml bottle/virology card for a 2nd sample.
12) Canon camera and flash unit.
8.2.2 The denominator - the population under study, and statistical
considerations
Statistical advice was sought early for the study from Dr. Lucas of Man¬
chester University Department of Medical Statistics. The estimated inci¬
dence of Bell's palsy from European studies was taken as approximately
20 per 100,000 per year. The aim of the study was to recruit 100 cases
of Bell's palsy over 1 year, which entailed finding a minimum study popu¬
lation of 500,000. This number would allow a reasonable descriptive
study to be performed. If a similar number of controls were found then
the study would have the power to test aetiological variables such as
preceding depression and URTI, and examine HSV disease itself (cold sore
history) for any strong associatons. Given the resources of the study
a larger and more powerful study of this relatively rare condition was




General practitioners were invited to support the study by a letter
distributed by the FPC's (Appendix 2a). The 10 FPC's of Greater Manchester
were contacted by letter for cooperation with the study (fig. 8.1).
8.2.3 Characteristics of the Greater Manchester population
Between 1971 and 1981 the OPCS reports a decrease of 4.9% of the popula¬
tion compared with an increase of 0.5% for England and Wales. There were
20.17 persons per hectare in Greater Manchester compared with a provisional
estimate of 3.24 for England and Wales. Manchester 38.61 was the most
densely populated part of Greater Manchester despite a decrease of 17.5%
of the population in 10 years, whereas Rochdale at 12.98 was the least
densely populated, but with an increase of 2.1% of the population. The
proportion of under 16's varied from 24.5% in Rochdale to 21.6% in Man¬
chester. The proportion of persons of pensionable age was highest in
Manchester 18.9% and lowest in Rochdale 15.7%.
Overall 5.8% of the usually resident population were born outside
the United Kingdom, and the Manchester population contained the highest
number of immigrants per region at 11.2%. The unemployment level for
Greater Manchester was 12.6%. The lowest incidence was in Stockport
8.5% and highest in Manchester at 18.1%. Households where no car was
available also varied from 34.6% in Stockport to 60.4% in Manchester.
Overcrowding as defined as more than one person per room was highest
in Manchester 5.7%, with a mean of 4.0% for the county.
8.2.4 Letters to the General Practitioners and notification of cases
A standard letter was sent to individual practitioners via the appropriate
FPC (see tables 4 & 6). Part-time practitioners were not included in the
study. The letter contained an invitation to help with the study and an
explanatory letter to encourage compliance and interest.
Table 4: Letter distribution to individual FPC's
Manchester Central 280 Bury 86
Bolton 130Salford 170
Tameside 100 Oldham 115
Stockport 140
Rochdale 100 Total 121
Agreement to notify new cases was signalled by return of a completed sheet
indicating agreement (Appendix 2b) to the Department of General Practice of
Manchester University at Walmer St., Rusholme, Manchester. The practitioner
needed to inform the department by telephone or letter of any new cases, and
provide details of patient address, phone number and date of onset.
Individual practitioners had to:-
1) Actively remember study is in progress
2) Be capable to diagnosing Bell's palsy
3) Secure agreement with patient to be studied
4) Notify the department.
Notification of the department by this method was necessary because
Bell's palsy is not a notifiable disease in the usual meaning of the
word. The patient would then be contacted by phone usually, or letter
occasionally, and a visit requested by the researcher (the author). This
usually took place within 3 weeks of the onset of the paralysis.
A further letter was sent on 2nd March 1986, 8 months into the
study to serve as a reminder (Appendix 2c). However this letter also
asked for a reply giving further details. The hypothesis was formulated
that if the General Practitioner did not reply to this letter it would
be unlikely that he was reporting any new cases of Bell's palsy he had
seen to the department. The details of the reply also allowed more
accurate information to be adduced about the study population. This
included list size and whether reported cases had been on the GP's list
or a partner's list.
The second letter also asked the GP if he had reported all new
cases and if he hadn't if he had forgotten the details, or could remember
them but the patient did not wish to be referred.
A list of participating GP's is given in Appendix 3b and those who
replied at 8 months are denoted by an asterisk. '1 case' indicates referral
of a case into the study. Of the participating GP's some were in single
and some in group practice, only a small proportion of the replies indicated
that they would report cases seen by their partners. Although GP's see
patients primarily on their own lists, a personal list system is certainly
not ubiquitous, and particularly in "urgent" situations a personal list
system is put under more strain. To obtain more accurate information
therefore 2 steps were taken.
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Table 5
Starting and finishing dates for individual FPC areas









Reporting encouraged for all doctors until 31/7/86 - no cases
needed to be excluded because of reporting after the completion
date.
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1) Patients who were referred were asked did their own doctor refer
them? This was then checked against the list of original replies.
2) At 8 months a second letter specifically asked the participating
doctors if they had referred a case had the patient been on their
own or their partner's list?
8.2.5 Geographical factors
All reported cases were located within a 16 mile radius of Manchester
Town Hall or 18 mile radius of Rusholme Health Centre (Univ. Dept.). The
twin cities of Manchester and Salford lie at the North Easterly edge of
the Cheshire plain. The lower reaches of the Pennines encroach on the
North Eastern parts of the conurbation. Most patients were referred from
either urban or industrial town practices with very few from more rural
practices.
8.2.6 Time scale of the study
It was determined that the study should be of 1 year duration. The main
reasons being:-
1) For a large General Practice based study a short study period increases
the compliance and improves the accuracy of the reporting.
2) The aetiological factors being studied in this acute condition might
be expected to act in short periods from hours to months before the
onset.
3) Speed of acquisition of data.
The disadvantages to this time-scale include:-
1) The incidence of the disease cannot be related to broad trends e.g.
in HSV epidemiology.
2) Fewer cases.
3) Evaluation of seasonal trends more difficult.
Different FPC's sent out the letters to GP's at different times. The
time the first GP from an FPC area replied being taken as the commencement
date (the FPC's sent out all the mail usually within 48 hours). This
varied from mid-June 1985 (Tameside) to the last week in July 1985
(Manchester) (see Table 5). The closing date was given as August 1st
1986. This included a prolongation of the 1 year period by several
weeks for most FPC areas in which patient delay in presentation could
be absorbed.
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8.2.7. Responses of FPC areas and General Practitioners
10 FPC areas of Greater Manchester were contacted. Of these 8 responded
positively from.the outset; Manchester Central, Salford, Tameside,
Stockport, Rochdale, Bury, Bolton and Oldham (appendix 3a). Trafford FPC
did not respond to the original letter or subsequent communications,
Wigan refused to help with the study, but revoked this decision 4 months
after the study had commenced - however this FPC was not then included.
252 GP's agreed to support the study, with an average list size
of 2,200 (FPC figures) giving an estimated study population of 550,000
at the start of the study. Information from the 1981 OPCS census of
Greater Manchester gives a figure of 2,575,407 persons usually resident.
Thus approximately 20% of the population of Greater Manchester appeared
to be available for the purposes of the study. More detailed information
was available from the 144 GP's who positively responded to the second
letter.
Table 6 - (see results p. 100), shows responses for individual
FPC areas by GP's to an initial letter and also one sent 8 months into
the study.
8.2.8. Exclusions from the study
Apart from those due to time of onset of the palsy. The exclusions
were as follows
1) 2 patients referred within 2-3 weeks of each other by separate Salford
GP's of cases of Ramsay Hunt syndrome where an auricular zoster rash
was in evidence as well as a facial palsy.
2) One patient excluded herself from the study and expressed annoyance
when visited that her general practitioner had referred her.
3) 2 suspected cases could not be contacted. One patient in Rochdale
did not respond to two letters sent to his home address. The other
had an incomplete address forwarded and the practitioner proved
difficult to contact and was finally unhelpful.
8.2.9 Outcome assessments
The following outcomes were studied:-
1) Severity and duration of paralysis
2) Associated clinical features
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3) Treatment type and commencement
4) Hospital referral
5) Recovery of paralysis - gradation and assessment
6) Recurrence
8.2.10 Follow-up arrangements
In the study several different types of follow-up were required. Firstly
some patients were selected for paired anti-sera for the antibody study
and this necessitated the patient's own GP seeing the patient 2 weeks
later. The patient was given a prepaid parcel with 10ml serum bottle,
virology card and explanatory/request letter for the GP (or contact
was directly by phone in place of this letter).
After a minimum of 6 months had elapsed patients were sent a further
letter in the form of a short questionnaire asking details of recovery
(Appendix 2e). Patients were also contacted by telephone where the
replies appeared unclear or no reply to the letter had been made. The
duration of the paralysis was confirmed, where this information was
still needed, as were details of hospital treatment and follow up.
Only one patient was lost to follow up.
8.2.11 Contact enquiry and evidence of clustering
All patients were asked about contact with other people who may have
had Bell's palsy in the past year including family members, associates
at their place of work, and socially. Pursuing HSV as a possible aetiological
agent the following selective questions were asked as part of a limited
enquiry:
1) had the patient recently kissed someone with cold sores?
2) suffered from genital herpes infection?
3) had cold sores recently?
4) had symptoms of Acute Gingivo Stomatitis (AGVS) recently?
Patients were questioned about possible HSV contacts and in parti¬
cular children as a source of infection, perhaps bringing a different
strain of virus into the household. An enquiry was also made
if appropriate as to which schools the children attended.
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8.3 The Case-Control Study
Control data was needed for the aetiological study which could then
be most appropriately analysed by match-pair analysis to examine for
differences in associations between the groups. The materials used
in this study include the control population, and the control and SRE
questionnaires (Appendices 1b, 1c).
8.3.1 Selection of controls
This represents one of the most difficult parts of the methods as the
aim was to find a similar group to cases except for exposure.
An equal number of controls as cases (80 of each) were found. It was
decided that controls should not be patients attending surgery as this
selective process would be prejudicial to the results. However patients
listed with participating general practitioners i.e. on their lists
should be approached at home for completion of the questionnaire in
a similar fashion to those with Bell's palsy.
Controls were matched for age (by decade) and sex to eliminate
effects of these confounding variables. It was also decided to match
broadly on social group (groups I and II; III and IV; V and VI).
To some extent this might represent over-matching of controls for
certain aspects of the study as HSV primary infection is related to
social group with lower social groups experiencing primary infection
at an earlier age. However neural reactivation of HSV which occurs
after a state of viral persistence e.g. latent period does not appear
to be directly related to social group. The value of matching by social
group would make differences found e.g. in stress, drinking behaviour,
U.R.T.I, etc. more significant.
Control data was not used for menstruation or pregnancy and control
serum samples were not taken.
For logistical reasons, as only 1 observer (the author) was available
for the study, a small sample of the practices compliant with the study
were used. This sample was not taken randomly. The listed patients of
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3 doctors at the university practice were used as a source, together
with the listed patients of 2 single handed practices where the author
worked as a locnm in an area east of Manchester centre 6 miles and
13 miles respectively. All 5 doctors had agreed to notify cases of
Bell's palsy and the combined list size was 11,402. As the university
inner city practice might be described with respect to listed patients
as more 'unusual' e.g. with very high numbers of young people and students
and low social group, attempts to offset this were made by matching
for age, sex and social group and also in the proportion of controls
collected from this practice 20 (list size 7,340). The number from
the Ashton practice was 42 (list size 2,742) and from Hadfield 18 (list
size 1,320).
The case notes were taken haphazardly rather than in truly random
fashion from the shelves and patient details of age, sex, and occupation
sought (and checked-in the university practice only - if the GP had
agreed to participate). These were checked against a 'Tally card' of
Bell's palsy patients and crossed off when appropriately matched. The
patients were usually phoned for an appointment but a few had letters.
There was also a delay between recruiting cases and controls. For practical
reasons controls were recruited into the study from October to August with
a "seasonal" delay of about 2-3 months for match-pairs (a relative surplus
of cases did however make it easier to find controls).
8.4 The Study Questionnaires
2 questionnaires were used in the epidemiological study, one for cases
and one for controls. In addition supplementary information was obtained
from a schedule of recent events check list (See appendices 1a, 1b, 1c). The
patients were visited in their homes to encourage compliance and minimise
loss of information. In addition assessment of the patient in their
home gave more social, community and geographical information.
8.4.1 Piloting the questionnaires
It was first necessary to pilot the questionnaires to iron-out problems
and reduce superfluous information. No cases of acute Bell's palsy
were seen by the author following formulation of the draft questionnaire,
and its introduction at the beginning of the study - mainly due to the
relatively rare nature of Bell's palsy. It was decided to critically
assess therefore the first 3 or 4 questionnaires completed. However it
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was possible to pilot the control questionnaire, a shortened and slightly
differently worded version of the case questionnaire. In addition comments
from colleagues-were invited and changes made to the drafts. The comments
from colleagues were most useful in revising the questionnaire and ques¬
tions like 'is there a past history of alcoholism' were changed to 'drink
problem' - a more acceptable question to patients and placed lower in
the order of questions because of its negative valuation. However the
most substantial changes came from piloting on 10 patients attending
surgery who were willing to answer questions used in the control question¬
naires. The main change was in rewriting and reformulation of questions
in a way which involved less medical jargon, and could be more readily
understood by patients. In addition it was decided that a photograph
of cold sores was a useful adjunct to those not quite clear what a cold
sore was - although most appeared to be, when this was described. Other
words in the questionnaire were expanded upon to clarify what was meant
by for example 'depression' (see questionnaire - Appendix 1a). Although
some 'jargon' words were left in the questionnaire as a concession to
brevity for example the word 'migraine', it was apparent from piloting
that a careful history was also needed. Certain types of wording were
more ambiguous than others.
After administering the first 3 or 4 case questionnaires a number
of modifications were introduced. These were as follows:-
1) to include a work address where relevant to help in considering
cases of contact with other Bell's palsy patients and to serve
as a reminder to ask about social contacts.
2) the order of questions 2 and 3 were changed as a complementary
question 2a was also asked.
3) The words 'prior to the facial weakness' were dropped from question
6 and this was reworded 'Have you noticed things taste differently?'
4) The doctors 'correction' for question 15 about emotional strain
(a parallel set of boxes) was dropped and subsequently the S.R.E.
check list was introduced.
94
As regards repeatability of the questions (or level of agreement
between replicate responses) it was apparent from piloting that the
questions about cold sore history produced most difficulty with anamnesis.
Expert advice was sought but it was felt that because of the use of
controls, and with supplementation from serology studies it was not
necessary to formally assess the repeatability of these questions.
8.4.2 Features of the case questionnaire design and content
The questionnaire was designed to unambiguously and efficiently collect
relevant data about the natural history of Bell's palsy - with particular
emphasis on exposure to herpes simplex virus and various biological
stressors associated with recrudescence and reactivation. Wherever
possible the patient was asked to recount his or her story in their
own words first. The questionnaire comprises a set of specific questions
designed for use by an interviewer, with elaborations and answers to
open questions recorded in the margin and at the end of the questionnaire
under 'comments'.
8.4.3 The control questionnaire
This was modified in a way in keeping with the general aims of the case
control study whilst being divested of inappropriate questions relating
to specific aspects of the features of facial paralysis. Further modifi¬
cation was required for the questions on exposure to alcohol and sunlight,
where because Bell's palsy patients were on average recalling events
just prior to a significant event (the onset of the palsy) on average
two to three weeks previously, it was felt no equivalent question was
possible for controls but in order to determine the likely exposure
to alcohol or sunlight as near accurately as possible the previous 24
hours were used, thus introducing a bias.
A number of questions on the control questionnaire also involved
rephrasing in a manner appropriate for well rather than ill people,
and this difference in state has also to be borne in mind in interpreta¬
tion of the results.
8.4.4 S.R.E. (Schedule of Recent Events) check list
Although Bell's palsy and stress have been studied the S.R.E. check
list has not been used before. This questionnaire attempts to assess
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more objectively the degree of stress individuals are under. A number
of studies have examined recent life events and illness (Holmes 1967;
Connolly 1985; -Cooke 1985, Walker 1988). Perhaps the main objection
to these questionnaires is the fact that the meaning of the events or
the significant impact to the individual is not explored by such quanti¬
tative evaluation. Furthermore the life events schedule was developed
as a questionnaire and not as a self-administered check list as used
by the author. Nonetheless the use of controls and the clear onset
in time of the facial paralysis make this information a useful supplement
to the questionnaire information. The different time periods involved
also have to be taken into consideration (6 months S.R.E., 1 month ques¬
tionnaire) when examining the results.
This check list was self administered after a short explanation
by the author and took on average 3 to 5 minutes to complete. An
administrative problem resulted in the S.R.E. only being used 2-3 months
into the study when some cases had already been interviewed and 'missed'
so that S.R.E. scores became available for 54 cases and 80 controls.
8.4.5 Validity of the questionnaires
The validity or extent to which the questionnaires measure what they
purport to measure can be assessed by indirect methods. The term validity
implies a 'gold standard', and this is not available for symptoms.
Many of the questions have been derived from what convention has
shown to be the best. A number of questions used are very similar to
those used by Mr Murray (The Edinburgh Royal Infirmary Bell's palsy
questionnaire). Furthermore the questionnaire was also shown to two North
Manchester consultants for their comments and assessment.
Some of the questions e.g. on skin-type, relating to reactions
to the sun, however, had not been independently assessed. In piloting
the questionnaire on patient volunteers, ease or difficulty in answering
such questions sometimes resulted in modification of the wording of
the question. It has already been mentioned that the most ambiguous
or difficult questions in the questionnaire related to previous exposure
of HSV and cold sore history. These questions were largely based on
Grout's epidemiological survey of cold sores (1976).
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A tendency to over or underreporting could be assessed by checking
responses of cases and controls, with the incidences or prevalences of
diseases known to be associated, or lacking an association, with Bell's
palsy. Some questions were validated by finding an expected correlation
e.g. between the S.R.E. stress score, and responses to the questions
on emotional strain and depression (see results discussion p.165).
The main method of validation was however by clinical assessment
by the author and this is discussed further under "observers in the
study". Further independent sources of information were from GP's records
over medication when this was in doubt, and from consultant letters
to GP's, where available.
The problem of subjectivity in reporting is inevitable in this
type of study but by comparison with controls any systematic bias should
be reduced.
8.4.6 Administration of the questionnaires (case and control)
For 78 patients and all controls the interviews took place in the home.
2 patients however were interviewed at work. 1 patient moved house
and had to be contacted through FPC records. Several patients required
more than one visit to find them in, despite letters agreeing a convenient
time. One patient in Oldham was finally contacted and interviewed after
4 visits.
The questionnaires took on average 30-40 minutes to complete for
cases (which included an examination) and 15 minutes for controls. Before
proceeding with the questionnaire the interviewer spent about 5 minutes





Processing Data, Computing and Statistics
9.1 Data Processing
In accordance with general communication theory, data has to be handled
or grouped in meaningful ways as information, before it can be processed
as knowledge. The data sets incorporated into the design of the question¬
naires come under 2 main categories:-
Cases Controls
1) Documentation of clinical features of + -
interest in Bell's palsy - history,
examination, outcomes
2) Aetiological a) general - preceding exposure
data to a variety of aetiological
agents




- HSV history and
exposure
Furthermore the data was collected such that should sufficient be collec¬
ted, prognostic theories could be tested e.g. pain, pregnancy, age, taste,
diabetes, etc. with outcomes e.g. poor recovery from the paralysis.
The questionnaires were designed to look primarily at possible aetio¬
logical factors rather than to assess unfavourable outcome; nonetheless
cross tabulations and multivariate analysis were performed on many of




Coding of the case and control data was performed by the author and checked
before entering on the computer. 75 separate responses and data were
collected as a maximum per case questionnaire and 59 for controls.
9.3 Computing
The coded data was entered onto the mainframe IBM Nottingham University
computer using SPSS X. From this much information about frequencies was
obtained. Chi square tests were performed on case control data as were
cross tabulations and multivariate analysis examining aetiologies and
outcomes.
It subsequently became necessary to transfer this information to
Southampton University's IBM computer and this was achieved through
J.A.N.E.T. The author was subsequently involved in matching code numbers
such that match pair analysis could be performed.
Computing and statistics materials
SPSSX, Version 2.2. SPSS Europe BV, The Netherlands.
Minitab, Release 5.1. Minitab Inc. CLE.COM Ltd, England.
Microsoft Chart. Microsoft Corporation, 1987. US and Canada.
Hardware: IBM 3090-150 mainframe computer.
9.4 Case Control Study Methods
All cases and controls were matched for age by decade, sex, and social
group (upper, middle and lower). McNemar tests (with correction for
continuity) were applied to case-control match pair data. The results







Of the 80 case pairs on reviewing the information 1 was noted to be
mismatched in terms of social group, differing by more than one group.
For specific analysis e.g. skin-type further exclusions were made e.g.
all 8 non-caucasian cases were not matched. In this instance n was
71 .
Results are presented in terms of numbers of cases or controls,
percentages of cases or controls chi square, (with continuity correction),
d.f., p values and 95% confidence intervals.
9 .5 Statistics Used
Chi-square tests (y2)
All Chi-square tests were performed with Yate's continuity correction
factor. 95% confidence intervals (CI) were calculated for the difference
between the two population proportions (Gardner and Altman, 1989).
Mann-Whitney U test (M-W)
95% confidence intervals for the differences in population medians (Camp¬
bell and Gardner, 1988) are also calculated for this non-parametric
test.
Non-parametric correlation




Results of Epidemiological Studies
DESCRIPTIVE STUDY












Bolton 130 11.2% 23 9.1% 18 12.5%
Bury 86 7.7% 27 10.7% 17 11.8%
Rochdale 100 8.9% 27 10.7% 23 16%
Salford 170 15.2% 29 11.5% 15 10.4%
Manchester 280 25% 52 20.6% 25 17.4%
Oldham 115 10.3% 22 8.7% 18 12.5%
Stockport 140 12.5% 41 16.2% 18 12.5%
Tameside 100 8.9% 31 12.3% 10 6.9%
TOTAL 1,121 100% 252 100% 144 100%
Respondents to first letter 252 G.P's or 22.5% of Greater Manchester G.P's
Respondents to second letter 144 G.P's - a response rate of 57%
(12.8% of Greater Manchester G.P's).
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10.1 Study Incidence
Denominator information and 'corrections'
Using the information from the more consistently responding G.P's at
8 months. (Appendices 3b, 3c).
The total list size at 8 months = 361,111
Analysing the G.P. responses to the second letter:-
121 gave personal list sizes
15 gave shared list sizes:




mean list size = 2,200 (FPC information).
Correction of denominator for 8 missing lists = 378,711
This figure includes partners lists from which cases may have been reported.
Known total shared list size = 77,850
Case reporting
The number of cases of Bell's palsy reported over 1 year by the 144
more consistently responding G.P's = 62 cases
56 cases on the list of a participating G.P
6 cases from the list of a non-participating G.P
Thus, 7.7% of cases came from a non-reporting G.P's list.
This figure is comaprable with the percentage of the total denominator
which known non-reporting G.P's list constitute:-
77,850 = mean list size 2162.5 per shared list G.P.
36
21 non-reporting G.P's total list estimated at 45,412.5
Therefore, percentage of total denominator known to include








16.4 cases of Bell's palsy per 100,000 population per year.
However, this figure is likely to be a considerable underestimate -
see discussion.
Geographical Distribution of Cases
See A3 Pull-out Ordnance Survey Map of Greater Manchester (back page).
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10.2 Descriptive Study Results - Figures and Tables
Fig. 10.1 Reported Incidence of New Cases of Bell's Palsy per month














































Table 7: % of cases of Bell's palsy in different age groups and
% of G.M. population by age compared (1981 OPCS)
Age group Population by age
Greater Manchester
Bell's palsy
% of cases by age
0-4 6.2% 1 .25%
5-15 16.9% 8.75%
16-24 14.4% 7.5%
25 - 34 14.2% 18.75%
35 - 44 11.8% 18.75%
45 - 60 (?) or 65 (d*) 19.3% 30%
60 (?) 65 (✓) - 75 17.3% 8.75%
( * 1 .6% 0%
75+















%Cases %GreaterManchesterPopulation (0PCS1981) I
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Table 8: % of cases of Bell's palsy in different social groups and
% of economically active G.M. population by social group
compared
Group No. of cases % cases % economically active
Greater Manchester
population
1 5 6.4 5.2
2 12 15.4 21 .4
3 (3n) 14 17.9 12.1
4 (3m) 25 32.0 36.5
5 16 20.5 18.1





TOTAL: 78(80) 100% 100%
(figures in last column obtained from OPCS 1981 survey).
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Fig. 10.4: Social group distribution of cases and
Greater Manchester population
SOCIAL GROUP
% cases in each Social Group
% of Greater Manchester population
in each Social Group (OPCS 1981)
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Table 9: Sex incidence
. male 35
female 45









Interval before review (by the author)
35% of cases seen within 10 days
50% of cases seen at 2 weeks
95% of cases seen within 3 months from the onset of the palsy.
Table 11; Side involved and bilateral palsy
Right 39 cases (48.7%)
Left 41 cases (51.2%)
Bilateral 0 cases
History of recurrent palsy
recurrent palsy 3 cases or 3.75%








56 or 70% occurred during first 12 hours of day
24 or 30% occurred durring second 12 hours of day
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Table 12: Day of onset of facial weakness with respect to the menstrual
cycle
Day of onset in the cycle
Days 1-14 Days 15 - 28
2 cases day 2 2 cases day 21
1 case day 4 1 case day 27
1 case day 5
1 case day 6
1 case day 7
2 cases day 10
1 case day 14
Total 9 3
(no cases occurred after day 28 in longer cycles)
Table 13: Pregnancy and puerperium
1st trimester 2nd trimester 3rd trimester puerperium
cases 0 1 2 2
Total: 5 cases
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Table 14: Clinical indication of speed of onset
from normal to noticeable weakness of face
No. of cases %
6 hours 20 31.7
6-12 hours 28 44.4
12-24 hours 5 7.9
Days 10 15.9
TOTAL 63 100%
(Unable to say) 17
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ASSOCIATED SYMPTOMS
Table 15: Symptom reporting in Bell's palsy patients
Symptom Response Cases Response Controls
Auricular pain 38 yes ( 47.5%)
42 no ( 52.5%)
controls 1 yes (1.31%)
Occipital headache 13 yes ( 16.3%)
67 no ( 83.8%)
controls 0 yes
Auricular rash 0 yes
80 no (100%)
controls 2 yes (2.5%)
Dry eye 9 yes ( 11.3%)
71 no ( 88.8%)
controls 0 yes
Hyperacusis 9 yes ( 11.3%)
71 no ( 88.8%)
controls 0 yes
Right facial numbness 11 yes ( 13.8%)
69 no ( 86.3%)
controls 0 yes
Left facial numbness 20 yes ( 25%)
60 no ( 75%)
controls 1 yes (1.3%)





controls 5 yes (6.3%)
Vertigo 4 yes ( 5%)
76 no ( 95%)
controls 5 yes (6.3%)
Burning sensation
of face
7 yes ( 8.8%)
73 no ( 91.3%)
controls 3 yes (3.8%)
Alteration of taste 32 yes ( 40%)
48 no ( 60%)
controls 1 yes (1.3%)
(Primarily descriptive but control information included for interest)
g£Dryeye 3co
r+CD >-!co O
Hyperacusis Taste Auricularpain Occipitalheadache
Rightandleftfacial





(noted in 30 or 37.5% of cases)





a) Several days before 10 33.3
b) 12-24 hours before 7 23.3
c) 6-12 hours before 2 6.7
d) 0-6 hours before 1 3.3
e) at the time of onset 3 10
f) 0-6 hours after 2 6.7
g) 6-12 hours after 1 3.3
h) 12-24 hours after 2 6.7
i) Several days after 1 3.3
Unable to say 1 3.3
TOTAL 30 100%
Table 16:
(b) % of those giving a history of taste disturbance (n = 29)
in relation to the onset of facial weakness
Before onset (a, b, c) 65.6%
Approximately
coincidental (d, e, f) 20.7%
After onset (g, h, i) 13.8%
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HOSPITAL REFERRAL
15 cases or 18.75%.
Examination findings
Table 17: Diminished pin prick sensation to face (5th nerve)
Right side 5 cases 6.25%
Left side 7 cases 8.75%
TOTAL 12 cases 15%
No abnormality of the palatal reflex was found in any case (test of
9th cranial nerve).
Inspection of the vocal cords was only possible because of the nature
of the study in two patients seen for follow up in the university depart¬
ment of general practice. No abnormality of movement or position of
the cords was noted.
Permission for blood to be taken was obtained in 46 cases - see antibody
results (p.120).
The urine was tested in 43 patients by dipstix method. 8 out of 43
or 18.5% had glycosuria.
Features of the facial paralysis
Table 18: Gradation of paralysis
Of 80 patients giving a clear history of a sudden onset of facial weakness
the gradation was assessed as follows:-
56 cases 70% partial
24 cases 30% complete
1 18
Table 19: Examination of facial paralysis
50 cases (62.5%) significant residual weakness
30 cases (37.5%) less than 10% loss of power or early recovery
26 right sided : 24 left sided cases of facial weakness
Facial Nerve Recovery:
Severity and duration of paralysis
Response to letter at 6 months - see appendix 2e
47 out of 80 patients responded (59% response rate)
Table 20: Facial nerve recovery - (letter)
complete recovery 33
incomplete recovery 12
unable to interpret 2
TOTAL 47
Of 33 non-responders, information was already available from the interview
and examination, and 15 were known to have made a complete recovery. The
remaining 18 were then telephoned for missing information. The results
of the telephone enquiry were:-
Table 21: Facial nerve recovery - (telephone enquiry)
complete recovery 12
incomplete recovery 1
unable to say or
not contactable 5
TOTAL 18
It was possible to look for agreement between the letter and examination
for those recorded incomplete recovery by letter (2 false negatives
with examination as the gold standard). Because a further examination
was not carried out at the same time as the letter the number of false
positives could not be determined.
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Table 22: Facial nerve recovery at 6 months
complete recovery 60 (82%)
incomplete recovery 13 (18%)
TOTAL 73
Missing information - 7 patients
The reported disability at 6 months were as follows for 13 patients
stating incomplete recovery.
Table ^3: Residual problems at 6 months
7 loss of power
5 abnormal facial movements
8 abnormal hearing
1 impaired taste
5 abnormal loudness of sound
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TO VZV IN BELLS
PALSY PATIENTS
1st 2nd Samples taken
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10.4 Case Report
A 31 year old female patient was given the Sabin oral polio vaccine
and she noted at once a burning sensation in the left half of her tongue
which persisted for over a week. She noted also that taste was altered
after taking the drops and this persisted for several days.
47 hours later she developed a complete left sided facial paralysis
which became noticeable several hours after waking. Just before the
weakness developed she noted a patch of circumoral numbness on the left
side. Subsequently this spread to involve the entire left side of her
face. After the onset of the weakness the patient also noted abnormal
loudness of sound and pain within the ear.
The patient was seen and examined 72 hours after the onset of the
palsy when a complete left lower motor neurone lesion of the seventh
nerve was noted. In addition there was objective diminution to pinprick
and light touch sensation over the territory of all 3 divisions of the
left 5th cranial nerve and a diminished corneal reflex on that side.
The patient had a normal gag reflex and otherwise normal examination.
There was no family history of facial paralysis or of diabetes.
The patient herself was not diabetic. There had been no preceding
U.R.T.I or recent evidence of HSV infection.
At 6 months having been treated solely with physiotherapy the out¬
come was of residual paralysis with approximately 60% recovery of move¬
ment. There was synkinesia and also crocodile tears.
A sample for antibody studies was taken during the convalescent
period and showed 1/80 to polio type I but no other titres were raised
(HSV, VZV).
This case report is an interesting association between facial paraly¬
sis and taking Sabin vaccine. Previous reports to the C.S.M. include
1 optic neuritis, 1 encephalitis, 1 dizziness, 2 meningitis, 2
"paralysis" and 4 flaccid paralysis and 1 auditory vestibular tinnitus,
but no facial paralysis.
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Facial diplegia is known to occur during polio epidemics as part
of a bulbar palsy. May speculated that the ascending route of infection,
i.e. via the chorda tympani nerve is the principal route of entry of
virus in cases of Bell's palsy. The virus travelling at a rate of
2mm hour (slow axonal transport) would however probably take 2 days
to reach the geniculate ganglion and longer than this to reach the
brain stem. The early symptoms represent 5th nerve involvement as
well as the chorda tympani (taste pathways).
Both burning and taste disturbance were experienced immediately.
It is of some interest then that the patient went on to develop an
objective 5th and 7th nerve weakness on the corresponding side only
48 hours later. It is known that viraemia following the polio vaccine
does not usually occur until the 9th day. Thus the vaccine may have
acted by producing a "multifocal" reactivation of another virus rather
than being directly responsible for the nerve injuries itself although
serological support is lacking for this assertion. Alternatively the
burning might have represented a contaminant but this had not been





Clinical features of a left lower motor neurone facial lesion.
1) Face at rest
2) Smiling - lower divisions affected
3) Frowning - anterior belly of occipitofrontalis affected




RESULTS OF CASE-CONTROL STUDY
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GENETIC FACTORS
Table 25; Positive family history of Bell's palsy







Other relatives 4 0
Total Relatives 13 1
chi square 5.82 d.f. 1 p 0.02 95% C.I. 0.03, 0.20
Numbers of cases with a positive family history 11 or 13.8%
Number of controls with a positive family history 1 or 1.3%
Of the affected relatives of cases:-
9 or 69.2% were first degree
4 or 30.8% were second degree
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DIABETES
Individuals giving a personal history of diabetes.
3 cases, 3.8% non-insulin dependent type
0 controls
Table 26: : Positive family history of diabetes
Relative Cases Controls
1° relatives
Parent 4 (N), 1 (I) 4 (N), 3 (I)
Child 1 (N) 1 (N)
Sibling 0 0
2° relatives
Grandparents 3 (N), 1 (I) 6 (N)
Other relatives 3 (N), 3 (I) 2 (N)
Total relatives 16 16
A separate history of insulin dependent or non-insulin dependent diabetes
was recorded. (N) = non-insulin dependent, (I) = insulin dependent).
Number of cases with a positive family history of diabetes, 15 or 18.81%
Number of controls with a positive family history of diabetes, 14 or
17.51%.
Of affected relatives:-
1st degree relatives 6 cases, 43% and 8, 57% controls




Condition Cases Controls chi-
square
df P 95% C I
Pancreatitis 0 0 - - - -
Menibres
disease 1 (1.3%) 1 (1.3%) 0.50 1 0.48 - -
Migraine 10(12.5%) 13(16.25%) 0.21 1 0.65 -0.15 0.07
Schizophrenia 0 0 - - - - -
As thma 2 (2.5%) 6 (7.6%) 1.12 1 0.29 -0.13 0.02
Drink problem 0 0 - - - - -
Heart trouble 4 (15%) 2 (2.5%) 0.00 1 1 .00 -0.04 0.0
Endocrine,
e.g. thyroid 0 7 (8.9%) - - - - -
Rare endocrine
disease 0 0 — — — — —
Genital herpes 0 0 - - - - -
Mouth ulcers 10(12.5%) 25(31.6%) 6.76 1 0.01 -0.34 0.0
Hypertension 12(15%) 5 (6.3%) 2.12 1 0.145 -0.01 0.20
Drug history
Diuretics - 7 cases, 2 controls; tablets for arthritis - 3 cases, 4
controls;
Analgesics - 0 cases, 0 controls; pentazocine, 0 cases, 0 controls;
chlorpropamide, 0 cases, 0 controls.
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Table 28: Alcohol consumption/preceding exposure
Alcohol consumption 24 hours before onset of facial weakness - cases
Alcohol consumption previous 24 hours - controls.
Cases Controls
Alcohol consumed YES 9 (11.3%) 29 (36.3%)
NO 69 (86.3%) 51 (63.8%)
chi-squared 12.00 d.f. 1 p < 0.001 95% C.1 - 0.39, -0.11
Table 29:Smoking habits
Cases Controls
YES 31 (38.8%) 22 (27.8%)
NO 49 (61.2%) 57 (62.2%)
chi-squared 1.73 d.f. 1 p 0 19 95% C.1 -0.04 , 0.28
Table 30:Nailbiting
Cases Controls
with habit 22 (27.5%) 20. (25%)
chi-squared 0.03 d .f. 1 p 0.86 95% C.1 -0.12, 0.17
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Table 31:Non-specific or upper respiratory tract infection in previous
2 weeks
Symptoms Cases Controls chi- d.f P 95% C.1
squared
an illness with
a temperature 18 (22.5%) 4 (5.1%) 6.86 1 0.01 0.05, 0.29
A cough, cold or
chest infection 25 (31.3%) 10 (12.7%) 4.97 1 0.03 0.03, 0.31
a sore throat 20 (25.0%) 9 (11.0%) 4.76 1 0.03 0.03, 0.26
Table 32: Exposure to draught
Cases Controls
YES 12 (15.0%) 6 (7.5%)
chi-squared 0.64 d.f.1 p 0.42 95% C.1 -0.04, 0.15
Table 33:Exposure to cold or chilling
Cases Controls
YES 6 (7.5%) 2 (2.5%)
chi-squared 1.50 d.f. 1 p 0.22 95% C.1 -0.01, 0.11
Table 34: Increased physical strain or work
(in 2 weeks prior to facial weakness cases -
or previous 2 weeks controls).
Cases Controls
YES 9 (11.3%) 3 (3.8%)
chi-squared 2.08 d.f. 1 p 0.15 95% C.1 -0.01, 0.17
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Table 35; Exposure to bright sunlight
(24 hours prior to onset of facial weakness - cases
previous 24 hours, controls).
Cases Controls
YES 6 (7.5%) 2 (2.5%)
chi-squared 1.12 d.f. 1 p 0.29 95% C.1 -0.02, 0.12
Table 36: Skin type
Type Cases Controls
Burn 33 (46.5%) 17 (21.5%)
Burn > Tan 13 (18.3%) 17 (21.5%)
Tan > Burn 7 (9.9%) 23 (29.1%)
Tan 18 (25.9%) 22 (27.8%)
chi-squared 7.50 d.f. 1 p 0.01 95% C.1 0.08, 0.41
Table 37:Recent history - previous 3 months, of depression
Cases Controls
YES 16 (20.3%) 3 (3.8%)
chi-squared 8.47 d.f. 1 p < 0.01 95% C.1 0.07, 0.28
Table38: Emotional strain in preceding month - subjective assessment


























Table 39: History of gingivo stomatitis
Cases Controls
YES 0 2 (2.5%)
chi-squared 0.00 d.f. 1 p 1.00 95% C.1 -0.11, 0.07
Table 40: History of cold sores / first noted
Those giving a clear history of cold sores
40 (51%) cases and 36 (49%) controls
chi-squared 0.25 d.f. 1 p. 0.62 95% C.1 -0.11, 0.22














cold sores first noted as a child versus not as a child
chi-squared 0.00 d.f. 1 p. 1.00 95% C.1 -0.55, 0.30
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d.f P- 95% C . I.
Positive family B.P. history 5.82 1 0.02 0.03 0. 20
Family history diabetes 0.00 1 .00 -0.11 0. 14
History Menihres disease 0.50 1 0.48 - -
History migraine 0.21 1 0.65 -0.15 0. 07
History asthma 1.12 1 0.29 -0.13 0. 02
History heart trouble 0.00 1 1 .00 -0.04 0. 07
History mouth ulcers 6.76 1 0.01 -0.34 0. 06
History hypertension 2.12 1 0.15 -0.01 0. 20
Alcohol consumption
(previous 24 hours) 12.00 1 <0.001 -0.39 -0. 1 1
Smoking habits 1 .73 1 0.19 -0.04 0. 28
Nailbiting habits 0.03 1 0.86 -0.12 0. 17
Recent history of
depressive illness 8.47 1 <0.01 0.07 0. 28
An illness with a
temperature - 6.86 1 0.01 0.05 0. 29
URTI cough, cold or
chest infection - 4.97 1 0.03 0.03 0. 31
URTI sore throat 4.76 1 0.03 0.03 0. 26
Exposure to draught 0.64 1 0.42 -0.04 0. 15
Exposure to cold or
chilling - 1 .50 1 0.22 -0.01 0. 1 1
Increased physical work or
strain in previous 2 weeks - 2.08 1 0.15 -0.01 0. 17
Exposure to bright sunlight
in last 24 hours - 1 .12 1 0.29 -0.02 0. 12
Skin type 7.50 1 0.01 0.08 0. 41
Emotional strain/stress over
preceding month 9.76 1 <0.01 -0.44 -0. 1 1
History gingivo stomatitis 0.00 1 1.00 -0.11 0. 07
History of cold sores 0.25 1 0.62 -0.11 0. 22
Cold sores first noted as
a child v. not child - 0.00 1 1 .00 -0.55 0. 30
138
CHAPTER 11
Further Background to the Epidemiological Studies
and discussion of the results
11.1 Introduction
The purpose of this chapter is to cite unequivocal evidence of relevance
to the discussion, and at the same time highlight the complexity of
linkages between proposed and supposedly simple aetiological factors
such that the results are not interpreted in an oversimplistic or un-
thought out way.
Much of the research background and particularly that of relevance
to the case-control (aetiological) study can be found in the first three
chapters. This review then, examines a wide background under numerous
headings which relate to either individual questions or themes in the
questionnaires. These themes are firstly pure description of the clini¬
cal condition in British general practice and secondly aetiological
themes. This second group includes genetic factors, physiological factors
and HSV disease and its associations and also general factors of
aetiological significance not readily fitting the above categories.
The approach is however one based on particular clinical or epidemiological
observations of value to the discussion. Later, expansion is made using
humoral patterns as an epidemiological theme. The advantage of this
is to show the possible interrelatedness rather than separateness of
proposed aetiological factors. This discussion is under the headings
of menstruation and pregnancy; Bell's palsy, diabetes and opioid sensi¬
tivity; and opioid sensitivity - further considerations. HSV reactivation
and recrudescence are also reviewed at the end of this section - for
although many aetiological agents are involved in these processes physio¬
logical "disorders"; "stress, menstruation or further humoral patterns
are again discernible. This is highly relevant to the proposed aetiology
of Bell's palsy because of the observed aetiological similarities".
The case control study examines for differences in "humoral patterns"
between Bell's palsy cases and controls. The addition of an antibody
study (for HSV) would give an indication of the proportion of cases
(with negative serology) where humoral factors if present would have
to be acting independently of an HSV associated aetiology.
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Ideally any background review should be impartial and the author
is aware of his own partial or selective bias which cannot be avoided
in setting up such a study.
11.2 Clinical Incidence and Background
The incidence of 'infratemporal' facial palsy varies in Europe between
11.5 and 18.8 patients per 100,000 per year, although higher figures
are reported from Egypt, Columbia and India (from the proceedings of
the 3rd International Sympsium on Facial Nerve Surgery, Ed. U. Fisch
1977). In America, Hauser (1971) calculated the incidence of Bell's
palsy in Minnesota at 22.8 per 100,000 population per year. Verjaal
in Holland (1955) estimated an incidence of 20 per 100,000 adults and
5 per 100,000 children. In a study by Fisch (1979) the percentage of
cases of Bell's palsy occurring in children was 20.5% (365 patients
total).
In Australia a survey (Seymour 1977) demonstrated that 57.6% of
GP's see 1-3 cases of Bell's palsy a year, 37% see less than 1 case
per year and 6% see more than 3 cases per year.
Hamberger collected a series of national incidence figures (cited
by Fisch 1977) :-
England 16.6 per 100,000 per year
Scotland 16 "
Norway North 18.8 "
Sweden South 11.5 "
Sweden Whole 16 "
In adult series the percentage of facial palsies classified as idiopathic
is 63% (Cawthorne and Haynes 1956), 80% (Ztllch 1970), and 66% (Tomita
1972). In children's series 60% were noted to be idiopathic by Manning
and Adour 1972 but only 28% by Albert! and Biagioni 1977.
Adour in 1974 examined 419 patients in the San Francisco Bay area
with Bell's palsy over a 3 year period. He found no evidence of
periodicity or epidemicity considering the group as a whole or studying
age-sex subgroups using Edwards (1961) method of statistical analysis.
He concludes that a 'common cause' for Bell's palsy would have to be
non-contagious, randomly distributed in a general population affect
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persons of all age groups and not be temporally related to the seasons
of the year (cases following a random Poisson distribution). However
diseases involving a carrier or latent state and where subclinical
illness is common, may confound easy explanations as for example did
early attempts to understand polio epidemics. This may be argued to
be the case in Bell's palsy which furthermore has a low incidence.
In 1978 Adour makes the unsupported assumption that epidemics do
occur on the basis of his clinical impression but generally the disease
appears not to be contagious. Brodie in a retrospective study of 104
cases found a lower incidence in the summer months May, June and July.
El-Abiary and Leibowitz in an Egyptian study showed an increased incidence
in August using age sub-groups.
Gomes (cited by Fisch 1977) has shown the incidence of Bell's palsy
is greater at altitude (22 per 100,000 at 9,000ft) than sea level (15
per 100,000). He argues that a low atmospheric pressure 560mmHg, hypoxia
and hypocarbia predispose to Bell's palsy, and that Bell's palsy was
higher in the months in which there was more fluctuation in atmospheric
pressure. Devreise (1982) however argues that atmospheric pressure
influences the different pressure systems equally and accordingly does
not disturb the pressure gradients.
11.2.1 Age-sex distribution
According to Adour (1978) the incidence of Bell's palsy increases with
each decade of life but it is clear that these are not corrected incidence
figures. The incidence reaches 30-35 per 100,000 per year after the
age of 60. In this study the overall incidence of males to females
was approximately equal, but in the second decade of life the condition
was twice as common in females. Brodie (1979) found a ratio of 5:1,
F:M in this decade, Hauser (1971) and El-Abiary (1971) also found an increased
F:M ratio in this decade. Adour also noted that after the age of 40
Bell's palsy was 1.5x more common in males and suggested that this shows
a relation to menarche and menopause.
11.2.2 Recurrence and side of palsy
El-Abriary (1971) noted recurrence was twice as common in females as
males.
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In Brodie's (1979) hospital based retrospective study 8.9% of the
patients gave a history of previous facial palsy. Adour (1975) found
a previous palsy in 9.4%. In two large retrosepctive series from Japan
(Yanagihara N. et al. 1984) the incidence of recurrence was 2.2% (1,154
patients) and 2.0% (1,119 patients) for unilateral Bell's palsy. The
incidence of bilateral disease was 0.7% and 1.2% respectively - for simul¬
taneous palsies and 2,1% and 3.3% for alternating bilateral palsies.
Thus the majority of patients with Bell's palsy belong to the
unilateral nonrecurrent type. Yanagihara found that male preponderance
was apparent in the simultaneous bilateral type 20 patients (91%), and
female preponderance in the unilateral recurrent type 31 patients (61%),
particularly under 19 years of age. The interval between attacks is
more than one year in the majority of cases.
11.2.3 Preceding exposure and associated symptoms
Adour (1978) records a preceding URTI in 20%, fever in only 2%, facial spasm
in 22%, headache in 10%, fatigue in 3%,and facial numbness in 32% with
undetermined symptoms in 36%. Pecket (1982) found that taste dis¬
turbance was commoner in non-diabetics, 83%, as opposed to those who had
diabetes, 14%.
Adour (1974) found no evidence of an increased incidence in winter
months rather than summer months. This does not really test the 'draught'
hypothesis, as draughts cannot be quantified seasonally.
Pieterson (cited by U. Fisch 1977) gives the historical incidence
of exposure to:-
draught 15%
colds and influenza 8%
(and preceding taste disorders in 35%)
However no control figures are given by either Adour or Pieterson in
their studies.
11.2.4 P.acial factors
Seymour (cited by U. Fisch 1977) reporting on the incidence of Bell's
palsy found no difference between the general Australian population -
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predominantly Caucasian, and aborigines. Not only do aborigines differ
genetically but they also exhibit a different pattern of primary H.S.V.
infection. Unlike Caucasians most primary infection occurs in early
life (before 4 years) and the secondary peak in teenage years noted
in Europeans is absent. It would be interesting to know if Bell's palsy
occurred in a younger age group in aborigines than Caucasians as this
would give information as to whether timing of first exposure to HSV
(primary infection) was important in developing Bell's palsy.
11.2.5 Genetic factors in Bell's palsy
A positive family history is one in which Bell's palsy occurs in a first
degree relative i.e. parent, sibling, child, or second degree relative
i.e. grandparent, grandchild, cousin, aunt, uncle, nephew or niece.
Alter in 1963 studied 105 patients with presumed Bell's palsy and
found 30 of their relatives had a positive family history of facial
paralysis which would fit with a diagnosis of Bell's palsy. In 105
controls he noted only 4 relatives had a history of paralysis. Alter
concludes that Bell's palsy is a dominantly inherited disease with reduced
penetrance.
De Santo and Shubert (1969) reported 10 cases of Bell's palsy in
a single family spread over 83 years, but the highest reported family
incidence of Bell's palsy was by Willebrand (1974) who noted 29 cases
in three generations over 40 years. A 6% family history was noted by
Willebrand out of 230 cases. This study also concluded that an autosomal
dominant inheritance with incomplete penetration was the likely mode
of inheritance.
Adour (1978) found that 8% of relatives had a positive family history
of Bell's palsy and Brodie in a Scottish study found 13% of rela¬
tives had a positive family history. In neither study was a control
rate given. A Mexican study (Alfonso-Vilat®la 1979) gave the highest
positive family history in world literature at 30.5% for first degree
relatives and the control group figure was 3.6%. These authors propose
multifactorial inheritance.
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Autosomal dominant inheritance seems the most favoured. Presley
(1978) a general practitioner observed 5 members of one family with
Bell's palsy. Further support comes from Hilger 1949, Wilson and Bruce
1953, Danforth 1964 and Kakar et al 1966. Autosomal recessive inheri¬
tance was reported by Johnson and Stoesser 1937 and Danforth 1964.
11.2.6 Menstrual cycle
In Adour's 1978 study 123 women offered a menstrual history of 28 days.
The rate of Bell's palsy was highest on the first menstrual days with
a small secondary peak from day 11 to 17 (around the time of ovulation).
65% of cases occurred in the first half of the menstrual cycle with
a sharp decline in incidence the week before the next menses. It appears
that women who do not menstruate every 28 days were excluded from this
study!
11.2.7 Pregnancy
Sir Charles Bell first suggested a possible association of facial
paralysis with pregnancy in 1830. A number of authors have further
studied this state for statistical correlation but because of few cases,
Pope 1969, Korczyn 1971 and Robinson 1972 failed to demonstrate an asso¬
ciation of Bell's palsy with pregnancy. Hilsinger in 1975 found the
frequency of Bell's palsy in pregnant women was 45.1 per 100,000 births.
Per year of exposure the increased risk of pregnant women was calculated
as 3.3 x higher than for non-pregnant women in the same age groups.
The incidence in the third trimester and puerperium was 118.2 per 100,000
per year of exposure, showing this to be the greatest 'at risk' period.
Adour in 1978 apparently using the same cohort as Hilsinger states that
Bell's palsy is 3x more likely to develop in the third trimester than
in the first c>r second trimesters.




Hilsinger 1975 6 31 5 42
Adour 1978 1 8 28 7 44
From the above table it can be seen that the increased risk is actually
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much greater, 10.3 (Hilsinger) and 6.5 (Adour) averaging the first two
trimesters.
Although the numbers used in this study are small the finding of
only 1 patient in the first trimester might be interpreted that early
pregnancy has a protective effect on potential Bell's palsy sufferers!
11.3 Humoral Patterns
11.3.1 Menstruation and pregnancy
"The monthly activities of the ovaries which marks the advent of puberty
in women has a notable effect upon the mind and body: wherefore it
may become an important cause of mental and physical derangement"
- Henry Maudsley 1873. The diversity of such activity is well reviewed
by Magos and Studd (1985).
Hilsinger in 1975 writes that "there was no apparent correlation
between hormonal changes that characterize the phases of the menstrual
cycle and the observed higher incidence of Bell's palsy during the first
half of the cycle of the women in this series. These events also cast
doubt on the possible aetiological relation of hormones to facial
paralysis in pregnancy". However during that same year endogenous opioid
peptides were discovered and much has since been done to define the
complex physiology of these neuropeptides. Fachinetti1 (1987) notes
that g-endorphin levels have a rhythm throughout the normal menstrual
cycle. The acrophase occurring around mid-cycle L.H. peak, and ovulation.
In this study the plasma B-endorphin level (which seems to parallel CSF
opioid activity - Fachinetti 19872) varied very little. However in
11 patients with premenstrual syndrome a fall in B-endorphin activity
occurred 8 days before menstruation with low levels occurring from 5
days before menstruation to the second or third day of menstruation
with a peak of endorphin activity on the fourth day of menstruation
(p < 0.05).
This pattern would appear to approximately mirror the observed
incidence of Bell's palsy with the menstrual cycle, whereas oestrogen,
progesterone, FSH and LH levels do not. As Bancroft (1985) states,
it is difficult to be certain in view of the subjectivity involved how
many women suffer from premenstrual syndrome - "but the possibility
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that large numbers of women are adversely affected by premenstrual
changes has to be taken seriously". This author quotes figures of
between 29-97% from retrospective studies. Immature humoral cycles
characterize the second decade of life, a group in which conceivably
endorphin levels may fluctuate and predispose to Bell's palsy?
With respect to the menopause* g-endorphin levels are increased
at the onset of subjective flushes and naloxone reduces the number of
flushes as well as the number of L.H. pulses (Genazanni 1984, Light-
man 1979, 1981) pointing to a role for opioid peptides in menopausal
flushes. However some authors have disputed these findings (Tulandi
1985) .
During human pregnancy plasma concentrations of ACTH and ACTH
related peptides increase significantly (Csontos et al 1979, Carr et
al 1981, Newnham et al 1983, Abou Samra et al 1984). g-endorphin rises
from low plasma levels at 9-12 weeks to normal values at 13-16 weeks
with further progressive and significant increases until term. At term
the values are the highest recorded during pregnancy with maximum values
occurring during delivery (Genazzani 1981). Fletcher et al (1980) found
g-endorphin levels were low before labour but rose dramatically in second
stage with the highest levels being recorded post partum (> 60 t mol/ml
plasma of gE.L.l). The increased sense of well being and raised pain
threshold of the puerperium suggests that g-endorphin levels remain
high during this period.
Thus g-endorphin changes in pregnancy from low to high values also
reflect the changing incidence of Bell's palsy throughout pregnancy
and the puerperium. The correct interpretation of the significance
of such an association however requires further information.
In pregnancy other peripheral neuropathies may occur such as
brachial neuralgia and carpal tunnel syndrome. In the latter condition
fluid retention is thought to cause compression and ischaemia of the
median nerve under the flexor retinaculum. It has been speculated that
Bell's palsy is caused by the involvement of the facial nerve in the
oedema process, causing compression in the temporal bone. Mair points
out that there is no association of Bell's palsy with the combined oral
contraceptive pill, which also produces tissue oedema. Hilsinger (1975)
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found no association of Bell's palsy with toxaemia of pregnancy, a condition
also associated with tissue oedema. A further argument against oedema
as a cause comes from the observation that the inferior alveolar nerve
which also runs a long course through a bony canal is not affected
during pregnancy.
Certain viral infections are commoner in pregnancy e.g. C.M.V.
infection, also HSV infection is commoner in pregnancy (Naib 1973) and
the lesions appear to be more severe. Gestational immunosuppression
induced by high steroid levels is one theory as to why HSV may reactivate
during pregnancy (Jewett 1975). HSV is also reactivated during menstruation
and by rises in body temperature.
In conclusion it would appear that Bell's palsy is more likely
to occur when (^-endorphin levels are likely to be high and least common
when the levels are likely to be low (premenstrually in some women
and early pregnancy). It could be then that susceptibility to
rapidly fluctuating levels of g-endorphin at menarche, menstrually and
at ovulation, menopausally and later pregnancy and the puerperium, is
the more important factor in such an hypothesis.
A viral reactivation hypothesis is also supported by the weak
epidemiological evidence and it is the author's contention that either
the viral or humoral hypotheses remain tenable upon reflection of these
observations.
11.3.2 Diabetes, Bell's palsy and 'opioid sensitivity'
Adour in 1978 stated that Bell's palsy is 4.5 x more likely to develop
in the diabetic than the non-diabetic person. The high incidence of
diabetes in Bell's palsy patients noted by Korczyn (1971) has already
been stated - with 66% of patients having abnormal G.T.T's or overt
diabetes. Of 130 patients, 18 were known diabetics, another 8 had a
fasting blood glucose above 130mg/100ml and 62 had abnormal G.T.T.'s.
The author states that Bell's palsy may be the first manifestation of
diabetes; and that in any patient presenting with this neurological
deficit glucose tolerance should be checked. However it should be noted
that the control frequency in the Israeli population is between 12-14%.
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Adour in 1975 found an 11.4% incidence of diabetes in an American
study. Pecket (1982) in another Israeli study found that out of 126
patients with Bell's palsy overt (chemical) diabetes mellitus was found
in 39% of cases using Fajam and Conn's criteria (1959), and postulates that
some cases of Bell's palsy may be a diabetic mononeuropathy. This
figure might be further increased if Bell's palsy patients were
followed up over a period of many years as many Bell's palsy patients
suffer their condition at an age (mean age for this study 44 yrs) which pre¬
dates the likelihood of N.I.D.D developing (mean age 58 yrs, Burrows et al.
1987). Thus in this sense the strength of the association between the
two conditions might be underestimated.
In a Dutch study Abraham-Inpijn 1982 could not find an association
of diabetes with Bell's palsy using controls although the incidence
was high in both; 56% in B.P. and 45% in controls using WHO criteria.
Brodie's study revealed that only 2 of 104 cases were known diabetics,
but was disadvantaged by being retrospective, and it is not clear if
urine or blood was tested for glucose in all cases.
Factors which make studies difficult to interpret are geographical
variations in the incidence of diabetes; the criteria by which diabetes
is diagnosed; the sex and mean age of the screened group; the lack
of controls; and the severity of the nerve lesion produced. Furthermore
the more carefully any condition is looked for the more likely it is
to be found.
It is interesting that ether nerves affected by a mononeuropathy
all traverse an anatomically enclosed space which makes them especially
vulnerable to the effects of ischaemia (Richards 1951). Pecket argues
because taste is spared more often in diabetes the lesion must be distal
to the bifurcation of the facial nerve and chorda tympani. However
this assumes that all fibre types myelinated and non-myelinated are
affected equally by the disease process. Damage to the nerve is presumed
to be due to a microangiopathy, but evidence for this is lacking
histologically in Bell's palsy.
Diabetic mononeuropathy tends to occur in mild diabetes (N.I.D.D)
of short duration, and independent of other types of diabetic neuropathy
(Fraser 1979). Vascular manifestations of diabetes are thought to be
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independent of the metabolic abnormality. Precisely how these vascular
manifestations come about is unknown. Interestingly Pike in 1978 has
defined a population genetically more susceptible to N.I.D.D. who flush
with chlorpropamide and alcohol. He attributes this to an underlying
sensitivity to opioid peptides. Although the mode of inheritance
postulated has since been contested (autosomal dominant with impaired
penetrance) the opioid hypothesis remains a tenable one.
To date several studies exist which confirm a strong genetic element
in the transmission of susceptibility to Bell's palsy and considering
the association of Bell's palsy with abnormal G.T.T's, it seems reasonable
to suggest that those with "a genetically determined underlying sensitivity
to opioids" are also a susceptible group for developing Bell's palsy.
It is surprising that this hypothesis has not been advanced considering
the epidemiological associations of "stress" with the onset of acute
Bell's palsies.
11.3.3 Opioid sensitivity and further considerations
Individuals might be collectively grouped into those in whom production
of endogenous opioid peptides has been increased for whatever reason,
and those with receptor population distribution and characteristics
determining a "sensitive" response.
Opioid sensitivity may be determined by receptor type with certain
individuals more predisposed to respond. For example the kappa receptor
is not significantly present in about frd of the general population
as evidenced by only ird responding to pentazocine as an analgesic.
Pentazocine is a kappa agonist with little demonstrable activity on
jjm or 6 receptors. Little is known of the genetics of opioid receptor
type distribution. N.I.D.D. has been postulated as an 'opioid sensitive'
disease. Could the basis in both N.I.D.D. and Bell's palsy be connec¬
ted with the kappa response? This would group certain individuals
(approx. ird of the population) as opioid 'sensitive' who would be 'at
risk' of developing either disease.
A variety of stimuli will increase the production of endogenous
opioids (pituitary B-endorphin), cold stress, physical stresses,
psychological or emotional stress, bright sunlight (POMC), menstruation,
ovulation, late pregnancy and the puerperium. And some stimuli will
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lower endogenous opioid production e.g. exogenous high dose steroid
administration and early pregnancy. (These lists exclude endocrine
diseases).
The effect of increasing age on opioid peptides is broadly to
increase opioid receptor populations due to falling transmitter
production. Early in life opioid receptors may be few. During periods
of marked growth G.H. levels can be found to be raised and 'growing
pains' may be due to low endorphin levels? These two hormones enjoy a
reciprocal relationship with opioid pathways involved in control of
G.H. release. During periods of rapid growth 0-7 and 12-20 the incidence
of B.P. is low, except in the second group in young girls where maturation
of menstrual cycle control may be a compounding factor. It is interes¬
ting to speculate why recurrent Bell's palsy should be most frequent
in teenage girls, and this observation should surely lend weight to
a humoral hypothesis.
Evidence of a circadian rhythm in the incidence of Bell's palsy
would also lend support to a humoral hypothesis.
11.4 HSV Reactivation and Bell's Palsy
HSV reactivation is reviewed by Klein (1982). It must be admitted that
little is known of the exact nature of HSV latency in neurones. Even
less is known about the mechanisms of virus reactivation. Triggers
to reactivation may occur at either the level of the ganglion or skin.
If the ganglion is the site of reactivation then the virus must travel
centrifugally to the periphery where it may then produce an infection
of the skin or mucosa (recrudescent lesion). Longson (1970) writes
that whatever the mechanism of the phenomenon of reactivation is, "reac¬
tivation of endogenous HSV to produce recurrent herpes is a common,
almost physiological, even if unwelcomed 'fact of life' for almost half
of mankind".
Factors associated with HSV reactivation in animal experiments
include; section of the nerve (Walz et al 1974) intratracheal injection
of pneumococci (Steven et al 1975) postganglionic neurectomy (Price
and Schmitz 1978) cyclophosphamide or Xrays (Openshaw 1979) cyclophosphamide,
prednisolone, antithymocyte serum or trauma to the ganglion (Hill et al
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1981) dry ice on the lip (Openshaw 1979) cellophane type stripping/
depilation, xylene, retinoic acid or DMSO (Harbour et al 1983). Of
all these perhaps only intratracheal pneumococci is of direct relevance
to Bell's palsy epidemiology where preceding URTI has been noted by
Adour 1975. It is also puzzling that prednisolone may produce a reac¬
tivation (by immunosuppression?) yet at the same time be used to treat
Bell's palsies.
It must be stated that there is still much to learn about the process
of HSV neural reactivation and its likely frequency in human subjects.
It is interesting to note that stimulation of the pain pathways or proto-
pathic receptors produces reactivation.
11.4.1 Recurrent HSV and Bell's palsy
Recurrent HSV has been recognised for centuries:-
O'er ladies' lips, who straight in kisses dream.
Which oft the angry Mab with blisters plagues
Romeo and Juliet, Act I, Scene iv.
More recently Grout (1976) has described the epidemiology of cold sores
in general practice. Wildy (1982) when describing recurrence states
that "the factors leading up to it are so complex that except for
immunological factors and mediators of inflammation - in particular
the prostaglandins - little direct use can be made of the findings".
He also considers "latency and reactivation in the ganglion represent
a phenomenon quite distinct from recurrence of infection or recrudescence
at the periphery". Thus factors associated with HSV recurrence and
associated with Bell's palsy need cautious interpretation. Factors
associated with recurrence include pyrexia (Warren 1940, Greenberg 1969)
sunburn and UV light (Blyth 1976, Spruance 1985), trauma (Hill 1978)
menstruation and pregnancy (Scott 1957) and stress (Schmidt 1985).
Of this list of factors all have been implicated in Bell's palsy
aetiology. Of these stress and fatigue and UV light exposure have not
been "quantified". In Schmidt's study the appearance of recurrent herpes
labialis appeared to be related to "state not trait", that is to stress¬
ful life events and anxiety rather than personality factors.
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However no studies to date have looked at recent stressful life
events and Bell's palsy incidence. U.V. light exposure is difficult
to quantify in a study of this type although the skin's response to
U.V. light may be assessed (skin type). In both types of assessment
controls are necessary.
Recent interest has focused on the role of surgical trauma and
associated Bell's palsy. 6 cases being reported by Smith et al. (1990)
on average 5 days after uncomplicated stapedectomy. The reasons for
such delay in presentation though obscure could be conceivably related
to the delay involved in ganglionic reactivation of HSV and in inter¬
feron/opioid production. Because of the comparative rarity of such
procedures and the fact that recent head injury would have resulted
in diagnostic exclusion, trauma was not examined as a possible aetiolo-
gical agent in this study.
11.5 Comments on Results and Findings with Discussion of the Methods
The observers in the studies and the selection process
The patient, their families, friends and associates are the first obser¬
vers of the illness and their sensitivities and responses will richly
vary. The referral process begins with the patient him or herself and
depends on the many factors which influence illness behaviour. In the
case of Bell's palsy loss of power to the face has a 'frightening
immediacy' to it, and older patients may think they are experiencing
a stroke. It is highly likely therefore that patients with a noticeable
weakness of the face will be seen by their practitioner. 70% of nerve
fibres may degenerate before facial movements become noticeably weaker
leading to the belief that sub-clinical Bell's palsy must be relatively
common. Screening the population by electroneurography and seeing which
patients develop a Bell's palsy is not a viable proposition however!
This observation is unimportant from a descriptive standpoint but is
highly relevant to the aetiological study.
There is an important difference in health status between the Bell's
palsy cases and the relatively healthy controls which introduces a bias
into the case-control study results. In my clinical experience patients
generally possess a greater degree of sensitivity than healthy people
in observing aspects of human behaviour as w°ll as being involved in
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self-rationalizing the phenomenon of illness. Furthermore ill people
are more likely to consider themselves depressed than healthy people.
The General Practitioner as observer
By and large, Bell's palsy is a condition which general practitioners
diagnose well. It is a clearly visible sudden weakness of the face,
often in a young person. Only 2 false positives were noted by the author
in 82 referrals. It should be noted that the GP's in the study were
self-selecting, in terms of interest, with only 22.6% of all GP's contac¬
ted initially responding.
The author as observer
In this study a single observer was used to confirm the diagnosis of
Bell's palsy and to interview cases and controls. This has both advan¬
tages and disadvantages. For all interviews (case and control), the
disadvantages include observer bias (tends to be random), inconsistent
application or lack of stringency in diagnostic criteria, and dangers
of any systematic misclassification. The diagnosis of Bells palsy cases
by the author correlates highly with the diagnosis achieved by other
GP's. This consistency of observation only validates the general prac¬
titioners and the author if one accepts that adequately stringent criteria
were applied by the author.
Bell's palsy and secondary care
Difficulties exist because of the referral system as to which specialist
normally reviews Bell's palsy patients, but these include ENT surgeons,
neurologists, general physicians, general surgeons, paediatricians and
casualty consultants. Furthermore in Greater Manchester a patient with
Bell's palsy might normally be seen in any of 20 district and teaching
hospitals. The inpatient register would only identify those cases of
Bell's palsy admitted to hospital which are very few compared to those
seen in O.P.D.; and as a 1 in 10 sample cases may well be missed.
Validation by means of hospital information was considered too problema¬
tical for a study of this size.
In some instances the practitioner decided to refer the patient
to a hospital consultant but a large percentage (81%) were not so
referred. It may be argued that this percentage is so large because
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referral to the department acted as a "substitute hospital referral".
The process of referral in this study differs from the usual 'vertical'
referral to a hospital consultant, and is unusual inasmuch as it consti¬
tutes a more 'lateral' referral e.g. to. a fellow general practitioner
albeit in academic practice. Such a process is inherently selective,
however severity, worrying clinical features, or patient demand should
operate less strongly in this type of referral, given the nature of
the study. On balance it is not unreasonable to suppose that this type
of study generates more cases of less severe types of Bell's palsy and
is more representative of Bell's palsy as seen in general practice;
and may be reasonably claimed to be more typical of the natural history
of the disease than is encountered in hospital.
11.6 Discussion of the Descriptive Epidemiological Study
This study is unique in being a large general practice based study of
Bell's palsy in this country. Only V5th of cases were referred to
hospital and so the study sets out features of the natural history of
the condition as experienced in primary, rather than secondary care.
Indeed, 37.5% of patients who had given a clear history of facial weakness,
and whom the GP had diagnosed as Bell's palsy, had regained over 90%
of facial function by three weeks. Thus, the case sample reflects,
as one might expect, a high preponderance of less severely affected
individuals, in which to study features of the condition. Although
perhaps surprisingly this figure is not that different from Pietersen's
(1982) study - 30% recovery at 1 month.
The study incidence is an approximation of the true incidence in
as much as it can be determined. It does not take account of those
cases not reported to the author for whatever reason, and no checking
system could be reliably applied by the author, e.g. from hospital refer¬
ral information. The incidence of 16.4 per 100,000 population per year
is comparable with other European studies, however this figure is likely,
by interpretation, to be a considerable underestimate.
Reporting throughout the study coincided more with the initial
contact and an 8 month reminder letter, as can be inferred from the
two peaks shown on the seasonal distribution histogram (fig. 10.1),
with the March peak being two to three times higher than the previous
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month. The FPCs were recruited over a limited period in June and July
1985 but reporting was until 1 August 1986 for all FPCs. This, comparing
the recruiting period June/July 1985, 16 new cases were reported in
those months, at a time when the study population was theoretically
much less, compared to only three cases reported in June/July 1986.
Thus, it a.ppears that any seasonal trends are, in this study, unfortuna¬
tely eclipsed by significant reporting differences as the study proceeded.
What is of considerable interest is that the true incidence is likely
to be of the order of two to three times higher than the quoted figure
of 16.4 per 100,000 per year, it being impossible to accurately estimate
the number of unreported cases.
It may be that Bell's palsy is commoner in the summer months, but
a limitation of this study is that it has not been able to demonstrate
this. Extending this study into consecutive years would still be diffi¬
cult to interpret for the same reasons. Seasonal differences in most
reported studies and indeed many inferences must be open to question
if they are only reflecting the 19% of cases estimated to be referred
to hospital by this study.
The fall-off in reporting might be taken to indicate that enthusiasm
for the study rather than clinical features was a more common reason
for referral into the study.
Table 6 shows that GPs in different FPC areas responded differently
to reporting throughout the study. Rochdale, for example, contained
a higher proportion of consistent responders, as evidenced by their
reply to the reminder letter.
11.6.1 Geographical distribution and contact enquiry
From the map (A3 pullout) it can be seen that the distribution of cases
is fairly uniform, with no particular FPC area showing a preponderance.
There is no excess in the number of reported cases when comparing North
and South Manchester as was thought half way though the study, and no
strong evidence of clustering. The Wythenshawe area in South Manchester
shows seven cases in near proximity but careful enquiry about social
contacts, school and work environments revealed no common denominator
to suggest transmission of infection. Thus the geographical distribution
of cases in the study provides no evidence to suggest an infective cause
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of Bell's palsy. Cases appearing to occur in a 'random fashion'.
11.6.2 Age distribution
The age distribution of cases of Bell's palsy shows that the 50-60 age
group reveals the highest incidence of Bell's palsy. Paralysis is also
noted to be common in 20-40 year olds. The bimodal distribution shown
in some studies is not here demonstrated.
When correction is made for the age characteristics of the Greater
Manchester population, it would appear that individuals have a decreased
risk of acquiring Bell's palsy up to the age of 25 and an increased
risk after this age (up to 75 years of age). Thus any apparent peaks
of increased incidence in younger children, as reported in some studies
in 6-12 year olds, may represent a greater willingness amongst GPs to
refer such young children. The age distribution does not suggest a
primary infection as the cause of Bell's palsy or degenerative diseases.
11.6.3 Social group distribution
The majority of cases of Bell's palsy occurred in Social Group 4
(= 3 Manual) reflecting the social distribution of the Greater Manchester
population. No discernible trend can be identified from the study,
again making a primary inection with HSV a less likely cause of Bell's
palsy.
11.6.4 Ethnic origin distribution
Only 8 cases occurred in non-caucasians which is commensurate with the
preponderance of races distributed in the community.
11.6.5 Sex incidence, side and recurrence
A male to female ratio of 1 : 1.3 shows a slight female preponderance,
which a larger general practice study might confirm. The side of the
paralysis was approximately equal, with 39 cases being right sided and
41 cases being left sided in keeping with the literature. No bilateral
palsies were noted in this study.
Recurrent paralysis was noted in three cases or 3.75%, confirming
the idea that Bell's palsy is, indeed, for most people a "once in a
lifetime event".
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11.6.6 Time of day paralysis noted
Bell's palsy, being a fairly notable event, is often clearly remembered
by individuals with respect to the time of day of its occurrence. The
majority of patients (70%) awake with the paralysis or develop it soon
after, whereas only 30% pf patients develop the paralysis in the last
12 hours of the day. It would thus appear that a true diurnal variation
exists for Bell's palsy. This in turn suggests that an individual's
physiological state is important for the timing of the onset of Bell's
palsy, and perhaps even for its initiation.
11.6.7 Menstrual cycle, pregnancy and Bell's palsy
In this study, 11 women gave a clear menstrual history as defined by
their being able to remember accurately or having recorded it, and were
able to remember the time of onset of the paralysis. Of these, eight
cases occurred during the first half of the menstrual cycle and three
in the second half. This study records insufficient numbers to make
a meaningful statement, but is in keeping with the findings of Adour's
and Hilsinger's studies, which show a similar pattern.
Five women were pregnant or had just had a baby. The distribution
was zero in the first trimester, one in the second, two in the third
and two in the puerperium, again in keeping with the findings of the
previous studies, and also that of McGregor (1987). This supports the belief
that a humoral effect related to menstruation and pregnancy may be involved
in the aetiology of Bell's palsy. Furthermore, 12 cases occurred in
women in the peri-menopausal age group (46-56), (compared to 6 cases in
men of the same age group), a group in which the endorphin levels
might be expected to fluctuate markedly, supporting the general view
of an opioid aetiology. The findings of this study contrast with Adour's
study in which he found a male preponderance in this age group.
11.6.8 Indication of speed of onset
It is a common clinical experience that Bell's palsy is of a dramati¬
cally acute onset J that is, a sudden weakness which develops over several
hours. It was asked how long it was between last noticing normal facial
movements and'hoticeabld'weakness, thus introducing considerable leeway
for variations in memory and interpretation. However, it was felt to
be a rough guide to the suddenness of the onset of the palsy. The
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Fig. 11.11
Venn diagram of symptom reporting;altered or diminished
sensation to the face?
Cases only
Key:
A - History of left facial numbness = 1 or
history of right facial numbness = 1
B - History of burning or flushed sensation to face = 1
C - History of left facial numbness = 1 or
history of right facial numbness = 1 and
history of burning or flushed sensation to face = 1
158
majority of patients noticed it had developed in between six and twelve
hours, and this often corresponded to going to bed with nothing amiss
to awaking with the palsy, or noting it soon afterwards. The very sudden¬
ness of the onset suggests a vascular mechanism, although acute
demyelination from other causes is a reasonable alternative explanation.
11.6.9 Associated symptoms
Interpretation of the significance of reported symptoms can be a variably
difficult task. Numbness of the face, for example, being a particularly
difficult symptom to interpret. It might be supposed that an inability
to move the face would be described as numbness by some respondents,
and for this reason an additional explanation was always given during
the interview, including the description of "numbness like that experien¬
ced after a dental injection". Burning of the face was also included
as a separate question suggesting paraesthesia, but might also be inter¬
preted as facial flushing (see fig. 11.11). Overall, the tabulation
of the associated symptoms represents a description of these symptoms
as experienced in general practice. Perhaps surprisingly, depending
on interpretation, there is still evidence of polyneuropathy, with the
5th nerve being involved in 38.8% of cases in this study, which is com¬
parable with Adour's hospital-based figure. This is of some interest,
and indeed suggests that referral tends not to be on this basis.
11.6.10 Taste alteration
This important symptom is discussed separately because of its relevance
to the aetiology of Bell's palsy and the suspected level of nerve damage.
Of the 80 cases of Bell's palsy in this study, 30 or 37.5% gave a history
of taste disturbance and of these, 66% noted the disturbance before
facial weakness and 14% noticed it after the onset of facial weakness,
with 20% noting it approximately coincidental with the weakness. This
suggests that the smaller, non-myelinated axons are more sensitive and
damaged earlier than the larger motor neurones, or possibly that this
disturbance is, in fact, initially a physiological hyperpolarization
of neurones or nerve block (taste fibres being first affected by the
virus, by the ascending chorda tympani route?). Although 60% of patients
appears a large proportion of cases to give no history of taste distur¬
bance if the disease is primarily geniculate in origin, it must be
considered that a unilateral loss of taste may not be notable.
159
to an individual unless it is "altered" in some way, e.g. becomes
metallic; or is tested for. Interferon-induced neuropathies may also
produce taste and smell disorders; although these are extremely uncommon
they are the pathways most frequently affected.
11.6.11 Examination findings
More substantive evidence of polyneuropathy in particular of 5th nerve
involvement was found on examination in 12 or 15% of cases (diminution
of pin prick sensation). No abnormality was noted of the palatal reflex
in any cases (9th nerve involvement).
Glycosuria was noted in 8 out of 43 patients or 18.6% who provided
urine specimens. However the sensitivity and specificity of this test
does not allow meaningful conclusions tc be drawn. Fasting blood glucose
would have been better but was not feasible in this study.
11.7 The Antibody Study
To determine the exposure to HSV in Bell's palsy cases, 46 patients
who agreed, had blood samples taken after the onset of the facial weakness
(usually by 3 weeks). Twelve, or approximately a quarter of cases had
no discernible complement fixing antibodies to HSV. Only three patients
had titres of 1 in 80 or above. Of 12 paired antisera no significant
rises were noted to HSV CF Ab, but one patient had a significant elevation
of Cf Ab's to VZV (out of 9 paired antisera). The results of this small
study indicate that HSV is unlikely to be a ubiquitous cause of Bell's
palsy with no discernible antibodies in a quarter of patients and in
contrast to Adour's study, no patients had high titres to HSV.
11.8 Facial Nerve Damage and Recovery
Facial nerve function was assessed at the initial examination and at
a minimum interval of 6 months after the paralysis by means of a letter
(Appendix 2c) with 18 of the non-respondents having to be contacted
by telephone. An estimation of complete recovery occurred in 60
or 82% of patients with 13 or 18% making an incomplete recovery.
Again this figure is comparable with Pietersen's 1982 study if his grades
0 and I are combined - 84% recovery. Problems with lacrimation occurred
in 8 patients, 7 had loss of power, and 5 had hyperacusis.
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Otalgia = Yes 15 8.00 3.00
Otalgia = No 26 5.50 3.00









8.00 0.31 -5.00 1.00
NON-PARAMETRIC CORRELATION
Spearman rank correlation for duration of paralysis versus age
= 0.18, n = 41, p = 0.26.
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11.9 Analysis for Prognostic Features
Several workers have noted unfavourable prognostic associations such
as age (Taverner 1971) and taste disturbance (Adour 1974, Pecket 1982)
and intrauricular pain (Taverner 1959, McGovern 1966) with outcomes
in Bell's palsy.
To make a realistic assessment of outcome cases need to be assessed
in terms of severity in relation to time. This fragmentation reduced the
power of the epidemiological study. A further confounding variable of
the utmost importance is the type of treatment and its commencement in
relationship to the onset of the paralysis (Taverner 1971). Although
tabulated in this study there was insufficient power to consider the
effects of this variable.
Again, although it was not the primary aim of the epidemiological
study to look for outcomes, information was processed using Mann-Whitney
U tests for all likely determinants of poor outcome. Duration of paralysis
with respect to age and pain in the ear are presented in Table 40. It
can be seen that this study does not have the power to reveal a statis¬
tically significant association.
11.10 Discussion of the Case Control Study
11.10.1 Genetic factors
The number of cases of Bell's palsy with a positive family history was
13.8% comparable with Brodie's retrospective study (13%). Of these
relatives 69% were first degree and 31% second degree. The majority of
individuals had only 1 affected relative although several had more than
one. The frequency of attacks did not approach that of Presley's study
from general practice (6 attacks in 5 relatives). The control history
was 1.3% for Bell's palsy. The McNemar chi square was 5.82 and a p value
of 0.02 revealing a significant association of Bell's palsy with a
family history of Bell's palsy. It could be argued that patients with
Bell's palsy are more likely to have thought about possible affected
relatives or had instituted inquiries whereas controls may have revealed
less perception of family history and or a greater reluctance not to
"label" dubious historical events as "Bell's palsy". Nonetheless controls
were asked to think carefully about possible affected relatives and it
is argued that the study does provide the much needed control informa¬
tion needed for interpretation of the findings in Bell's palsy cases.
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In conclusion genetic factors are likely tc play a significant
role in predisposing to Bell's palsy.
11.10.2 Family history and diabetes
Non-insulin dependent diabetes appeared to occur with the same frequency
in Bell's palsy and control group relatives. It is known that like
Bell's palsy genetic factors are involved in the aetiology of N.I.D.D.
With an incidence of N.I.D.D. at 1-2% in the general population a family
history of between 10-20% though high would not appear to be significant.
However the finding that 3 cases and 0 controls had personally been
diagnosed as N.I.D. Diabetics and the finding of significant glycosuria
in 8 out of 43 patients does suggest an association with diabetes. It
is possible that the control figure is abnormally high in this study
and it is apparent that the power of the study is not such as to
demonstrate a genetic association between the two conditions if it
exists. Those patients who also had a family history of Bell's palsy
were too few to examine for differences in history of diabetic relatives.
Thus in terms of an association with non-insulin dependent diabetes,
this study remains inconclusive but does tend to weakly support those
studies showing an association with diabetes.
11.10.3 Drug history
A limited enquiry was made into the drug taking history to see if any
associations existed between medication and Bell's palsy. In particular
chlorpropamide, which might induce flushing was noted not to be the
method of control for the 3 N.I.D.D.'s. Analgesics such as opioid
agonists were not regularly taken by cases or controls. Pentazocine
which might be expected to be only effective in individuals with
Kappa receptors was not taken by either cases or controls.
11.10.4 Past medical history
This enquiry was made to explore possible associations between various
neurological, herpetic and common diseases with Bell's palsy. It further
allowed assessment of reporting differences between cases and controls
by comparison with known frequencies for the incidence of these conditions.
The only significant association appeared to be a negative correlation
of mouth ulcers with Bell's palsy p=0.01 (13% of cases and 32% of
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controls) which is interesting on 2 accounts. Firstly HSV has been
a speculated although somewhat dubious cause of mouth ulcers and secondly
they occur more"frequently in stressed individuals. (The Bell's palsy
cases were the more stressed group in this study). The lifetime
prevalence of recurrent apthous ulcerations in this country is 20.1%
(Sircus 1957). It is likely therefore that the Bell's palsy group have
a low incidence of apthous ulceration when considering other studies
(Embil 1975) give prevalence figures of 66% for recurrent apthous
ulceration. The lifetime prevalence figures do depend on long term
memory but the cumulative effect of age should be eliminated in this
study by the match pair analysis.
This negative correlation of Bell's palsy with mouth ulcers, far
from disproving an association with HSV if it is a cause of mouth ulcers,
could in fact be an observation of a complex relationship of HSV with
its host.
A further point of interest is that a history of hypertension was
not significantly different between the group, contrary to some findings
in Bell's palsy studies (Abraham-Inpijn 1982, 1987).
11.10.5 Habits
Nailbiting appeared no different between the two groups in the subgroup
of recurrent palsies, a condition in which conceivably herpetic
transmission from hand to mouth might be relevant, numbers were too
small to derive any conclusions. Smoking as defined by taking 1 cigarette
or more per day appeared to be no different between the groups.
11.10.6 Alcohol
The taking of alcohol in the previous 24 hours for control, and 24 hours
prior to the paralysis for cases appears to be significantly different
between the two groups p 0.001. This effect could be explained by the
fact that cases were recalling events on average 3 weeks earlier and
may have forgotten previous alcohol consumption. If Bell's palsy patients
had a generally low consumntion of alcohol this comparison might still
be valid. A better enquiry would have been into normal drinking habits
and approximate number of units consumed per week.
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11.10.7 Draughts and chilling
The classical explanation of sitting in a draught showed no statistically
significant difference in exposure between cases and controls. Again
differences in memory over different time periods between cases and
controls have to be considered. Nonetheless there would not appear
to be a significant association. Severe cold or chilling, more likely
to be remembered, did not reach a significant level of association.
11.10.8 Preceding physical strain
Increased physical strain or work appeared to be no different between
the groups in terms of preceding exposure.
11.10.9 Preceding infection
It is known that Bell's palsy often follows on after an upper respiratory
infection. This study showed significant differences between cases
and controls in reporting preceding upper respiratory infection. Given
the seasonal variation of many viral illnesses and the lag in interviewing
controls it is possible that seasonal effects may be causing differences
between the groups. However considering the study year the incidence
of respiratory infection is not only higher in Bell's palsy patients
than controls but also higher than predicted taking the frequency of
coryza in the population as 3 or 4 attacks per year. This further
strengthens the case for an association between the two.
However perhaps the most interesting conclusion and the most
statistically significant is that "any illness in which the patient
perceived they had a temperature" was more likely to have occurred in
the two weeks prior to the onset of facial weakness than in the preceding
2 weeks for controls. A reasonable hypothesis from this information
would be that "herpes febrilis" is being reactivated by a preceding
illness. An alternative explanation is that numerous viruses produce
Bell's palsy by producing a pyrexia.
11.10.10 Skjn-type and Bell's palsy
Although preceding exposure to bright sunlight appeared to be no different
between cases and controls the type of skin possessed by an individual
in terms of "sensitivity to sunlight" was felt to be an important sub¬
sidiary question (vide infra).
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Four grades of "skin sensitivity" to sunlight were designated in
the study; as predominantly burning; tending to burn more than tan;
tending to tan more than burn; and predominantly tanning when exposed
to the sun. The numbers in each of these self assessed groups was
fairly even for the controls, but showing a higher proportion of cases
in the "predominantly burning" group. For the purposes of analysis
the first two groups and the second two groups were combined and a
McNemar test performed. The chi squared test was 7.5 and p 0.01 shows
a significant difference between the groups. Thus it would appear that
fair skinned people are at greater risk of developing a Bell's palsy.
This is not however supported from incidence studies comparing Norway
with Columbia for example. Racial and genetic determinants may explain
these differences. In this study all non-caucasian races were excluded
from analysis.
The explanation as to why sunlight is associated with cold sores
is likely to be due to prostaglandin levels in the skin being elevated
facilitating the development of recrudescent lesions rather than
reactivations (Hill and Blythe, 1976, skin trigger theory). A further
problem considering skin triggers is the fact that the facial nerves
somatic sensory distribution is confined to the ear canal, an area
unlikely to be exposed to sunlight! The systemic response to sunlight
may however well be different between fair and tanned individuals -
with differing P.O.M.C. and endorphin levels and these constitute
physiological variables of possible significance in terms of ganglionic
reactivation.
11.10.11 Stress, depression and Bell's palsy
Subjective assessment of emotional strain was assessed in the month
preceding the paralysis for cases and preceding month for controls.
The patient was first encouraged to speak openly, and then asked if
they felt this emotional strain was less than normal, about the normal
amount, more than normal or much more than normal. For the purposes
of analysis the first two and second two groups were combined. A McNemar
chi squared test with continuity correction gave a value of 9.76 and
a p value of <0.01 showing a significant association of a subjective
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category = Normal 65 46.00 25.00, 76.00 <0.001 -45.90, -17.00
= > Normal 50 75.00 49.50, 109.00
Table 45
CHI-SQUARE TESTS
Recent history of depression and subjective stress categories
Interquartile
n Median Range P 95% CI
Recent history of depression
YES NO
Subjective stress category Normal 3 100
Subjective stress category > Normal 16 38
19 138
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A further assessment of stress in the preceding 6 months was made
by using a self administered SRE checklist with a brief explanation
to cases and controls. The results can be seen in Fig. 10.10 showing
that higher scores between 130-260 were much more frequent in Bell's
palsy cases than their age and sex matched controls. These results
tend to confirm the findings of subjective emotional strain assessment.
As a means of validating the data on stress from the subjective and
SRE assessment, one would expect to find an association between a stress
category of greater than normal versus normal in the subjective emotional
strain response and the SRE score. This association was assessed by
using the Mann-Whitney U Test (see table 45 opposite).
Thus, the difference in the median SRE ratings of subjective stress
category normal cases versus > normal cases is 46.00 - 75.00 = -29.00.
Thus it is estimated that the SRE rating will be 29% lower in normal cases
than in > normal cases. The 95% CI for the difference ranges from
-45.90% to -17.00%.
Before claiming that differences in the groups are due to differences
in subjective feelings of stress or recent life events, confounding
variables should be considered. One such variable is a recent history
of depression, which when assessed by the author for an intermediate
period of 3 months appeared to be significantly different between the
two groups p <0.01. It is known that people with depression are likely
to have experienced a recent life event, and this is implied in the
definition ''reactive depression".
When a statistical test (chi-square) is made for the association
between subjective assessment of emotional strain and history of recent
depression as interpreted by the author, it can be seen from the results
that there is a very significant association p <0.001. This further
confirms the validity of the study information and also reveals the
difficulties in too simplistic an approach when trying to interpret
information concerning the interrelated variables of subjective assessment
of stress, recent life events and recent depression. From table 46
opposite it can be determined that a recent history of depression and
a subjective assessment of greater than normal emotional strain are
significantly associated. The \2 = 21.3 df = 1 p < 0.001 95% CI =
0.747, -0.37. It is estimated that there will be 56.7% fewer cases
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with a normal subjective stress assessment in those who give a history
of recent depression than those who do not.
In conclusion subjective assessments whether made by the patient
or the author show a significant association of increased emotional
strain and depression before the occurrence of a Bell's palsy when compared
with age and sex matched controls. Furthermore the highest SRE scores
occurred much more frequently in the cases than the controls. It is
argued that this evidence taken as a whole, even allowing for differen¬
ces in health status between the groups strongly supports the notion
that depression, emotional strain and recent life events are significantly
associated with Bell's palsies.
11.10.12 History of HSV exposure
McCormick when postulating on HSV and Bell's palsy wrote that an increased
incidence of cold sores in patients with Bell's palsy would tend to
confirm his theory. The findings of this study are all essentially
negative. There was no correlation between history of cold sores in
the Bell's palsy and control groups. Both suffered them with comparable
frequency. However it is quite erroneous to presume recrudescent lesions
(cold sores) are equivalent to reactivation of HSV. Although a positive
association here would have been helpful in strengthening the association
of HSV "disease" and Bell's palsy, lack of correlation has very little
to offer against an HSV "reactivation" theory, expecially if one accepts
Hill and Blythe's animal model in which neural reactivations are believed
to be frequent subclinical occurrences. Furthermore a study group of
approximately twice the size would be needed to have sufficient power
to show a 10% difference in cold sore history between the groups (Machin
and Campbell 1987).
Similarly no correlation could be found between age of first
noticing cold sores between the groups suggesting the time of primary
infection with HSV has no significance in the aetiology of Bell's palsy,
although memory factors and study size make these conclusions rather
weak. History of primary infection with HSV was remembered by only





The purpose of this chapter is to discuss and summarize the findings of
the temporal bone and epidemiological studies, to consider further the
implications, and the direction of future research.
Firstly, it would appear that the two studies are somewhat at variance.
For example, the temporal bone study suggests herpes simplex virus is
ubiquitously resident in the geniculate ganglion of the population. However,
the epidemiological study could not demonstrate herpes simplex virus anti¬
bodies in 25% of cases. In the epidemiological study, the history of
cold sores between the two groups appeared to be no different.
The findings of the temporal bone study are likely to be very signifi¬
cant if they are repeatable. Not only in terms of explaining an aetiolo-
gical mechanism in Bell's palsy, but in their own right, and with respect
to a route of entry of herpes simplex virus to the Central Nervous System
in herpes encephalitis. The implications of this study are firstly that
it is quite possible for herpes simplex virus to be a cause of Bell's
palsy, since it is usually resident in the geniculate ganglion of the
general population; in this much the hypothesis resisted falsification.
However, the converse argument also becomes more forceful because of the
observed frequency, namely that the observation of that which is frequent
cannot alone explain that which evidence suggests occurs infrequently.
Thus, these arguments present limitations to the inferences that can be
drawn from such a study and indeed are inherent in its design. It has,
however, provided further information to consider which, if repeatable,
should be taken into account by other researchers when considering the
aetiology of Bell's palsy. Although herpes simplex virus has not thus
far been grown by co-cultivation from geniculate ganglia, from fresh specimens
or cadavers, the findings of the virus in biopsy material would have to
be interpreted with caution.
In summary, the results of the virological temporal bone study here
presented are "permissive"of the outlined hypothesis. The hypothesis requires
further evidence as to how and which factors operate selectively to limit
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the frequency of Bell's palsy to that observed. In effect, if herpes
simplex virus is involved in Bell's palsy, it is part of a multi-factorial
process.
The epidemiological study, on its own, is an outline of a condition
not reported to this extent in general practice in this country. As such,
it is hoped it may be used as a reference description of the clinical
condition of Bell's palsy. Reporting differences by GPs in this
particular study suggests that the incidence of Bell's palsy is, in fact,
higher than that previously reported in most of the world literature.
Taken as a whole, and upon reflection of the findings of the descriptive
study, the forcefulness of the patterns suggesting the importance of
humoral and physiological factors in the mechanism in Bell's palsy are
quite striking.
Those features identified from the epidemiological studies most
likely to be associated with Bell's palsy are the 25-75 age group, part¬
icularly advancing age, being fair skinned as defined by burning rather
than tanning in the sun, having a positive family history of Bell's
palsy, being subjectively under more than the normal amount of emotional
strain, having a higher SRE score and being depressed, having had an
illness with a temperature in the previous two weeks or upper respiratory
infection, being in the later stages of pregnancy, peri menopausal or
in the first half of the menstrual cycle, during the first 12 hours
of the day and not having a history of mouth ulcers.
A history of hypertension was no different between the groups
nor is the history of cold sores. The findings of the antibody study
contrasted with those of Adour in not finding "high but stationary
antibody levels to HSV in the majority of individuals", but rather no
significantly high levels, and in 25% no discemable C.F. antibody to
HSV at all!
The association of Bell's palsy with diabetes remains unresolved
by this study with 3 cases of N.I.D.D. identified out of 80 cases but
no controls. It does however seem likely from other work involving G.T.T.'s
that there is an association which this study failed to demonstrate.
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12.2 The Hypothesis in the Light of the Evidence
The hypothesis discussed is an ambitious one and the evidence from these
studies by comparison modest. One can take the view that the mechanism(s)
of Bell's palsy will always be a riddle, or that much depends on future
discovery, or that to look for a common mechanism is a categorical mistake.
All these views however can be criticised on a basis of failing to assess
current if somewhat diverse evidence and the first and last views as alien
to the empirical approach on which science is based.
Taking the results of the temporal bone study first HSV would appear
to reside in the geniculate ganglia of the general population to such
an extent that it cannot account for a condition of such low incidence.
Clearly the process of reactivation is central to the hypothesis and it
is by no means certain or inevitable that persistence in afferent ganglia
of the virus implies it will reactivate. In vivo tissue culture studies
suggest neural reactivation is a one-off event (Wildy 1982), whereas work
by Hill and Blyth (1976) in mice suggests neural reactivations are frequent
but decreasing with time or application of the stimulus. If one inclines
to the latter view, but bearing in mind that mice are not the natural
host of HSV, then the results of the temporal bone study emphasize the
need to consider a multifactorial aetiology. If one inclines to the former
view it is less important to consider the aetiology in terms of a multi¬
factorial process.
Secondly considering the results of the epidemiological studies
there appears much to support a multifactorial aetiology in Bell's palsy.
Firstly there is the disappointing evidence for protagonists of HSV as
a sole cause from the antibody study* where it is clear that some individuals
do not appear to have antibodies to HSV at all. The antibody study itself
might be criticized in terms of few paired antisera being taken, its small
size, and the fact that some bloods would have been taken before it might
presumably be expected antibodies to develop. Nonetheless it appears
HSV cannot be a universal cause, and this is supported by other negative
antibody studies.
The case control studies suggest the importance of genetic factors
in the aetiology of Bell's palsy. If one also considers the work showing
a strong association of N.I.D.D. with Bell's palsy perhaps in up to 50%
of cases then it is tempting to speculate a common genetic link between
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the two. This link may be in terms of an underlying sensitivity to opioid
peptides. This is particularly pertinent when one considers that chlor¬
propamide alcohol flushing must involve (by intelligent speculation) the
branches of the external carotid supplying the suprageniculate part of
the facial nerve.
Further evidence for a complex aetiology comes from the variety
of "physiological stressors" which are associated with Bell's palsy. When
considering the response of biological systems to stress it is perhaps
too easy to fall into the trap of unification by labelling what is in fact
a diverse and complex system i.e. that of the opioid peptidesj and
by unnecessary speculation in areas where little evidence exists. Such
is not the purpose of epidemiological research but rather by observation
and reflection of curious features of Bell's palsy to discern patterns
and decide what is or may be common features unique to Bell's palsy but
not controls. "Stress" is common and patterns of stressors likely to
repeat themselves. Bell's palsy by and large is not common and does not
repeat itself. Therefore if "stress" is acting in the mechanism its actions
are triggering or magnifying some other process which occurs infrequently
or is infrequently noticed, or the resultant disease process renders un¬
likely to happen again.
The patterns discerned in the epidemiological study are indeed compa¬
tible with what little is known about the neural reactivation process
of HSV and this process may itself be a means of amplifying the stress
response at least locally to the ganglia (or part of the CNS) in which
it occurs. Furthermore though this process may be frequent the extent
to which a significant or marked peptide/vascular response is produced
is likely to be much less frequent.
The hypothesis outlined is further dependent on an increased produc¬
tion of interferon and opioid peptides from ganglion cells which of
themselves, the author suggests, produce damage by sustained vasodilation.
It can reasonably be speculated that this process will vary biologically
in terms of both output, the half life of the peptide, their removal
rate and the vascular sensitivity or responsiveness. This system or
series of systems might go some way to explaining how stress operates
selectively with only sensitive individuals or those with a high/sustained
interferon/opioid output producing sufficient vasodilation to produce
clinically noticeable events.
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Anatomical factors may also be of critical importance in determining
the frequency of serious nerve damage. Of particular relevance is the
diameter of the entrance to the Fallopian canal.
Interferon levels but not opioid peptide levels have been studied
in Bell's palsy. Aviel has demonstrated that interferon levels are
often high in Bell's palsy. The finding in this study that an illness
with a temperature often preceded Bell's palsy again might suggest a
role for interferon, which together with prostaglandins is incriminated
in producing pyrexia.
In summary the extended hypothesis appears to withstand the
evidence with the proviso that other stimuli of the interferon opioid
system e.g. other viruses might reasonably act as triggers for the
interferon/opioid/vasular mechanism. The proof of the hypothesis
however lies with further research.
12.3 Suggested Further Research
Very little is known of the genetics of opioid receptor distribution
in populations. This would be most interesting to study and in particular
whether there are common links with for example the Kappa receptor,
Bell's palsy and N.I.D.D. Chlorpropamide alcohol flushing could be
performed in patients with Bell's palsy and if the incidence observed,
were high» similar to that found in N.I.D.D.'s this would tend to confirm
the hypothesis.
Larger general practice studies might further be performed over
longer periods of time to look for trends or seasonal variation. Other
clinical studies might include double-blind placebo controlled trials
of Naloxone in Bell's palsy with improved outcomes in the treatment group
tending to confirm the hypothesis. Blood or CSF interferon or endorphin
levels might further be studied in Bell's palsy. Local enkephalin levels
in the CSF in the proximity of the nerve would prove problematical in
obtaining and in interpreting where delay was involved.
Further work in understanding interferon neuropathy and whether
this might be a vascular effect would be most interesting.
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Animal experiments perhaps using fluorescein and observing the
effects of opioid peptides and interferon on the cerebral blood flow
in-vivo might further strengthen the case for a specific local vascular
response produced by these substances.
Work needs to be done defining the neurotransmitters of the
geniculate ganglia in human subjects.
The temporal bone studies need to be repeated using specific e.g.
the PA29 probe.
In conclusion it is the author's belief that the aetiology of
Bell's palsy is of truly labyrinthine complexity. The evidence from
this thesis is unable to dismiss HSV reactivation as a cause amongst
causes of Bell's palsy but supports a multifactorial process in which
humoral factors appear to be very important. It is also hoped that
the hypothesis will prove of sufficient interest to merit further
original investigations. The patient shown in fig. 10.9 has sadly not
made a full recovery.
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1) When did you first notice your face wasn't moving properly?
on getting up or soon after approx. hrs
round about what time hrs
unable to say
2 a) Thinking back to when you first noticed you couldn't move the side
of your face properly, can you remember how long before that it
was working normally?
0-6 hrs
6 - 12 hrs
12 - 24 hrs
days
unable to say




3) If you have periods how many' days do they usually last?
How long do you go between periods?
Thinking back to the day your face was first affected can
you remember where you were up to with your periods?
(1st day of period day 1) day
unable to say
4) Has one side of your face been affected or both sides? bilateral
If only one side, which side? Right
Left
Since this happened have you always been able to move the
affected side of your face, at least a little? (Such as raise
your eyebrow, partly close your eye, make a grimace, or move
the corner of your mouth) Yes
No
Have you ever had anything like this before?
confirmed as a Bells palsy Yes
No
5) In the week before or after this happened had you
noticed anything else the matter?
For example have you had:
headaches at the back of your head
pain in the ear
a rash in or around the ear
a dry eye
sounds seeming abnormally loud
numbness or loss of feeling in the face R
L
a 'hoarse voice'
an abnormal feeling of movement such as the room spinning
a burning or a flushed feeling in the face
6) Have you noticed that things taste differently? Yes
No
If yes, can you remember if this was before the weakness in











7) Where applicable: Is the patient pregnant?
or had a baby within 6 weeks of the
onset of paralysis? N/A
If yes then ask how many weeks of pregnancy





8) Has anybody in the family ever had an unexplained














10) If you have taken fortral before, was it
effective in relieving pain?
N/A
Yes/No
1 1 ) Are you a known diabetic?
Yes/No
12) If yes do you need to take insulin or not?
Yes/No
13) Do you know if anyone in the family has had diabetes?
Yes/No
If yes did they need to take insulin (an injection) or not?
Grandparent
parent
(1 - insulin dependant \ sibling2 - N.I.D.D. ) child3 - unable to say J other relative
14) Have you ever suffered from any other illnesses?
Have you ever had any of the following?
an inflammed pancreas?







gland trouble e.g. thyroid?
a rare hormone disease?
painful ulcers of the genitals?
ulcers of the mouth?
high blood pressure?
15) In the month before your face became
affected how much more emotional strain did
you feel you were under?




16) In the 3 months before your face was affected would you
say you felt depressed? (Feeling low with a low image
of yourself with a poor appetite or weight loss or
sleeping difficulties).
Yes/No
17) If yes have you needed treatment from your
doctor for this?
Yes/No
18) In the 2 weeks before your face was affected had
you undertaken more physical exercise or work
than usual?
Yes/No
19) In the day or two before the face was affected can







20) When you go out into the sun for any length of time
do you tend to ....
burn easily?
burn more than you tan?
tan more than you burn?
tan easily?
21) The day prior to the face becoming affected
can you remember if you
- had you been in cold conditions causing chilling?
- or been in a draught?
- or consumed alcohol?
22) Have you ever suffered from whitlows
- painful swellings on the fingers usually near the nails? Yes/No
23) Do you bite your nails? Yes/No
24) Do you smoke Yes/No
25) In the two weeks before your face was affected can you
remember did you suffer
from an illness with a temperature?
a cough, cold, or chest infection?
a sore throat?
26) Can you remember ever having suffered from painful
lips and gums which were swollen and red?
Y/N/U
27) If yes can you remember how old you were?
a child
a teenager
over 20 yrs old
unable to say
28) How recently was this?
less than 6 months ago
longer than 6 months ago
longer than 5 years ago
unable to say
29) Have you ever suffered from cold sores?
A tender red patch of skin around the edge of the
lip often containing a little straw coloured fluid
(see photograph)
Y/N/U
30) If you suffer from cold sores can you remember
when you first started with them?
as a child
as a teenager
over 20 yrs old
unable to say
31) Can you remember when you last had a cold
sore?
in the 2 weeks before
the face was affected,
in the previous 6 months
longer than 6 months
unable to say
32) Do the cold sores affect?
only the left side
mostly the left side
the middle or both sides
mostly the right side
only the right side
unable to say
33) Have you recently kissed anyone with cold sores? Y/N/U
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Clinical examination ENT examination
neck examination




Blood for antibodies (HSV) taken

















































1) In the past few days have you noticed any
of the following symptoms?
headaches at the back of your head
pain in the ear
a rash in or around the ear
a dry eye
sounds seeming abnormally loud
numbness or loss of feeling in the face R
L
a 'hoarse voice*
an abnormal feeling of movement such as the room spinning
a burning or a flushed feeling in the face




3) Where applicable: Is the patient pregnant? N/A
If yes then ask how many weeks of first trimester
pregnancy or after second trimester
third trimester
puerperium
4) Has anybody in the family had an unexplained















6) If you have taken fortral before, was it
effective in relieving pain?
N/A
Yes/No
7) Are you a known diabetic? Yes/No
8) If yes do you need to take insulin or not? Yes/No
9) Do you know if anyone in the family has had
diabetes? Yes/No
If yes did they need to take insulin (an injection) or not?
Grandparent
parent
1 - insulin dependant \ sibling
2 - N.I.D.D. J child
3 - unable to say / other relative
10) Have you ever suffered from any other illnesses?
Have you ever had any of the following?
an inflammed pancreas?







gland trouble e.g. thyroid?
a rare hormone disease?
painful ulcers of the genitals?
ulcers of the mouth?
high blood pressure?
11) Thinking back over the past month how much
emotional strain did you feel you were under?
Would you say
less strain than normal
about the normal amount
more than normal
much more than normal
12) In the past 3 months would you say
you felt depressed? (Feeling low with a
low image of yourself with a poor appetite
or weight loss or sleeping difficulties) Yes/No
13) If yes have you needed treatment from
your doctor for this? Yes/No
14) Over the past 2 weeks have you undertaken
more physical exercise or work than usual? Yes/No
15) Can you remember if you were out in
very bright sunshine yesterday? Yes/No
16) When you go out into the sun for any length
of time do you tend to
burn easily?
burn more than you tan?
tan more than you burn?
tan easily?
17) Can you remember if yesterday you had
- been in cold conditions causing chilling?
- or been in a draught?
- or consumed alcohol?
18) Have you ever suffered from whitlows -
painful swellings on the fingers usually
near the nails? Yes/No
19) Do you bite your nails? Yes/No
20) Do you smoke? Yes/No
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21) In the past 2 weeks have you suffered from
an illness with a temperature?
a cough, cold or chest infection?
a sore throat?
22) Can you remember ever having suffered from painful
lips and gums which were swollen and red?




over 20 yrs old
unable to say
24) How recently was this?
less than 6 months ago
longer than 6 months ago
longer than 5 years ago
unable to say
25) Have you ever suffered from cold sores?
A tender red patch of skin around the edge of
the lip often containing a little straw coloured
fluid (see photograph)
26) If you suffer from cold sores can you remember when




over 20 yrs old
unable to say
27) Can you remember when you last had a cold sore?
in the 2 weeks before
the face was affected
in the previous 6 months
longer than 6 months
28) Do the cold sores affect?
only the left side
mostly the left side
the middle or both sides
mostly the right side
only the right side
unable to say
29) Have you recently kissed anyone with cold sores? Y/N/U
Appendix 1c
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PLEASE TICK LIFE EVENTS
FAMILY Death of spouse
Divorce
Marital separation
Death of close family member
Marriage
Marital reconciliation
Major change in health of family
Pregnancy
Addition of new family member
Major change in arguments with wife/husband
Son or daughter leaving home
In-law troubles
Wife starting or ending work
Major change in family get-togethers
PERSONAL Detention in jail
Major personal injury or illness
Sexual difficulties
Death of a close friend
Outstanding personal achievement
Start or end of formal schooling
Major change in living conditions
Major revision of personal habits
Changing to a new school
Change in residence
Major change in recreation
Major change in church activities
Major change in sleeping habits
Major change in eating habits
Vacation
Christmas
Minor violations of the law
WORK Being fired from work
Retirement from work
Major business adjustment
Changing to different line of work
Major change in work responsibilities
Trouble with boss
Major change in working conditions
FINANCIAL Major change in financial state
Mortgage or loan over £10,000
Mortgage foreclosure




THE DEPARTMENT OF GENERAL PRACTICE
RUSHOLME HEALTH CENTRE
WALMER STREET
MANCHESTER Ml 4 5NP
PROFESSOR DAVID METCALFE TELEPHONE: 061-225 6693
June 1985
Dear Doctor,
I am writing to ask your co-operation in a unique clinical study which is
being carried out by a trainee in this Department. It concerns questions
regarding the nature and aetiology of Bell's palsy. We need, over the
course of 12 months, to be able to see about 100 cases of this disease in
order to ascertain some facts about co-existing factors and to take blood
for viral studies. Dr. Williamson will visit each of the patients to
ascertain these facts (by using a questionnaire) and take a sample of blood.
As you are aware, Bell's palsy is not a notifiable condition and its incidence
is low (20/100,000 of the population per year). We therefore need to have
the co-operation of a large number of general practitioners in the region
who will notify this Department of any case of Bell's palsy which they see.
What we are asking therefore is whether you will agree to help by:-
1) Notifying (by telephone or letter) this Department of any
case of Bell's palsy seen in the next 12 months;
2) Agreeing that Dr. I.G. Williamson (trainee GP) may visit
your patient for the purpose of completing a questionnaire
and taking a blood sample.
The patient's permission would be sought before the interview and you would
be sent copies of the completed questionnaire and viral studies report.
The work involved by you will be minimal, in fact only notification, but the
overall results may be a significant improvement in our understanding of a
condition which sometimes results in permanent disfigurement.
I enclose an outline of the study and will also send you a copy of the
questionnaire and the references if you would like them. Please would
you complete the enclosed pro forma and return it to this Department.
With very many thanks for your co-operation.
Yours sincerely,




A STUDY OF BELL'S PALSY
Introduction
Bell's palsy or idiopathic facial paralysis is essentially a diagnosis of
exclusion and may represent a heterogeneous group of conditions. However
there are features which suggest a common aetiological mechanism although
exactly what this is remains contentious. The two most widely held
theories are the viral and the vascular, although there is no reason to
suppose that they are mutually exclusive. In 1972 McCormick first
postulated herpes simplex as a cause for Bell's palsy and since than a
number of workers have produced evidence to corroborate this theory.
Adour, in San Fransisco, in an extensive epidemiological study, showed
a high association between patients suffering from the disease and elevated
herpes simplex antibodies. It is argued by supporters of herpes simplex
as a cause that reactivations of this virus often occur without demonstrable
rises in antibody levels. Furthermore, most of the population of over
30 year olds already have antibodies to herpes simplex. Thus conventional
clinical methods of proof are inadequate in incriminating this virus.
Herpes simplex nevertheless remains a good candidate for several reasons.
Work over the past 12 years has shown a predilection of this virus for
neural tissue and primary afferent sensory ganglia in particular.
Krisstensen (1977) has shown in animal models that the virus produces local
demyelination similar to that seen in Bell's palsy. Reactivation of
herpes infection is thus problematical in terms of proof and epidemiological
studies remain the only way of confirming such a hypothesis. Direct
biopsy of the facial nerve is not an ethical alternative. Isolating the
virus from cadaveric geniculate ganglia might be a possibility and this is
being pursued.
Vascular theories are also held by many clinicians including Kettel,
Cawthorne and Janetta. In support of these are the abrupt onset of
paralysis and the discrete anatomical localisation of nerve damage.
Fisch proposes that the nerve damage is produced by a viral vasoactive
toxin. The interesting point of this idea is not so much that viruses do
not produce toxins, but that interferon and the neuro-transmitters found
in the geniculate ganglion (opiod peptides) are vasoactive and may mediate
vascular damage (Scott; Hanko). A considerable amount of work has been
done in this field, particularly by Blalock and Smith, and all within the
past five years. Both interferons and opioid peptides have very short
half-lives in plasma, which means that serum levels are not true indicators
of local processes where the concentration level may be marked. It is
known that such factors as age, circadian rhythm, emotional stress, cold
stress, menstruation, pregnancy, drugs, endocrine disorders, all alter the
bodies 'opioid' status. A condition which is known to be associated with
sensitivity to opioid peptides is non-insulin dependent diabetes, a disease
in which Bell's palsy often occurs. A study of a reasonably large number
of cases of Bell's palsy to determine associations between the disease and
any of the above opioid sensitive factors would therefore be interesting




The purpose of the study is to determine whether in Bell's palsy there is
an increased incidence of certain factors which are known to increase the
bodies opioid sensitivity. This will be achieved by collecting, in the
North West region, 100 cases of Bell's palsy presenting to their general
practitioners and comparing them with an equal number of randomly sampled
controls matched for age, sex, social class and geographical area.
Fundamental Hypothesis
That Bell's palsy (idiopathic facial) is produced as a result of a neural
reactivation of herpes simplex virus persistent in the geniculate ganglion
This results in an activation of the interferon/opioid system resulting in
high, but localised, concentrations of these vasoactive substances. The
resultant vasodilation causes neuro-praxia to the facial nerve, and where
anatomical factors conspire to produce irreversible ischaemic changes in
the nerve.
This study is aimed at demonstrating the increased likeliness of this
reactivation and vascular 'toxic' effect in certain specific opioid
sensitive situations.
Incidence
The most frequently quoted figure for incidence of this condition in
Western Europe is 20/100,000 per year.
Logistics
1) The study will involve the collection of 100 cases of Bell's palsy
over the course of one year. This will involve drawing from a
population base of 500,000 patients.
2) To achieve this it will be necessary to recruit 250 general
practitioners in the region who are prepared to notify all their
cases of Bell's palsy to the researcher within this Department.
3) When the case has been notified the researcher will visit each
patient to fill in a questionnaire and take a small sample of
blood for viral antibody studies.
4) A further 100 patients will serve as matched controls and will
answer the appropriate questions in the same questionnaire.




Reply Slip to First Letter
Please TICK the appropriate boxes
I agree to notify Bell's palsy patients
during the next year
I do not agree to notify Bell's palsy
patients during the next year
I require stamped addressed envelopes
for the purpose of this notification
I do not require stamped addressed





PLEASE RETURN THIS FORM TO:-
Dr. E.I. Williams








THE DEPARTMENT OF GENERAL PRACTICE
RUSHOLME HEALTH CENTRE
WALMER STREET
MANCHESTER M1 4 5NP
PROFESSOR DAVID METCALFE TELEPHONE: 061-225 6699
March 1986
Dear Doctor,
This is a reminder about the Bell's palsy study.
Thank you for your continued interest and help. 253 general
practitioners in the Greater Manchester area are participating,
giving a population base of approximately half a million. So
far 50 cases of Bell's palsy have been admitted to the study
and preliminary analysis of the data shows interesting
epidemiological evidence, thus far consistent with a 'herpes
simplex reactivation model' as a cause. There is an apparent
increase in incidence in North Manchester regions, eg Middleton,
and the incidence in North Manchester as a whole appears to
be three or four times that of South Manchester. We are of
course very anxious to make sure that this is a real difference,
and not merely due to doctors forgetting to notify cases, so
as to obtain a true picture of the incidence in a defined
population during the study period.
Could you therefore complete and return the attached sheet
which will provide some further information for analysis.
If you have already reported a case of Bell's palsy to the
Department, thank you for doing so. Such cases will be
followed up at six months from the onset to allow other
possible (but unlikely) pathology to present itself, and to





Reply to Second Letter
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NAME OF PRACTITIONER Date_
1. My list size is
2. My FPC area is (eg Stockport, Rochdale, etc)
3. I have reported all new cases of Bell's palsy since j j j I
notification (June-August 1985)
Yes No
4. If NO, then:-
a) there have been cases but I cannot remember details
b) the patient did not wish referral u





Phone no Phone no
Approx onset Approx onset
5. I have reported a case which was on my partner's list LI U
Yes No
Name of partner
6. I will continue to report all new cases of Bell's palsy to the
Department (no patient has been seen against his/her wishes)










TELEPHONE: 061-225 6699 Ext
February 1987
Dear
I am extremely grateful for your co-operation in the Bell's Palsy
Study. The information collected should indeed be very valuable.
Before this information is processed on the computer however I would
be grateful if you could complete the following short questionnaire:
Has the face now fully recovered? (please tick)
1) Complete recovery
2) Incomplete recovery
If INCOMPLETE, is there:












Ian Williamson MB ChB MRCGP FRCS
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List of Participating G.P's
Names and addresses of 252 participating general practitioners.
* denotes a positive response to the reminder letter at 8 months.
The number of cases reported by each G.P. is also given.
Dr. H.W.K. Acheson Dr. M.J. Beard Dr. P.F. Brien
Department of General Practice Royton Health Centre 212 Eccles Old Road
Rusholme Health Centre. Rochdale Road Salford 6.
ROYTON * 1 case
Dr. V.P. Addis Oldham.
Whitefield Health Centre Dr. A.L. Brown
Bury New Road Dr. D. Jane Bell Rusholme Health Centre.
Whitefield 2 Bleak Hey Road * 2 cases
MANCHESTER M25 6GH. MANCHESTER M22 5ES.
* * Dr. S.M. Brown
Dr. I.J. Benett Capital Road Surgery
Dr. J. Agarwala Hulme House HIGHER OPENSHAW





Dr. D.G. Bennett Richmond Group Practice
Dr. M. Alam Clarendon House Crickets Lane Health Centre
Heaton Norris Health Centre HYDE ASHTON-UNDER-LYNE
Short Street Cheshire. Lanes.
STOCKPORT SK4 1SX. *
Dr. P.W. Bennett Dr. A. Cahill
Dr. S. Alam Clarendon House Cheadle Medical Practice
Mosley Health Centre Clarendon Street 1-3 Ashfield Crescent
Market Street HYDE CHEADLE
MOSSLEY. Cheshire. Cheshire.
Dr. A. Allan Dr. W.G. Bennett Dr. B.M. Caldwell
10 Broadgate Donneybrook House- Wellfield Surgery
Ladybridge Clarendon Street 291 Oldham Road
BOLTON. HYDE ROCHDALE.
Cheshire SK14 2AH. *
Dr. M. Allan .
Heaton Norris Health Centre Nr. N.C. Beriwal Dr. P. Callow,
Cheviot Close The Health Centre 2 Edward Street,
Stockport Market Place WERNETH
Cheshire. MOSSLEY Oldham
Lanes 0L5 OHE. Lanes.
Dr. J.A. Ambrose * k
379 Greenbrow Road
NEWALL GREEN Dr. J.M. Bernstein Dr. T.G.S. Cameron
Wythenshawe. The Surgery 15 Bridge Street
53-55 Crescent Road Heywood
Dr. R. Apte MANCHESTER M8 7JT. Lanes.
523 Liverpool Road *
Irlam Dr. Bhatt
MANCHESTER M30 6BH. The Surgery Dr. Capek
Simmondley 216 Wythenshawe Road,
Dr. 'W.D. Ashworth Glossop. Northern Moor
The Smithy k MANCHESTER M23 OPH.
4 Market Street Dr. D. Bora
HOLLINGWORTH Avondale Health Centre Dr. J. Cassidy




Craven Street, Dr. Borkin Dr. J.M. Chang
DROYLSDEN. Eccles Health Centre Shaw Heath Health Centre
ECCLES Gilmore Street
Dr. S. Bailey Manchester M30 OEQ. STOCKPORT.
The Surgery *
Block Lane Dr. P.J.L. Chapman
CHADDERTON Dr. Joyce Bourne Heald Green Health Centre
Oldham. Clarendon Surgery Finney Lane,
72 Denbigh Place HEALD GREEN
Dr. D. Barlow SALFORD M5 4BE. Cheadle.
2 Edward Street k
OLDHAM 0L9 7QW. Dr. C.Y. Cheong
Dr. M.C. Brady 12 Vernon Road
Dr. D.C. Bayman Springfield House Greenmount
The Health Centre 275 Huddersfield Road BURY.
Ashton Road West OLDHAM.












MANCHESTER Ml 5 5FR.
*
Dr. H.R. Chowdhury










































































































































































Astley Bridge Health Centre















































































































West Gorton Medical Centre
6a Wenlock Way


















































































































































































































































































































































































































































































































































Drs. Sandle, Flyn, Coates, Burt
Kay, Crowther and Kowk
Barlow Medical Centre




































Heaton Moor Health Centre

































































































































































Individual List Sizes for G.P's Replying at 8 Months






Total of list sizes = 361,111
77,850 total of shared list sizes given.
Bolton Bury Rochdale Salford Manchester Oldham Stockport Tames ic
1 ,700 2,459 2,470 400 ? ? 2,100 ?
2,100 3,200 2,000 2,000 3,050 1 2,900 2,850
2,000 2,700 2,500 2,600 1 ,822 1 ,500 2,600 2,950
2,340 6,800 930 4,000 2,000 2,800 2,400 1 ,500
6,000 2 2,500 2,000 2,175 3,400 3,160 2,500
3,000 2,200 3,220 3,000 3,500 3,000 2,300 2,400
3,900 5,100 1 ,440 1 ,200 2,400 1 ,000 1,060 1 ,900
2,400 200 750 3,500 2,800 3,400 1 2,600
13,000 1 ,000 600 1 ,400 2,300 1 ,126 500 2,800
1 ,840 3,200 2,600 1 ,500 2,500 3,121 3,100 2,500
2,900 4,200 2,802 3,800 780 2,936 2,800
2,200 2,500 4,550 1 ,600 1 2,700 2,800
1 2,200 3,500 1 900 2,100 2,792
2,500 4,000 2,200 7,900 635 2,100 1 ,800
2,600 1 ,086 3,000 1 ,500 1,300 2,800 3,490
2,500 3,800 1 ,375 7,500 3,500 2,300
7,000 200 1 ,200 2,500 1 ,700 2,800








57,080 49,047 51,687 36,400 62,512 41,183 41,202 22,000
J_8 J_7 23 _1_5 25 J! J! JO
Appendix 4a
Photographs of Cold Sores
(shown to patients)
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POST MORTEM DECLARATION FORM
Name of late patient Hosp. Record No
Ward Consultant
I do not object to a post mortem examination being carried out on the body
of and I am not aware that he/she would have objected or that
another surviving relative objects. I understand that this examination is carried out—
(a) To verify the cause of death and to study the effects of treatment
















































































































































































SUMMARY Thereisacertainhomologybetw enint rferoandopioi s.B thrkn wnc usskinre cti ns.Wmeas r d theflarreactionsonintrad rmali jectionofpurecombina tinte fero5p ti ntswithlaryng al papillomaandrepeatedth srdaylat rft rpretre tmentwi hn loxones ecif co io dt g nist. Naloxonedidn treducetheimmediatr actions,buappearedtreducethfail tre ctions8hoursf r injection3ofthe5pa i nts. MethodderivefromScottal.1980
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Appendix 4d - Cocultiyation Study - Data Sheet
NAME
CAUSE OF DEATH
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Scale 1 : 100,000
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